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Theory is when you know all and nothing works.  
Practice is when all works and nobody knows why.  
We have put together theory and practice:  
nothing works... and nobody knows why!  
 
Albert Einstein 
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ABSTRACT 
The monoclonal antibody market represents the fastest-growing segment within the 
biopharmaceutical industry (Evans and Das 2005). Indeed, recombinant antibodies and 
antibody fragments are widespread tools for research, diagnostics and therapy (Joosten 
et al., 2003). Large-scale production of recombinant antibodies and antibody fragments 
requires a suitable expression system which has to be cheap, accessible for genetic 
modifications, easily scaled up for greater demands and safe for use in consumer 
applications. However, the established eukaryotic systems are expensive, time 
consuming and sometimes inefficient (Farid, 2007). Although prokaryotic expression 
systems can reduce production costs, recombinant antibody production in conventional 
bacterial hosts, such as E. coli, often results in inclusion bodies formation (Baneyx and 
Mujacic 2004). Since the lowering of the expression temperature can increase product 
solubility facilitating its correct folding (Sahdev et al., 2008), a novel process for 
recombinant antibody fragments production at low temperatures was developed based 
on the use of the Antarctic Gram-negative bacterium P. haloplanktis TAC125 as 
recombinant expression host. To test the versatility of the new developed process, the 
production of three aggregation prone model proteins was evaluated corresponding to 
the most common formats of antibody fragments: Fab, ScFv and VHH. The construction 
of an ad hoc genetic expression system for each model protein followed a rational design 
where several critical aspects were considered including the selection of  molecular 
signals for  periplasmic protein addressing and the choice of optimal gene-expression 
strategy. For Fab fragment production in heterodimeric form an artificial operon was 
designed and constructed. Moreover, a new defined minimal medium was developed to 
maximise bacterial growth parameters and recombinant production yields. The 
production of model antibody fragments has been evaluated in lab-scale bioreactor and 
the effect of different cultivation operational strategies on production yields has been 
investigated. All model proteins were produced in soluble and biologically competent 
form in optimised conditions. About 5 mg L
-1
 of biologically active ScFv were obtained in 
P. haloplanktis TAC125 batch fermentation and up to 4 mg L
-1
 of soluble Fab in C-limited 
chemostat cultivation with a volumetric productivity of 0,2 mg L
-1 
h 
-1
. Moreover, a 
comparison of Fab fragment production by different microbial hosts including yeasts, 
filamentous fungi and bacteria was performed revealing that the psychrophilic expression 
system leads to the highest Fab specific productivity and best quality of recombinant 
product (Dragosit et al., submitted). In order to further optimise the novel process for 
recombinant production of biopharmaceuticals by the psychrophilic expression system, 
new genetic tools for recombinant gene expression and protein addressing in P. 
haloplanktis TAC125 were searched out and characterised. Transcriptional analysis of 
several target genes was performed in a cheap defined medium in the presence of 
inexpensive compounds of physical stimuli as inducers in order to identify new 
psychrophilic promoters for regulated expression of recombinant proteins at low 
temperatures. The analysis led to the identification of the gluconate permease 
PSHAb0479 and the alginate lyase PSHAa1748 promoters, strongly up-regulated by the 
presence of D-gluconic acid and alginic acid respectively. In order to improve 
extracellular secretion of recombinant proteins in psychrophilc expression system a deep 
investigation was performed on protein secretion machineries evolved by P. haloplanktis 
TAC125. Molecular characterisation of canonical T2SS was carried out and a deep study 
was performed on the still uncharacterised psychrophilic secretion system (PSS) 
responsible for the secretion of the recombinant alpha-amylase used as carrier for 
recombinant protein secretion in the psychrophilic bacterium. The function of pssA gene 
was related to the new secretion system. Data collected have provided important 
information which can be used for the construction of engineered P. haloplanktis TAC125 
strains with improved ability in recombinant proteins extracellular secretion.   
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RIASSUNTO 
 
Processi e prodotti innovativi per la produzione di farmaci ricombinanti per la 
terapia e la diagnostica molecolare 
 
Premesse scientifiche e metodologiche 
I recenti sviluppi nel campo della genetica molecolare e nella tecnologia del DNA 
ricombinante hanno dato  un forte contributo all’affermazione di proteine ricombinanti nel 
mercato dei biofarmaci. In particolare, oltre il 30% del mercato biofarmaceutico è 
attualmente occupato dagli anticorpi monoclonali (mAbs) (Evans and Das 2005). L’alta 
affinità e specificità di legame con l’antigene, infatti, fanno degli anticorpi monoclonali 
uno strumento molecolare di enorme valore applicativo. La recente disponibilità di 
frammenti anticorpali ricombinanti di ridotte dimensioni e ridotta complessità strutturale 
apre la strada a all’impiego di mAbs in numerose nuove applicazioni soprattutto in 
campo diagnostico e terapeutico (Joosten et al., 2003). L’impiego di mAbs e frammenti 
anticorpali ricombinanti in campo medico è però ad oggi limitato dall’alto costo della 
terapia. A causa del grande numero di pazienti e delle alte dosi richieste, sono necessari 
processi produttivi molto costosi per far fronte all’alta richiesta del mercato (Farid, 2007). 
L’impiego di anticorpi monoclonali ricombinanti su larga scala richiede dunque la 
disponibilità di un sistema di espressione adeguato che ne consenta la produzione in 
maniera rapida, efficiente ed economica. Il processo classico di produzione di mAbs 
prevede l’impiego di cellule di mammifero, in particolare cellule CHO ricombinanti, i cui 
costi di processo molto alti e rese contenute (1-2 mg/L) rendono il prezzo di mercato del 
prodotto finale molto poco competitivo (300-3000 USD/g) (Farid, 2007). Piante e animali 
transgenici mostrano rese più elevate e un sensibile abbattimento dei costi di produzione 
ma la bassa riproducibilità del processo e i potenziali rischi di contaminazione da parte di 
agenti infettivi limita l’utilizzo di questi sistemi (Ferrer-Miralles et al., 2009). L’impiego di 
sistemi di espressione procariotici può ridurre significativamente i costi di produzione di 
anticorpi monoclonali  grazie alla sensibile riduzione dei tempi del processo, la maggiore 
riproducibilità e la minore richiesta di nutrienti (Arbabi-Ghahroudi et al. 2005). Anche i 
sistemi di espressione procariotici convenzionalmente utilizzati per la produzione di 
proteine ricombinanti, primo tra tutti Escherichia coli, mostrano però delle limitazioni. 
Nonostante infatti sia spesso possibile ottenere alte concentrazioni di prodotto, 
altrettanto spesso esso si presenta sottoforma di aggregati proteici insolubili che 
prendono il nome di corpi di inclusione (Baneyx and Mujacic 2004). Nonostante siano 
molte le strategie messe a punto per limitare questo fenomeno, resta ancora da definire 
il sistema di espressione ideale per la produzione di frammenti anticorpali ricombinanti. 
Uno dei parametri che maggiormente influenza la resa di prodotto solubile è la 
temperatura di crescita dei batteri produttori (Sahdev et al., 2008). La diminuzione della 
temperatura infatti riduce il contributo entropico sfavorendo le interazioni idrofobiche che 
sono tra le cause principali della formazione dei corpi inclusi. Il recente sviluppo di 
sistemi di espressione innovativi che utilizzano batteri adattati al freddo rappresenta 
dunque una valida alternativa per la produzione su larga scala di frammenti anticorpali 
ricombinanti in forma solubile e biologicamente attiva. A tal proposito risulta 
particolarmente interessante il batterio psicrofilo Gram negativo Pseudoalteromonas 
haloplanktis TAC125. Questo batterio, per il quale sono già disponibili sistemi genetici 
per l’espressione e secrezione di proteine ricombinanti (Parrilli et al., 2008), è in grado di 
crescere in un ampio intervallo di temperature (4-28°C) e concentrazioni saline (0,5-45 
g/L NaCl) raggiungendo alte densità cellulari. Inoltre la disponibilità della sequenza del 
suo genoma (Medigue et al., 2005) rende P. haloplanktis TAC125 un possibile bersaglio 
per strategie di strain improvement.   
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Obiettivi 
L’obiettivo principale di questo progetto di ricerca è lo sviluppo e la messa a punto di un 
processo per la produzione di frammenti anticorpali ricombinanti nel batterio psicrofilo 
Pseudoalteromonas haloplanktis TAC125. L’efficienza del nuovo processo sarà valutata 
attraverso la produzione di tre proteine modello corrispondenti ai più comuni formati di 
anticorpi monoclonali, in particolare: 
-Fab (fragment antigen binding): nell’ambito del progetto europeo GENOPHYS il 
frammento Fab anti-idiotipo Ab2/2H5 Fab3H6 (Kunert et al., 2002) è stato scelto come 
proteina modello per l’analisi comparativa della produzione ricombinante di una proteina 
complessa in diversi organismi ospiti (lieviti, funghi filamentosi e batteri). Inoltre, il 
Fab3H6 è una molecola di grande interesse biofarmaceutico in quanto costituisce un 
elemento fondamentale nella formulazione di un vaccino contro un ampio spettro di 
ceppi del virus dell’immunodeficienza umana di tipo 1 (HIV-I) (Kunert et al., 2002). Il 
frammento Fab è un eterodimero di circa 50 kDa costituito da una catena leggera 
completa (CL + VL) legata mediante un ponte disolfurico ad un frammento della catena 
pesante che comprende il dominio variabile VH e il dominio costante CH1. 
-ScFv (Single chain variable Fragment): l’anticorpo a singola catena anti 2-fenil-5-
ossazolone ScFvOx (Fiedler and Conrad, 1995) è stato scelto come modello di questa 
classe di frammenti anticorpali in quanto si presenta come una proteina molto insolubile 
ed è utilizzata come modello per l’ottimizzazione di protocolli di refolding di corpi di 
inclusione (Patil et al., 2008). L’anticorpo a singola catena è un frammento contenente le 
sole regioni variabili della catena pesante e leggera di un anticorpo monoclonale legate 
da un linker flessibile in modo da  costituire un’unica catena polipeptidica di circa 30 kDa. 
-VHH (heavy chain antibody fragment): come modello per questa classe di frammenti 
anticopali che consiste nella sola regione variabile di anticorpi di camelidi caratterizzati 
dalla naturale mancanza della catena leggera, è stato scelto il VHH D6.1 diretto contro il 
fattore di crescita dei fibroblasti umano 1 (FGFR1). Questo anticorpo ricombinante è 
stato isolato da una library naive di lama (Monegal et al., 2009) ma la sua produzione su 
larga scala in E. coli è limitata a causa della formazione dei corpi di inclusione. Il 
frammento anticorpale VHH consiste di una singola catena polipeptidica di circa 15 kDa 
con un solo ponte disolfurico. 
Allo scopo di realizzare un efficiente sistema per la produzione di farmaci ricombinanti in 
forma solubile e biologicamente attiva nel nuovo sistema di espressione psicrofilo, altri 
obiettivi di questo lavoro saranno lo sviluppo  di nuovi prodotti per la produzione di 
proteine ricombinanti alle basse temperature. In primo luogo saranno identificati nuovi e 
più efficienti sistemi genetici (promotori regolati e costitutivi) per l’espressione 
ricombinante alle basse temperature. Inoltre sarà effettuato lo studio dei meccanismi di 
secrezione proteica extracellulare evoluti dal batterio psicrofilo al fine di ottimizzare i 
sistemi per l’espressione e secrezione di proteine ricombinanti a freddo.  
 
Risultati e discussione 
 
Parte 1. Nuovi processi per la produzione di frammenti anticorpali ricombinanti in 
P. haloplanktis TAC125 
Allestimento e validazione del sistema genetico di espressione: il primo passo 
necessario allo sviluppo di un processo per la produzione di frammenti anticorpali 
ricombinanti alle basse temperature è stato la messa a punto di opportune cassette di 
espressione utilizzando i sistemi genetici per l’espressione ricombinante a freddo già 
disponibili (Parrilli et al., 2008). In primo luogo, dal momento che per tutti i frammenti in 
esame la formazione di ponti disolfurici intramolecolari è necessaria per la corretta 
strutturazione dei domini immunoglobulinici e dunque per l’assunzione della struttura 
biologicamente attiva, si è reso necessario l’indirizzamento dei prodotti ricombinanti nello 
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spazio periplasmatico. Essendo disponibili due diversi peptidi segnale per la 
traslocazione periplasmatica, uno isolato dalla proteina periplasmatica endogena DsbA 
(Madonna et al., 2005) e l’altro dalla proteina psicrofila eterologa -amilasi da PhTAB23 
(Feller et al.,1998), la proteina modello ScFvOx è stata utilizzata per valutare l’efficienza 
di tali segnali nel promuoverne la secrezione nel periplasma. Il ScFvOx è stato scelto in 
quanto risulta avere una particolare tendenza ad aggregare se non messo in condizione 
di strutturarsi correttamente. Inoltre è stata valutata a possibilità di indirizzare il prodotto 
ricombinante nel mezzo extracellulare mediante la fusione con la proteina carrier -
amilasi, già dimostratasi in grado di promuovere la secrezione extracellulare di diverse 
proteine ricombinanti (Cusano et al., 2006). Il gene codificante l’anticorpo scFvOx è stato 
dunque fuso a valle delle due diverse sequenze segnale per la traslocazione 
periplasmatica e al gene codificante l’ -amilasi e posta sotto il controllo di un promotore 
costitutivo forte. L’analisi della localizzazione cellulare del prodotto ricombinante è stata 
condotta in terreno ricco attraverso esperimenti di Western blotting su estratti proteici 
citoplasmatici, periplasmatici e sul mezzo di coltura. L’analisi ha rivelato che il ScFvOx 
viene prodotto e correttamente traslocato nel compartimento periplasmatico solo quando 
fuso al peptide segnale isolato dalla DsbA. Non si osserva invece alcuna produzione 
quando la proteina è dotata del peptide segnale isolato dalla -amilasi. Inoltre, l’analisi 
della produzione del prodotto di fusione con la proteina carrier per la secrezione 
extracellulare ha rivelato un accumulo intracellulare e una conseguente degradazione 
proteolitica del prodotto ricombinante. Le ragioni di quanto osservato possono risiedere 
nel diverso meccanismo per la traslocazione periplasmatica guidato dai due diversi 
peptidi segnale. L’ -amilasi infatti viene traslocata nel periplasma attraverso il sistema 
post-traduzionale Sec (Wickner et al., 1996). Il peptide segnale della DsbA invece 
presenta caratteristiche comuni a proteine riconosciute dal sistema di traslocazione 
SRP-like che invece segue un meccanismo co-traduzionale (Schierle et al., 2003). 
Probabilmente, la cinetica di aggregazione del ScFvOx nel citoplasma è maggiore di 
quella di secrezione periplasmatica guidata dal sistema Sec da cui consegue l’accumulo 
e la degradazione proteolitica del prodotto nel citoplasma. L’utilizzo di un sistema di 
secrezione co-traduzionale impedisce invece alla proteina di strutturarsi prima di 
raggiungere il compartimento periplasmatico. Per questi motivi si è scelto di utilizzare lo 
stesso segnale molecolare, PsDsbA, per la traslocazione periplasmatica di tutti i 
frammenti anticorpali in esame. Inoltre tutti i prodotti ricombinanti sono stati dotati di tag 
C-terminali (6xHis tag e c-Myc tag) per l’immunorivelazione e la successiva purificazione. 
Per quanto riguarda il frammento Fab, la sua natura eterodimerica richiede che le due 
catene siano sintetizzate all’interno del batterio ospite in maniera stechiometrica. A 
questo scopo è stato costruito un operone sintetico capace di esprimere i geni codificanti 
la catena leggera e il frammento VH + CH1 della catena pesante in un unico trascritto 
bicistronico, in modo da realizzare il coupling traduzionale dei due geni. L’operone 
artificiale è stato disegnato in base all’analisi in silico dei cluster genici di PhTAC125, 
focalizzando l’attenzione sulle regioni di sovrapposizione tra geni potenzialmente in 
coupling traduzionale. La costruzione ha dunque previsto una sovrapposizione tra il 
codone di stop del gene a monte (LC) con l’atg del gene a valle (HC) e di conseguenza 
l’inserimento della sequenza Shine-Dalgarno (SD), necessaria alla traduzione della HC, 
all’interno del gene LC attraverso l’introduzione di una mutazione silente. Dal momento 
che la lunghezza, la composizione e la posizione della sequenza SD hanno effetti 
sull’efficienza di inizio della traduzione, si è scelto di utilizzare una sequenza identica a 
quella che garantisce la traduzione del primo gene ed alla medesima distanza dal 
codone di start. Allo scopo di validare l’operone artificiale costruito è stata condotta 
un’analisi della produzione costitutiva e della localizzazione cellulare del prodotto il 
terreno ricco. Attraverso esperimenti di RT-PCR è stata verificata la stabilità del trascritto 
in vivo mentre mediante esperimenti di immunorivelazione condotti con anticorpi in grado 
5 
 
di riconoscere selettivamente la catena pesante e leggera del Fab è stata verificata la 
produzione bilanciata delle due catene e la loro corretta localizzazione periplasmatica. 
Al fine di utilizzare i costrutti ottenuti per l’espressione ricombinante di ScFvOx, Fab 3H6 
e VHH D6.1 in bioreattore, essi sono stati infine posti sotto il controllo del promotore 
psicrofilo inducibile da L-malato (Papa et al., 2007) in quanto esso risulta essere il 
promotore più efficiente tra quelli disponibili nel promuovere la trascrizione in terreno 
minimo. 
Sviluppo di un nuovo terreno di coltura sintetico per la produzione di rAbs a freddo: al 
fine di massimizzare le rese di produzione dei costrutti ricombinanti realizzati, si è scelto 
di agire sulla composizione del mezzo di coltura. Inoltre, la disponibilità di un terreno 
minimo e definito, ottimale per la crescita del microrganismo ospite, rende possibile lo 
sviluppo di processi in chemostato. Dati pregressi hanno rivelato una preferenza da 
parte di PhTAC125 per substrati di natura peptidica o amminoacidica (Medigue et al., 
2005) e sono state ottenute buone rese di produzione di proteine ricombinanti, alla 
temperatura di 15°C, in terreno minimo contenente una base salina SCHATZ e 
casaminoacidi come fonte di carbonio (Papa et al., 2007). Per questi motivi si è scelto di 
valutare diversi terreni sintetici contenenti singoli amminoacidi come unica fonte di 
carbonio le cui quantità sono state bilanciate sulla composizione del terreno di 
riferimento. Dall’analisi preliminare sono stati selezionati quattro terreni contenenti 
rispettivamente gli amminoacidi L-alanina, L-aspartato, L-glutammato e L-leucina come 
fonte di carbonio. Su questi terreni sono state allestite delle colture cellulari in beuta di  
ceppi di PhTAC125 esprimenti una -galattosidasi psicrofila sotto il controllo dello stesso 
promotore, inducibile da L-malato, scelto per la produzione dei frammenti anticorpali. La 
scelta è ricaduta su questo ceppo in quanto la produzione dell’enzima psicrofilo permette 
di quantizzare più rapidamente la produzione ricombinante e avere così indicazioni 
importanti sull’efficienza del promotore nei terreni formulati. Dall’analisi dei dati ottenuti è 
emerso che la produzione della -galattosidasi  nel terreno contenente L-Leu risulta 
aumentata di circa 5 volte rispetto al riferimento (casaminoacidi). Le rese di produzione 
ottenute con gli altri terreni analizzati risultano invece poco soddisfacenti. L’analisi ha 
inoltre permesso di valutare e comparare alcuni parametri di crescita del microrganismo 
sui terreni formulati. In particolare è stata osservata una maggiore velocità specifica di 
crescita nei terreni contenenti L-Glu e L-Asp rispetto al riferimento. Dal momento che il 
terreno sintetico contenente L-Leu come unica fonte di carbonio ha mostrato le maggiori 
rese di biomassa e di prodotto ricombinante si è scelto di utilizzare tale substrato nella 
formulazione del terreno per l’allestimento della colture di PhTAC125 in bioreattore. In un 
fermentatore STR sono state allestite colture cellulari in terreni contenenti oltre che la 
sola L-Leu anche la stessa  in combinazione con gli amminoacidi con i quali è stata 
osservata una elevata velocità di crescita (L-Glu, L-Asp, L-Glu+L-Asp, L-Glu+L-Ala), alla 
temperatura di esercizio di 15°C. Ancora una volta è stata osservata una resa di prodotto 
ricombinante molto più elevata nel terreno contenente la sola L-Leu. La persistenza di 
una lunga fase di latenza e i lunghi tempi di duplicazione che caratterizzano la crescita 
del microrganismo rende però questo terreno inadeguato per un utilizzo in un processo 
industriale. Inoltre l’aumento della concentrazione di leucina nel mezzo di coltura causa 
un’inibizione della crescita del batterio psicrofilo. Dati di letteratura (Quay et al.,1977) 
hanno evidenziato in E. coli la dipendenza della velocità di uptake della L-Leu dalla 
presenza degli altri amminoacidi ramificati (L-Ile e L-Val) nel mezzo di coltura. È stato 
dunque formulato un nuovo terreno di coltura contenente i tre amminoacidi ramificati L-
Ile, L-Leu e L-Val (LIV) in un rapporto molare 1:1:2. In tale terreno è stato possibile 
osservare una drastica riduzione della fase di latenza della crescita cellulare e un 
aumento della velocità specifica di crescita a valori paragonabili a quelli ottenuti nel 
terreno di riferimento. Sono inoltre state condotte analisi del consumo dei substrati nel 
terreno di coltura per valutare la cinetica di consumo dei singoli componenti durante la 
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fase di crescita esponenziale e la loro concentrazione residua al termine della crescita. 
La curva del consumo dei substrati evidenzia che i tre amminoacidi sono consumati 
velocemente all’inizio della fase di crescita esponenziale mentre la concentrazione di 
acido L-malico resta pressoché invariata. Dopo 24 ore di crescita la velocità di consumo 
degli amminoacidi diminuisce sensibilmente mentre si ha un rapido consumo del malato 
la cui concentrazione si riduce a valori prossimi allo zero. Alla fine della fase di batch la 
concentrazione degli amminoacidi residua nel mezzo di coltura è ancora non 
trascurabile. Alla luce di quanto osservato, la insufficiente conversione dei substrati in 
biomassa (Yx/s=30%) potrebbe essere causata da uno squilibrio di nutrienti nel mezzo di 
coltura e potrebbe essere aumentata riformulando il brodo di coltura in base alla 
composizione elementare del microrganismo. È stata infine valutata la produzione di 
ammonio nel mezzo di coltura ed è stata osservata una cinetica di accumulo 
sovrapponibile a quella osservata per la curva di crescita. Questo dato concorda con 
l’osservazione di una forte tendenza del batterio a rendere più basico il pH del mezzo di 
crescita e potrebbe essere dovuto ad un eccesso di azoto nel terreno di coltura. Sulla 
base di quanto osservato, è stato inoltre allestito un processo per la crescita di 
PhTAC125 in continuo. Dopo una fase batch in terreno LIV è stato mantenuto lo steady 
state per 5 tempi di residenza addizionando L-Leu con una velocità di diluizione pari a 
0,05 h
-1
. 
Scale up del processo di produzione dei frammenti anticorpali in bireattore: la produzione 
del frammento anticorpale Fab3H6 è stata effettuata in primo luogo in modalità batch in 
un bioreattore STR nel terreno di crescita precedentemente ottimizzato e in presenza 
dell’induttore L-malato. L’analisi della produzione, effettuata mediante saggio ELISA su 
campioni prelevati a diversi tempi di crescita, ha rivelato una accumulo del Fab3H6 fino a 
una resa di circa 4 mg L
-1
. Attraverso esperimenti di Western blotting è stata inoltre 
dimostrata la completa traslocazione del prodotto ricombinante nel periplasma. 
Nell’ambito del progetto europeo GENOPHYS, inoltre, la produzione del frammento 
Fab3H6 è stata valutata in chemostato utilizzando terreno LIV sia per la fase di crescita 
in batch che per l’alimentazione. Nelle condizioni scelte è stato possibile stabilizzare una 
produttività volumetrica di Fab3H6 periplasmatico di circa 200 g L
-1
 h
1
. Inoltre 
dall’analisi comparativa della produzione del Fab3H6 in diversi microrganismi ospite è 
emerso che PhTAC125 mostra la più alta resa di prodotto per grammo di biomassa e 
rese di produzione paragonabili a quelle ottenute nel consolidato Pichia pastoris. Il 
processo di produzione del Fab3H6 in continuo è stato ulteriormente ottimizzato 
attraverso l’utilizzo della sola L-Leu nel terreno di feeding. Le rese di prodotto ottenute 
con il nuovo processo sono paragonabili a quelle in terreno LIV ma i costi di processo 
risultano sensibilmente ridotti.   
Il processo per la produzione del frammento anticorpale ricombinante ScFvOx è stato 
esercito in modalità batch nelle condizioni precedentemente descritte per il Fab3H6. 
L’analisi della produzione, effettuata attraverso esperimenti di ELISA su estratti cellulari 
solubili prelevati a diversi tempi di crescita, ha rivelato un accumulo del prodotto 
ricombinate con una resa di produzione massima in tarda fase esponenziale (48h) di 
circa 4,7 mg L
-1
. La verifica della corretta localizzazione cellulare è stata effettuata 
mediante SDS-PAGE su estratti periplasmatici, citoplasmatici e totali di aliquote di 
coltura cellulare prelevate dopo 48 ore di crescita. Dall’analisi è emerso che l’anticorpo 
ScFvOx è prodotto in forma solubile e correttamente localizzato nel periplasma nelle 
condizioni analizzate. Il prodotto ricombinante è stato dunque purificato su piccola scala 
mediante cromatografia di pseudo affinità sfruttando la coda di poli-istidine presenta 
all’estremità C-terminale del prodotto di interesse. È stata infine condotta un’analisi 
dell’attività biologica del prodotto ricombinante ottenuto mediante esperimenti di ELISA in 
presenza dell’aptene 2-fenil-ossazolone. L’analisi ha rivelato una resa di proteina pura e 
biologicamente attiva di circa 4 mg per litro di coltura. L’analisi della produzione del 
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frammento ScFvOx è stata effettuata inoltre in colture cellulari in continuo. La 
stabilizzazione del processo in continuo è stata ottenuta in terreno LIV con D=0,05
-1
 e la 
produttività volumetrica di ScFvOx osservata è stata pari a 230 g L
-1
 h
-1
.  
La produzione del frammento anticorpale VHH D6.1, infine, è stata effettuata in un 
processo in batch nelle condizioni già ottimizzate per gli altri frammenti. La verifica della 
produzione, effettuata attraverso esperimenti di immunorivelazione ha rivelato la 
presenza di una banda specifica di peso molecolare apparente di circa 30kDa, superiore 
alla massa attesa (≈15KDa), in corrispondenza degli estratti periplasmatici ottenuti da 
aliquote di coltura cellulare prelevati a diversi tempi di crescita. Il prodotto ottenuto è 
stato parzialmente purificato mediante cromatografia di pseudo affinità sfruttando la coda 
di poli-istidine presenta all’estremità C-terminale ma non è stato possibile effettuare un 
saggio di attività biologica in quanto il prodotto purificato è risultato poco stabile in 
soluzione.  
 
Parte 2. Nuovi prodotti per la produzione di farmaci ricombinanti in P. haloplanktis 
TAC125 
Identificazione di nuovi promotori regolati e costitutivi per l’espressione genica 
ricombinante in PhTAC125 
Allo scopo di migliorare l’efficienza del nuovo sistema di espressione a freddo e di 
rendere i processi di produzione di farmaci ricombinanti in PhTAC125 più competitivi in 
campo industriale si è scelto di sfruttare la conoscenza della sequenza del genoma del 
batterio psicrofilo per l’identificazione di nuovi e più efficienti sistemi per l’espressione 
regolata di geni ricombinanti. Il processo per la produzione di frammenti anticorpali 
ricombinanti precedentemente ottimizzato, basato sull’utilizzo del promotore indotto dalla 
presenza di L-malato nel mezzo di coltura, può risultare infatti economicamente 
vantaggioso solo se il prodotto presenta un elevato valore aggiunto, considerati l’alto 
costo dei substrati richiesti per massimizzare l’efficienza trascrizionale e quello 
dell’induttore stesso. Per questo motivo, mediante analisi in silico del genoma batterico, 
sono stati identificati alcuni promotori potenzialmente regolati e ne è stata valutata 
l’efficienza trascrizionale in vivo, in presenza ed in assenza di induzione, in un terreno di 
crescita minimo, molto economico, contenente L-glutammato come unica fonte di 
carbonio. In questo terreno infatti PhTAC125 mostra un’alta velocità specifica di crescita 
e una discreta resa in biomassa (Yx/s≥40%). In particolare, attraverso esperimenti di 
Real Time PCR, è stata valutata la variazione del numero di copie dei trascritti in esame 
nelle condizioni di induzione rispetto alla condizione standard (terreno con L-Glu, 
T=15°C). E’ stata dunque valutata la variazione del numero di copie dei seguenti 
trascritti: il gene galT appartenente all’operone del galattosio, in assenza e i presenza di 
galattosio; la CDS PSHAa1748 codificante una putativa alginato liasi, in presenza e in 
assenza di alginato; la CDS PSHAb0479 codificante una gluconato permeasi, in 
presenza e assenza di gluconato. Tutti i potenziali induttori sono stati addizionati al 
terreno standard a t=0 alla concentrazione di 4,0 g L
-1. E’ stata inoltre valutata la 
variazione dell’efficienza trascrizionale del promotore  del gene PSHAa2063 codificante il 
Trigger Factor (TF) alle temperature di 15°C e 4°C. Il TF è stato infatti precedentemente 
identificato, mediante analisi di proteomica differenziale, tra le proteine di PhTAC125 
sovraespresse a basse temperature. L’analisi ha rivelato un effetto di induzione solo da 
parte dell’alginato (circa 10 volte rispetto alle condizioni standard) e del gluconato (circa 
20 volte) sui rispettivi promotori che potranno dunque essere utilizzati per la costruzione 
di nuovi vettori per l’espressione regolata di geni ricombinanti a freddo. 
 
Studio dei sistemi di secrezione extracellulare nel batterio PhTAC125 
La comprensione dei meccanismi di secrezione sfruttati dal batterio antartico PhTAC125 
è un presupposto indispensabile per poter ottimizzare i processi di produzione di farmaci 
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ricombinanti a basse temperature. La collocazione extracellulare del prodotto di 
interesse consente infatti di agevolare notevolmente i processi di downstream data la 
minore concentrazione e complessità del contenuto proteico nel mezzo extracellulare. La 
recente disponibilità della sequenza completa del genoma di PhTAC125 ha facilitato lo 
studio della secrezione nel batterio antartico. Dall’analisi in silico del genoma è emerso 
che, nonostante il gran numero di proteine secrete dal batterio, PhTAC125 possiede solo 
uno dei sistemi di secrezione finora caratterizzati nei Gram negativi, il sistema di tipo II 
GSP (General Secretory Pathway). Attraverso la costruzione di un mutante genomico in 
cui il gene gspE, codificante l’ATPasi del sistema GSP, è stato inattivato, è stato 
dimostrato che il T2SS è responsabile della secrezione della maggior parte delle 
esoproteasi in PhTAC125. Il dato più interessante emerso da questo studio è che, 
nonostante l’unico sistema di secrezione del batterio risulti inattivato, il mutante 
PhTAC125 (gspE
-
) è ancora in grado di secernere proteine nel mezzo extracellulare 
indicando la presenza di almeno un altro sistema di secrezione, non ancora 
caratterizzato, evolutosi nel batterio psicrofilo. Inoltre, il sistema GSP non risulta essere 
in alcun modo responsabile della secrezione della -amilasi eterologa, utilizzata come 
carrier per la secrezione di proteine ricombinanti nel batterio psicrofilo (Parrilli et al., 
2008). Allo scopo di identificare il nuovo sistema di secrezione responsabile della 
localizzazione extracellulare dell’ -amilasi nel batterio psicrofilo, il sistema PSS 
(Psychrophilic Secretion System), è stata realizzata una strategia di complementazione 
che ha previsto la costruzione di una genoteca cosmidica di PhTAC125 e il suo 
trasferimento in cellule di E. coli ricombinanti in grado di produrre l’ -amilasi psicrofila ma 
non di secernerla nel mezzo di coltura. Tale strategia ha permesso di isolare un solo 
clone cosmidico, contenente una regione di circa 37Kb del cromosoma b di PhTAC125, 
in grado di conferire al batterio mesofilo la capacità di secernere l’ -amilasi nel mezzo 
extracellulare. Dall’analisi della sintenia della porzione genica di PhTAC125 contenuta 
nel cosmide selezionato con genomi di organismi ad esso vicini filogeneticamente è 
emerso che la regione comprendente le CDS dalla PSHAb0134 alla PSHAb0142 è molto 
conservata nei microrganismi selezionati tranne per la CDS PSHAb0140. Inoltre non è 
presente un omologo di tale gene in E. coli. Per comprendere il ruolo della funzione 
codificata dal gene PSHAb0140 nella secrezione dell’ -amilasi è stato costruito un 
mutante genomico di PhTAC125 in cui tale gene è stato deleto. Tale mutante non è in 
grado di secernere l’ -amilasi nel mezzo di coltura dimostrando che il prodotto della CDS 
PSHAb0140, d’ora in avanti chiamato PssA, è necessario per il corretto funzionamento 
del nuovo sistema di secrezione PSS. Dall’analisi in silico si evince che PssA è 
un’ipotetica lipoproteina costituita da un peptide leader caratteristico di questa famiglia di 
proteine che la colloca nello spazio periplasmatico ancorata alla membrana esterna, da 
tre domini TPR (Tetratricopeptide Reapeat Domain) presenti all’estremità N-terminale e 
da due domini LysM di legame al peptidoglicano all’estremità C-terminale. Queste 
caratteristiche insieme ai risultati sperimentali ottenuti suggeriscono per la proteina PssA 
un ruolo di adattatore molecolare incaricato di reclutare altri gli componenti cellulari 
necessari alla secrezione dell’ -amilasi e degli altri substrati del sistema PSS nel mezzo 
di coltura.  
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INTRODUCTION 
 
Monoclonal antibodies and antibody fragments as biopharmaceuticals 
According to recent reports, it is clear that recombinant antibodies have come of age 
as biopharmaceuticals. The global sales of monoclonal antibodies were $33 billion in 
2008 as compared to $27 billion in 2007 and total revenues are predicted to increase 
in the next years (Canadian Corporate News Report, 2008). 
Antibodies are glycoproteins which specifically recognise foreign molecules 
(antigens). IgG antibodies are large molecules of about 150 kDa composed of 4 
peptide chains. They contain two identical heavy chains of about 50 kDa and two 
identical light chains of about 25 kDa, thus tetrameric quaternary structure. The two 
heavy chains are linked to each other and to a light chain each by disulfide bonds. 
The resulting tetramer has two 
identical halves which together form 
the Y-like shape. Each end of the 
fork contains an identical antigen 
binding site (Fig. 1). The unique 
ability of antibodies to specifically 
recognise and bind with high affinity 
to virtually any type of antigen, 
made them interesting molecules 
for medical and scientific research. 
In 1975 Köhler and Milstein 
developed the monoclonal antibody 
technology  (Köhler  et al. 1975) by 
immortalising mouse cell lines that 
secreted only one single type of 
antibody with unique antigen 
specificity, called monoclonal 
antibodies (mAbs). With this 
technology, isolation and production 
of mAbs against protein, 
carbohydrate, nucleic acids and hapten antigens was achieved resulting in a rapid 
development of the use of antibodies in diagnostics, human therapeutics and as 
fundamental research tools. The development and applications of recombinant DNA 
technology led to the design of several formats of recombinant antibody fragments 
(Fig.2). Smaller recombinant antibody fragments (for example, classic monovalent 
antibody fragments (Fab, scFv) and engineered variants (diabodies, triabodies, 
minibodies and single-domain antibodies) retain the targeting specificity of whole 
mAbs  and possess other unique and superior properties for a range of diagnostic 
and therapeutic applications. Indeed, for some clinical applications small antibody 
fragments have advantages over whole antibodies. Firstly, the lack of Fc regions 
reduces the risks of immune response. Secondly, the small size permits them to 
penetrate tissues and solid tumours more rapidly than whole antibodies (Yokota et 
al., 1992). Furthermore smaller antibody fragments have a much faster clearance rate 
in the blood circulation, which leads to differences of selectivity (Yokota et al., 1992). 
By recombinant DNA technology, antibody fragments have been forged into 
multivalent and multispecific reagents and engineered for enhanced therapeutic 
efficacy. A new use of the binding capacity of antibody fragments is the design of a 
fusion approach, in which an antigen recognising antibody fragment is coupled to a 
Figure 1: Structural regions of an antibody molecule. Lehninger, 
Principles of Biochemistry Fifth Edition. Figure 5.21a. © 2008 W.H. 
Freeman and Company 
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range of effector molecules (Fig.3) including enzymes for prodrug therapy, toxins for 
cancer treatment (Schrama et al., 2006), viruses for gene therapy, cationic tails for 
DNA delivery, liposomes for improved drug delivery and biosensors for real-time 
detection of target molecules (Spooner et al., 1994).  The use of bi-functional 
antibodies in medicine is aimed at delivery of an effecter which is only active where it 
is required. It thereby limits the dose of the drug, resulting in less side effects of the 
drug towards healthy tissue and/or less immunogenic response to the drug itself. 
Also the physical interaction between the target and the effector molecule increases 
the potency of the effecter.  
More applications outside research and medicine can be considered, such as 
consumer applications. Single-domain antibodies are anticipated to significantly 
expand the repertoire of antibody-based reagents against the vast range of novel 
biomarkers being discovered 
through proteomics. 
Examples are the use in 
biosensors, treatment of 
wastewater (Graham et al., 
1995), industrial scale 
separation processes such 
as separation of chiral 
molecules (Got et al., 1997), 
purification of specific 
components like proteins 
from biological materials or 
the use as abzymes (Wade 
et al., 1997). They have also 
been considered as 
components of novel 
consumer goods with new 
improved functionalities like 
the use of antibodies in shampoos to prevent the formation of dandruff or in 
toothpaste to protect against tooth decay caused by caries (Frenken et al., 1998). 
Antibody therapeutics are already a multi-billion dollar a year market and a large 
number of monoclonal antibodies and antibody fragments are at various stages of 
clinical trials (Evans and Das 2005). However, they are amongst the most expensive 
of all drugs where the annual cost per patient can reach $35,000 for treating cancer 
Figure 2: Antibody fragments overview (taken from Hollinger & Hudson, 2005) 
Figure 3: Multispecific antibody fragments (Schrama et al., 2006).  
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(Farid, 2007). Indeed  antibody therapies involve most often high doses (>1 g per 
patient per year) for a large number of patients and this comes up to a total 
production demand in the range of multi-tons per year (Farid, 2007). Consequently, 
expensive large-scale production capacity is required to fulfill market demand. 
 
Industrial production of monoclonal antibodies 
To be able to use monoclonal antibodies, antibody fragments and antibody fusion 
proteins in  large scale applications, a suitable expression system has to be chosen. 
The possibility of large-scale production of antibodies and fragments requires that the 
production system is cheap, accessible for genetic modifications, easily scaled up for 
greater demands and safe for use in consumer applications. Several expression 
systems are available, both from eukaryotic (Table 1) and prokaryotic (Table 2) 
origin. 
Eukaryotic expression systems 
Several eukaryotic systems can be envisaged for large-scale production of 
monoclonal antibodies and fragments like mammalian cells, insect cells, plants, 
transgenic animals and lower eukaryotes. Most of the approved monoclonal 
antibodies are manufactured in mammalian cells. The majority of them use batch/fed 
batch cultures followed by purification steps that rely primarily on chromatography 
with intermediate filtration and viral clearance operations. However, large-scale 
production is expensive and time-consuming (Farid, 2007). Cultured insect cells are 
used as hosts for recombinant baculovirus infections. The production of a 
recombinant viral vector for gene expression is time-consuming, the cell growth is 
slow when compared with former expression systems, the cost of growth medium is 
high and each protein batch preparation has to be obtained from fresh cells since 
viral infection is lethal. (Ferrer-Miralles 2009). Plants show several advantages as 
large-scale antibody production systems, like the ease and low costs of growing 
plants, even in large quantities. However, the generation of transgenic plants that 
express antibodies is a time consuming process and the downstream processing to 
isolate the recombinant antibodies from the plant parts is relatively expensive and 
laborious (Joosten et al., 2003). An attractive possibility for the cost-effective large-
scale production of antibody fragments and antibody fusion proteins are yeast or 
fungal fermentations. Large-scale fermentation of these organisms is an established 
+++ = excellent, ++ = good, + = sufficient, +/- = poor. * With transgenic animals in this context is mentioned the production 
of antibodies or antibody fragments in the milk of transgenic animals, for example rabbits, sheep, goats or cows 
1 
With 
economical feasibility is mentioned the time and cost of molecular cloning, upscaling and downstream processing 
(purification). 
2 
Pathogenic contaminants like viruses or pyrogens. Modified from: Joosten et al. 2003 
Table 1 
Eukaryotic expression systems for heterologous protein production and possible advantages 
and disadvantages of the expression system. 
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technology already used for bulk production of several other recombinant proteins 
and extensive knowledge is available on downstream processes. Besides that, 
yeasts and filamentous fungi are accessible for genetic modifications and the protein 
of interest may be secreted into the culture medium. The main pitfall of this 
expression system is related to N-linked glycosylation patterns which differ from 
higher eukaryotes, in which sugar side chains of high mannose content affect the 
serum half-life and immunogenicity of the final product (Ferrer-Mirales et al., 2009). 
Furthermore, although less studied than in bacteria, the production of recombinant 
proteins in yeasts also triggers conformational stress responses and produced 
proteins fail sometimes to reach their native conformation (Gasser et al., 2008). 
Prokaryotic expression systems 
Bacterial expression systems have also been investigated for their potential to 
produce mAbs and different mAb fragments. While many bacterial strains, either 
Gram positive and Gram negative, have been tested for recombinant antibodies 
production with different extents (Tab.2), most experience has been gathered with 
Escherichia coli (Ferrer-Mirales et al., 2009). Incentives for the use of E. coli 
expression systems include simple fermentation conditions, ease of genetic 
manipulation, ease of scale-up, relatively short duration between transformation and 
protein purification, no concerns about viruses that are harmful to humans and 
relatively low capital costs for fermentation (Arbabi-Ghahroudi et al. 2005). However, 
several obstacles to the production of quality proteins limit its application as a factory 
for recombinant pharmaceuticals. Indeed, heterologous proteins over-expression in 
E. coli often results in insoluble aggregates production as cytoplasmic or periplasmic 
inclusion bodies (Baneyx and Mujacic 2004). Inclusion body (IB) proteins need 
elaborate and cost-intensive solubilisation, refolding and purification procedures to 
recover functionally active product (Vallejo et al., 2004). Hence, the final yield of 
fragments is only a small percentage of the protein that was initially present in the 
inclusion bodies and this causes a huge increase of process costs. In order to face 
the challenge to achieve a finer balance between the quality and the yield of 
recombinant proteins many strategies have been explored including expression of 
chimerical proteins (Park et al., 2008) and co-expression with chaperones (Kolaj et 
al., 2009). Expression of “difficult” proteins has also been carried out by lowering the 
temperature at the physiological limit allowed for the growth of mesophilic host 
organism (between 15 and 18°C). Lowering the temperature, in fact, has a pleiotropic 
effect on the folding process, destabilizing the hydrophobic interactions needed for 
intermediates aggregation (Sahdev et al., 2008). Although in some cases this 
approach has been reported to increase yields of soluble and active recombinant 
protein products, the major drawback in E. coli cultivation at sub-optimal 
temperatures is the decrease in biomass production which reduces the global 
process productivity. Therefore the exploitation of an industrial process performed in 
this conditions might hardly be considered. A rational alternative to improve the 
quality or recombinant products is to explore the potential of naturally cold-adapted 
bacteria as hosts for protein production at low temperature (even at around 0°C). In 
this context, a few cold adapted species are under early but intense exploration as 
cold cell factories, among them, Pseudoalteromonas haloplanktis being a 
representative example. The development of a cold expression system for 
recombinant proteins production in P. haloplanktis TAC125 was already described 
(Parrilli et al., 2008) and examples of  fully soluble and biologically competent 
production of  several thermal-labile and aggregation-prone proteins were extensively 
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reported (Vigentini et al., 2006; Papa et al., 2007). Furthermore, with respect to E. 
coli, P. haloplanktis TAC125 is extremely efficient in secreting proteins in the culture 
medium. By the use of a psychrophilic α-amylase as secretion carrier for the extra-
cellular targeting of recombinant proteins an efficient gene-expression system was 
set up (Cusano et al., 2006b). Observed efficiency of the cold-adapted system 
(secretion yield was always above 80%) placed it amongst the best heterologous 
secretion systems in Gram-negative bacteria reported so far. 
Therefore, the use of psychrophilic bacteria as alternative expression hosts is the 
compelling choice towards the exploitation of industrial processes for the production 
of soluble and biologically competent recombinant antibody fragments at low 
temperatures. 
 
Table 2 
Antibody fragments production in prokaryotic expression systems 
*ND = not determined. Modified from: Joosten et al., 2003  
 
The psychrophilic host: Pseudoalteromonas haloplanktis TAC125  
P. haloplanktis TAC125 is a Gram-negative bacterium isolated from an Antarctic 
coastal seawater sample collected in the vicinity of the French Antarctic station 
Dumont D’Urville, Terre Adélie. It can be classified as a Eurypsychrophile (i.e. a 
bacterium growing in a wide range of low temperatures; Atlas and Bartha, 1993) and 
was the first Antarctic Gram-negative bacterium of which the genome was fully 
sequenced and carefully annotated (Médigue et al., 2005). Genomic and metabolic 
features of this bacterium, accounting for its remarkable versatility and fast growth 
compared with other bacteria from aqueous environments, were discovered by 
combining genome sequencing and further in silico and in vivo analyses. P. 
haloplanktis TAC125 is able to duplicate in a wide range of temperatures (0-30°C), 
with an apparent optimal growth temperature a t 20°C, where the observed 
duplication time in rich medium is 31 minutes (Tutino et al., 1999). However, the 
bacterium still duplicates at fast speed even at lower temperatures (at 4°C, one cell 
division is completed in about 100 min; unpublished results from this laboratory) and, 
when provided with sufficient nutrients and aeration, it grows to very high density (up 
to A600=20) under laboratory settings, even at 0°C. This growth performance makes it 
one of the faster growing psychrophiles characterised so far. Fast growth rates, 
combined with the ability of P. haloplanktis TAC125 to reach very high cell densities 
even under laboratory growth conditions and to be easily transformed by intergeneric 
conjugation (Duilio et al., 2004), made this bacterium an attractive host for the 
development of an efficient gene expression system at low temperatures. 
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The psychrophilic expression system 
 
The psychrophilic expression vector 
A few other reported examples of recombinant protein production in psychrophiles 
made use of molecular signals (such as the origin of replication and the 
transcriptional promoter) derived from mesophiles. A different philosophy inspired the 
construction of our gene-expression systems, which derived from the proper 
assembly of true psychrophilic molecular signals into a modified E. coli cloning 
vector. By combining mesophilic and psychrophilic genetic signals a collection of 
gene-expression vectors was 
set up to produce recombinant 
proteins in P. haloplanktis 
TAC125 (Fig. 4). The 
mesophilic signals consist of 
the pUC18-derived origin of 
replication (OriC) and a 
selection marker gene (a -
lactamase encoding gene), 
allowing the plasmid to replicate 
either in E. coli or in the 
psychrophilic host. Another 
crucial mesophilic signal is 
represented by the OriT 
sequence, the conjugational  
DNA transfer origin from the 
broad host range plasmid pJB3 (Blatny at al., 1997). Structural and functional studies 
led to the isolation of the psychrophilic origin of replication (OriR) from the P. 
haloplanktis TAC125 endogenous plasmid pMtBL (Tutino et al., 2001). 
 
Psychrophilic promoters 
○ Constitutive expression 
The structural/functional characterisation of P. haloplanktis TAC125 promoters was 
carried out by random cloning of genomic DNA fragments and identification of 
promoter sequences by evaluating their capability to express a promoter-less 
reporter gene (Duilio et al., 2004). By this promoter-trap strategy, a collection of 
constitutive psychrophilic promoters showing different strengths at different 
temperatures was identified. The implementation of the above described 
psychrophilic promoters in the pMtBL-derived shuttle vectors resulted in the set up of 
cold-adapted gene-expression systems, characterised by the constitutive production 
of the recombinant protein. 
○ Regulated expression 
Sometimes efficient production can only be achieved by fine tuning the recombinant 
gene expression. This goal can be reached by using regulated promoters and 
efficient induction strategies. Recently, by using a differential proteomic approach, 
the isolation and characterisation of a two-component system has been carried out. 
This regulatory system is responsible for the transcriptional regulation of the gene 
coding for an outer protein porine, and it is strongly induced by the presence of L-
malate in the medium (Papa et al., 2006). The regulative region of the porine gene 
Figure 4: The psychrophilic expression vector 
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was used for the construction of an inducible cold expression vector, where the 
recombinant protein expression is under L-malate control (Papa et al., 2007).  
  
Molecular signals for protein addressing  
○ Periplasmic secretion 
Although the production of recombinant protein in the host cytoplasm is the preferred 
strategy many processes due to higher production yields, this approach cannot be 
pursued when the wanted product requires the correct formation of disulphide bonds 
to attain its catalytic competent conformation. Indeed as for all Gram-negative 
bacteria, P. haloplanktis TAC125 cytoplasm is a reducing environment and the 
formation of disulphide bridges is confined in the periplasmic space. From the 
genome analysis, we know that P. haloplanktis TAC125 contains all the canonical 
periplasmic export machineries (Medigue et al., 2005). Therefore, gene fragments 
encoding two signal peptides from psychrophilic secreted proteins following different 
translocation mechanisms have been cloned in the psychrophilic expression vectors, 
under the control of different promoters in order to allow the signal peptides N-
terminal fusion for periplasmic addressing of recombinant proteins.  
○ Extra-cellular secretion 
In order to combine the effects of low temperatures on the recombinant product 
solubility with the advantages linked to extra-cellular protein targeting, a gene 
expression system for the production and extra-cellular secretion of recombinant 
proteins in psychrophilic bacteria was set up. The novel system makes use of the 
psychrophilic -amylase from P. haloplanktis TAB23 (Feller et al., 1992) as a 
secretion carrier.  This exo-protein is produced and secreted as a larger precursor 
with a long C-terminal pro-peptide that is not mandatory for the -amylase secretion 
when it is produced by recombinant cold-adapted bacteria the propeptide (Tutino et 
al., 2002; Cusano et al., 2006a). Starting from the latter observation, the secretion of 
chimeric proteins obtained by the replacement of -amylase C-terminal propeptide 
with a passenger protein was studied (Cusano et al., 2006b). The novel genetic 
system  (Fig. 5) allows the easy in-frame cloning of any gene downstream of the 
mature psychrophilic -amylase 
encoding region. The spacer between 
the carrier and passenger proteins 
contains the motif -Ala-Ser-Ser-Thr- 
recognised and cleaved by a P. 
haloplanktis TAC125 secreted protease 
that allows the separation of the protein 
of interest from the secretion carrier 
when it reaches the extra-cellular 
medium. 
 
 
 
 
 
 
 
 
 
Figure 5: Schematic representation of recombinant proteins 
fusion to the secretion carrier 
SP    mature -amylase    passenger protein 
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Aim of the study 
The aim of this study is the development of novel processes, involving P. haloplanktis 
TAC125 as expression host, for large scale production of recombinant antibody 
fragments in soluble and biologically competent form and new products for 
recombinant production of biopharmaceuticals at low temperatures. 
 
New processes 
Based on the previously described genetic tools for recombinant protein production 
and cellular addressing in P. haloplanktis TAC125, an ad hoc expression system for 
recombinant antibody fragments soluble production will be constructed and validated. 
By a rational approach, a new defined medium will be developed in order to 
maximise the expression system efficiency and biomass productivity. 
Antibody fragments production processes will be scaled up to lab scale bioreactors 
and  tested in batch and continuous fermentation modes.  
To test the versatility of the psychrophilic expression system three different formats of 
recombinant antibody fragments will be considered: 
Fab (fragment antigen binding) 
Fab fragments (fragment antigen binding) are the antigen binding domains of an 
antibody molecule, containing the light chain (CL + VL) and the portion VH + CH1 of 
antibody heavy chain (Fig.5). Besides the four intramolecular disulfide bounds, one in 
each immunoglobulin domains, an additional interchain disulfide bridge  is present 
between CL and CH1. Due to the heterodimeric structure, Fab fragments are quite 
difficult to produce in biologically active form in microbial expression systems. 
Indeed, the correct assembly of recombinant light and heavy chain in functional Fab 
fragments can only be achieved if the two subunits are synthesized by the host cell in 
stoichiometric ratio. Unbalanced production can  lead to formation of soluble 
homodimers  (Hotta et al., 2004), very difficult to separate from the desired product 
without an antigen-affinity purification, or misfolded insoluble aggregates (Wu et al., 
1998). Therapeutic Fab fragments are mostly produced in mammalian expression 
systems or in yeasts while just a few examples are reported of Fab expression in 
bacteria (Peterson et al., 2006). 
 
Figure 5: Schematic representation of the structure of a conventional IgG and fragments that can be generated thereof 
and used in this work. The constant heavy-chain domains CH1, CH2 and CH3 are shown in yellow, the constant light-chain 
domain (CL) in green and the variable heavy-chain (VH) or light-chain (VL) domains in red and orange, respectively.                                   
Modified from Joosten et al., 2003 
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In the framework of the European project 
GENOPHYS the anti-idiotypic antibody 
Ab2/2H5 Fab 3H6 fragment (Fig. 6) was 
chosen as a protein model for genome-wide 
comparison of physiological bottlenecks in 
multi-subunit protein production in prokaryotic 
and eukaryotic microbial hosts.  
The mAb 2F5 is one of the very few antibodies 
with the ability to neutralize a wide spectrum of 
type 1 human immunodeficiency virus (HIV-1) 
strains and primary isolates. However, 
neutralizing 2F5 like antibodies are rarely 
detected in patients sera. The anti-idiotypic 
antibody Ab2/3H6 Fab is able to recognize the 
paratope of mAb 2H5 bearing a structural 
miming of ELDKWA , the core epitope of gp-
41, which is only exposed during the fusion of 
the virus to cells. It can therefore provide the means to induce a broadly neutralizing 
anti HIV-1 antibody response and could represent a key component in anti HIV 
vaccines formulation (Kunert et al., 2002). 
The Ab2/2H5 Fab 3H6 represents an interesting model of complex therapeutic 
protein to validate the new developed processes for recombinant biopharmaceuticals 
production by the psychrophilic expression system. Furthermore, in the framework of 
GENOPHYS European project, a comparison of Fab 3H6 production in different 
microbial hosts (bacteria, yeasts and filamentous fungi) will be performed  in 
chemostat cultivations. 
 
ScFv (Single chain variable Fragment) 
ScFv (Single chain variable Fragment) is the minimal fragment (~30 kDa) that still 
contains the whole antigen-binding site of a IgG antibody, composed of both the 
variable heavy chain (VH) and variable light chain (VL) joined by a hydrophilic and 
flexible linker peptide (Fig.4). The length of the linker (15–25 amino acids) is 
determinant for protein stability (Bird et al., 
1988). Single chain antibodies contain two 
immunoglobulinic domains each with one 
disulfide bond. ScFvs have the tendency to 
form aggregates especially when over-
produced in E. coli expression system (Baneyx 
and Mujacic 2004). To test the ability of 
psychrophilic expression system in 
recombinant biopharmaceuticals production in 
soluble form, the anti-2-phenyl-5-oxazolone 
single chain variable fragment (ScFvOx) was 
chosen as model (Fiedler and Conrad, 1995). 
ScFvOx (Fig. 7) is a typical example of 
aggregation-prone ScFv and it has been used 
for years as model for IB refolding protocol 
development (Patil et al., 2008).  
 
 
Figure 6: Crystal structure of the 2F5 Fab'-3H6 Fab 
complex. S.Bryson et al. 2008)  
Figure 7: Crystal structure of scFvOx in complex 
with its ligand (Scotti et al., 2006) 
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VHH (heavy chain antibody fragment) 
In 1993 Hamers-Casterman et al. discovered a novel class of IgG antibodies in 
Camelidae (camels, dromedaries and llamas). These antibodies are devoid of light 
chains and therefore called 'heavy-chain antibody” or HCAb (Fig. 8). HCAbs have a 
molecular weight of ~95 kDa instead of the ~150 kDa for conventional IgG 
antibodies. Their binding domains consist only of the heavy-chain variable domains, 
referred to as VHHs (Muyldermans et al., 1999) to distinguish it from conventional 
VHs. VHH is the smallest available intact antigen-binding fragment (~15 kDa) and it 
has a great potential in therapeutic and diagnostic application as multispecific fusion 
product (Joosten et al., 2003).  
To validate the new optimised process 
for recombinant antibody fragments 
production at low temperatures, it will 
be also tested for VHH format 
production.  
An anti- human fibroblast growth factor 
receptor 1 (FGFR1) VHH D6.1 was 
chosen as model protein. It has been 
selected by phage display from a pre-
immune llama library (Monegal et al., 
2009) but its large scale production in 
conventional E. coli expression systems 
was unsatisfactory due to inclusion 
bodies formation (De Marco A., 
personal communication). A new 
production process leading to improve 
soluble production of VHH D6.1 is 
therefore required for its further 
characterization. 
 
 
New products 
In order to further optimise the novel processes for recombinant production of 
biopharmaceuticals by the psychrophilic expression system, new genetic tools for 
recombinant gene expression and protein addressing in P. haloplanktis TAC125 will 
be searched out and characterised.  
By in silico analysis of P. haloplanktis TAC125 genome several potentially regulated 
promoters will be identified and their transcriptional efficiency will be tested in 
minimal defined media in different conditions. The analysis will lead to the 
construction new expression vectors for regulated expression of recombinant 
proteins at low temperatures.  
In order to improve extracellular secretion of recombinant proteins in psychrophilc 
expression system and to identify new molecular signals for recombinant proteins 
addressing in culture medium,  a deep investigation will be performed on protein 
secretion machineries evolved by P. haloplanktis TAC125. Molecular characterisation 
of canonical type II secretion system (T2SS) GSP (General Secretory Pathway) will 
be carried out and a deep study will be performed on the still uncharacterised 
psychrophilic secretion system (PSS) responsible for the secretion of the 
recombinant alpha-amylase used as carrier for recombinant protein secretion.   
 
Figure 8 : Schematic representation of a heavy-chain IgG 
antibody and the variable heavy-chain antibody fragment (VHH) 
that can be generated of the latter. The constant heavy-chain 
domains CH1, CH2 and CH3 are shown in yellow, the constant 
light-chain domain (CL) in green and the variable heavy-chain 
(VH or VHH) or light-chain (VL) domains in red and orange, 
respectively. Modified from Joosten et al., 2003) 
19 
 
RESULTS AND DISCUSSION 
 
Part I: New Processes 
Section 1: Antibody fragments expression vector design and validation 
The first step for antibody fragments production in P. haloplanktis TAC125 was the 
construction of a suitable expression vector based on the available genetic tools for 
recombinant gene expression at low temperatures. The construction of an ad hoc 
genetic expression system for each model protein followed a rational design where 
several critical aspects were considered including the selection of  molecular signals 
for  recombinant products cellular addressing, the choice of optimal gene-expression 
strategy and the addition of molecular tags for subsequent protein immunodetection 
and purification. 
Choice of molecular signals for antibody fragments secretion 
Antibody fragments, as well as all antibody molecules, contain disulfide bonds in their 
tertiary structure each in every immunoglobulin domain. Moreover, Fab fragments 
contain an additional disulfide bridge which joins together light and heavy chains thus 
forming heterodimeric quaternary structure. To achieve soluble and biologically 
competent production of recombinant antibody fragments in P. haloplanktis TAC125 
a useful option is to address the recombinant proteins into the periplasmic 
compartment where the oxidising environment and the enzymatic repertoire facilitate 
disulfide bonds formation.  
Two different psychrophilic signal peptides were tested far for periplasmic secretion 
of recombinant proteins in P. haloplanktis TAC125: one (PsA) isolated from a 
psychrophilic P. haloplanktis TAB23 -amilase and the other (PsD) from the 
endogenous periplasmic protein DsbA (Disulfide bond  oxidoreductase I). In order to 
assess the ability of the available signal peptides to promote recombinant antibody 
fragments translocation across bacterial inner membrane, the sequences encoding 
the two different leader peptides were fused to the scFvOx gene. The protein 
ScFvOx was chosen because it shows the highest tendency to aggregate in non-
native conditions and therefore represents a valid model to test the secretion 
systems efficiency. The PCR amplified gene was cloned into the cold adapted 
periplasmic gene expression vectors pPM13psA and pPM13psD respectively 
(unpublished results) under the control of a strong constitutive psychrophilic promoter 
(Duilio et al., 2004). The resulting fusion proteins, PsA-ScFvOx and PsD-ScFvOx, 
both contained the c-Myc tag at their C-terminal end to allow the product 
immunodetection. In addition, extracellular secretion of recombinant ScFvOx was 
evaluated by a fusion approach involving the psychrophilic -amylase as secretion 
carrier (Cusano et al., 2006b). Hence, the scFvOx gene was cloned into pFFamy* 
vector for constitutive expression of -amylase-passenger protein chimeras.  
Recombinant P. haloplanktis TAC125 strains were grown in rich medium at 15°C in 
shaken flasks. Protein patterns of  the soluble cell extracts were analysed by SDS-
PAGE  to evaluate the production of the ScFvOx by the psychrophilic expression 
host. Interestingly, the analysis revealed that no ScFvOx production is obtained when 
its periplasmic translocation is driven by the -amylase signal peptide PsA (data not 
shown). On the contrary, the periplasmic protein PsD-ScFvOx was produced in 
soluble form by P. haloplanktis TAC125 recombinant cells (Fig. 9A).                            
Cellular localisation of recombinant ScFvOx was verified by cellular fractionation 
(cytoplasm and periplasm). The periplasmic extraction efficiency was evaluated 
looking at the distribution of the periplasmic alkaline phosphatase activity between 
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cytoplasmic and periplasmic fractions. 98% of total alkaline phosphatase was found 
in periplasmic fraction. Total cellular soluble extracts and corresponding periplasmic 
and cytoplasmic fractions of the recombinant and wild type P. haloplanktis TAC125 
strains were analysed by Western blotting using specific anti c-Myc monoclonal 
antibodies. As shown  in figure 9 panel B, a specific signal is present in total extract 
of recombinant cells showing an apparent molecular weight corresponding to the 
expected one for recombinant ScFvOx-c-Myc fusion protein (~35kDa). The same 
specific signal is present in the recombinant periplasmic fraction and completely 
absent in the corresponding cytoplasm indicating that PsD-ScFvOx-c-Myc protein is 
not only successfully produced in soluble form but also totally translocated in the 
bacterial periplasmic space.   
The analysis of  -amylase-ScFvOx  chimera cellular localisation was performed on 
cytoplasmic soluble protein extracts, periplasmic proteic fraction and extracellular 
medium by Western blotting experiments using specific polyclonal anti -amylase 
antibodies (Fig. 9C). Surprisingly, the analysis revealed specific signals, probably 
corresponding to proteolysis products, only in cytoplasmic fraction, indicating that the  
chimera is not able to reach the extracellular medium neither the periplasmic space 
but totally accumulates into bacterial cytoplasm.  
Due to the observed results, the correct ScFvOx translocation across the inner 
membrane seems to occur only when the PsD signal peptide is used as secretion 
leader. Either if fused to the carrier protein -amylase or to its signal peptide PsA 
alone, the recombinant antibody fragment accumulates into bacterial cytoplasm 
where it cannot fold properly and it is subjected to proteolytic degradation which 
results in complete degradation in the case of PsA-ScFvOx.  
This can be due to the different translocation mechanism driven by the two tested 
signal peptides. The PsA leader peptide is a canonical molecular determinant 
Mk   A    B    C   NC 
119 kDa 
79 kDa 
47 kDa 
33 kDa 
25 kDa 
 T       P      C     NC 
 ScFvOx 
~35 kDa 
 
 NC     Ec       P        C    -amy-ScFvOx 
~85 kDa 
 
 A    B   
 C   
Figure 9: Panel A: SDS-PAGE analysis of ScFvOx production. A, B and C are total soluble protein extracts from recombinant 
PhTAC125 (pPM13psDscFvOx) strain at respectively 24, 36, 48 hours cultivation. Panel B: anti c-Myc Western blotting 
analysis of ScFvOx cellular localization on total soluble proteins (T), periplasmic (P) and cytoplasmic fraction (C). Panel C: 
anti -amilase Western blotting analysis of -amilase-ScFvOx chimera cellular localization on extracellular medium (Ec), 
periplasmic (P) and cytoplasmic (C) extracts. Total soluble protein extract of P. haloplanktis TAC125 wild type strain was 
used as negative control (NC). Mk: molecular weight protein ladder. 
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recognised by Sec secretion machinery which promotes protein secretion across the 
inner membrane by a post-translational mechanism (Wickner et al., 1996). To allow 
the recognition of the preprotein by the Sec machinery the unfolded state of protein is 
required and therefore some translocation problems could be experienced by those 
proteins whose folding kinetic is faster than recognition event by the export system. 
Indeed, if the protein acquires any three-dimensional structure, it becomes an 
inadequate substrate for the translocation machinery and it is retained in the 
cytoplasm.  On the other hand, the PsD leader peptide is predicted to be a SRP-
dependent molecular signal for periplasmic secretion which follows a co-translational 
mechanism. The SRP system (Schierle et al., 2003) recognises the nascent 
polypeptide during its synthesis and its translation and translocation result to be 
simultaneous.  
Data reported demonstrate that only the co-translational molecular signal (PsD) 
allows the ScFvOx production, its periplasmic translocation and accumulation in 
soluble form. The total absence of protein in the cytoplasmic fraction indicates a 
proper recognition and an efficient translocation mechanism. This result is suggestive 
that the choice of a translocation system that drives periplasmic export of the protein 
during its synthesis allows to overcome the incorrect folding problems and the 
physiological barrier due to a fast folding kinetic and therefore the PsD signal peptide 
will be used for the periplasmic addressing of all the model antibody fragments used 
in this work. 
Construction of an artificial operon for Fab 3H6 expression  
The correct assembly of recombinant light and heavy chain in functional Fab 
fragments can only be achieved if the two subunits are synthesized by the host cell in 
stoichiometric ratio. In order to achieve a balanced soluble production of Fab 3H6 in 
P. haloplanktis TAC125 an artificial operon was constructed for the co-expression of 
Fab 3H6 light and heavy chains coding genes (Fig.10).  
Each gene was fused to the sequence encoding the psychrophilic signal peptide PsD 
for periplasmic secretion and a 6xHis tag coding sequence was added downstream 
of the heavy chain encoding gene. Moreover, particular attention was paid on the 
Fab 3H6 operon intergenic region design. Indeed, bacterial genes are commonly 
Figure 10: A: Schematic representation of Fab 3H6 artificial operon. LC, Light chain gene; HC, Heavy chain gene; PsD, 
PhDsbA signal peptide; SD, Shine Dalgarno sequence; Prom, generic psychrophilic promoter; term, psychrophilic 
terminator. Red arrows indicate the position of primers used for cDNA synthesis and amplification. B: Fab 3H6 operon  
intergenic region.  
A 
B 
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transcribed to form polycistronic mRNAs bearing reading frames whose respective 
translational efficiencies are controlled by a fine regulation. Normally, genes products 
which are associated with common cellular processes such as a metabolic pathway 
are synthesized in equimolar amounts from polycistronic messenger RNA molecules 
and the complete translation of the preceding gene is necessary for efficient 
translation of a distal gene. Therefore, translational coupling can be used to control 
the relative stoichiometry of proteins expression. Coupled genes are characterised by 
a particular structure at their intercistronic junction, identified for the first time in 
tryptophan operon of E. coli (Oppenheim and Yanofsky, 1980). In order to achieve 
balanced translation of the two Fab 3H6 chains through translational coupling, an in 
silico  analysis of the structural organisation of naturally coupled operons was 
performed on P. haloplanktis TAC125 genome. As reported in Table 3, most of the 
analysed operons show the same organisation where the start codon of the second 
gene of the cluster overlaps to the previous gene stop codon, sharing one base pair. 
Such structure was then used for Fab 3H6 artificial operon construction (Fig.10B). 
Since a ribosome binding site sequence is necessary for efficient expression of the 
distal gene of a translationally-coupled gene pair, the same Shine Dalgarno 
sequence placed upstream to the lc gene was added for HC translation by silent 
mutagenesis of the lc gene 3’ region.  
 
Table 3: Intergenic regions comparison of natural coupled operons in P. haloplanktis TAC125 
 
 
In order to assess the stabily of the bicistronic Fab 3H6 mRNA, the artificial operon 
was cloned into the psychrophilic expression vector pPM13 under the control of a 
strong constitutive psychrophilic promoter and reverse transcription experiments 
were carried out on  total RNA extracted from 
recombinant and wild type bacterial cells after 
48h cultivation in rich media at 15°C. PCR 
amplification of the synthesized cDNA was 
then performed by using specific primers 
annealing to the mRNA intergenic region and 
to the 3’ of hc gene respectively (Fig.10A). 
The analysis revealed a specific amplification 
of a fragment of the expected size of about 
770bp length (Fig.11) demonstrating that Fab 
3H6 artificial operon is correctly transcribed 
and its corresponding mRNA is stable within 
bacterial cell.   
Figure 11: Amplification of cDNA synthesized from 
PhTAC125 (pPM13-fab) (R) and wild type (wt) total 
RNA after growth in rich medium up to stationary 
phase. Plasmidic DNA (pPM13-Fab) was used as 
template in positive control (PC), and total RNA in 
negative control (NC).  
 
In blue are indicated the Shine Dalgarno sequences. Red circles: stop codons, Green circles: start codons. 
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A qualitative estimation of Fab 3H6 light and heavy chain relative production was 
also performed in order to evaluate the expression system efficiency at translational 
level. Recombinant pPM13-fab and wild type P. haloplanktis TAC125 strains were 
grown in rich media at 15°C and total soluble proteins were extracted from samples 
collected after about 48h cultivation and subjected to Western blotting analysis using 
specific antibodies directed against either the Fab light chain and the His-tag (present 
at the C-terminus of Fab heavy chain) in mild reducing condition (Fig.12 A-B). In 
these conditions, both heterodimeric Fab and free Fab chains should be detected in 
the analysed samples. Immunodetection performed with antibodies anti light chain 
revealed the presence of two specific signals, one showing an apparent molecular 
weight of about 50kDa which is the expected mass for Fab 3H6 heterodimer, and the 
other corresponding to free light 
chain of about 25kDa (Fig.12 A). 
The same experiment carried by 
anti His tag antibodies (Fig. 12B) 
revealed the same 
immunodetected signals indicating 
the presence of heavy chain either 
in monomeric and dimeric form. 
The collected data demonstrate 
that both light and heavy Fab 
chains are synthesised in soluble 
form by the host cells and 
suggest their correct assembly in 
soluble and heterodimeric form.  
 
Expression cassettes for antibody fragments production in P. haloplanktis TAC125 
The psychrophilic expression vector pUCRP (Papa et al., 2007) (Fig. 13) was chosen 
for large scale expression of recombinant antibody fragments in P. haloplanktis 
TAC125. It contains a regulated psychrophilic promoter which is strongly induced by 
the presence of L-malate in the culture medium and it shows the highest efficiency in 
minimal media among the available psychrophilic promoters (unpublished results). 
The pUCRP vector was previously modified by inserting a C-terminal 6xHis tag 
(unpublished result). The psD-scFvOx-c-myc gene was inserted into the modified 
pUCRP vector in frame with the His tag coding sequence thus creating a 
recombinant fusion protein containing, besides the N-terminal leader peptide for 
periplasmic secretion PsD, two consecutive C-
terminal tags: the c-Myc, for protein 
immunodetection and the 6xHis tag for affinity 
purification of recombinant product (Fig. 14 A).  
The same modified expression vector was also 
used for VHH D6.1production by replacing the 
scFvOx gene with the PCR amplified vhhD6.1 
one (Fig 14B). 
Fab 3H6 operon, already containing all the 
needed tags and signals for periplasmic 
addressing (Fig. 10) was instead directly digested 
from the previously constructed pPM13-fab and 
inserted into a non modified pUCRP vector. 
Figure 12: Western blotting analysis of recombinant Fab 3H6 
production on total proteins soluble extracts of recombinant (R) and 
wild type (NC) P. haloplanktis TAC125 cells. Immunodetection was 
performed with anti-human- -light chain monoclonal antibodies (Panel 
A) and anti His tag monoclonal antibodies (Panel B). LC, Fab light chain; 
HC, Fab heavy chain. 
Figure 13: pUCRP expression vector map. 
Modified from Papa et al., 2007 
A 
Fab 3H6 
~50 kDa 
 
LC 
~25kDa 
 
HC 
~25kDa 
 
  R    NC   R   NC 
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Section 2: Medium optimization for recombinant biopharmaceuticals 
production in P. haloplanktis TAC125 
The new regulated expression system recently developed for recombinant protein 
production at low temperatures, strongly induced by the presence of L-malate in 
culture medium (Papa et al., 2006) was chosen for recombinant antibody fragments 
production in P. haloplanktis TAC125. By this system, in optimised conditions, yields 
of 620 mg L-1 of a psychrophilic β-galactosidase and 27 mg L-1 of a mesophilic -
glucosidase were obtained in a fully soluble and catalytically competent form (Papa 
et al., 2007). However, performances of the new inducible expression system are still 
unsatisfactory for large scale recombinant protein production due to the low biomass 
yield (Papa et al., 2007) and consequently low recombinant protein productivity. 
The understanding of the growth physiology and the optimisation of cultivation 
strategies are essential factors to achieve the goal of high protein production by 
recombinant organisms. Indeed, when the product is cell-associated, the productivity 
is correlated to biomass level. In this case, the optimisation of the protein production 
is strictly depending on media composition and, in turn, closely related to the choice 
of the more suitable cultivation strategy to be used. 
To set up a new process for recombinant antibody fragments production in P. 
haloplanktis TAC125, the influence of medium composition and cultivation 
operational strategies on final biomass concentration, growth rate and recombinant 
protein production yields was investigated. 
 
Analysis of P. haloplanktis TAC125 growth profiles in amino acid-containing synthetic 
media 
According to the composition of the optimised medium for psychrophilic β-
galactosidase production, a mineral medium supplemented with 0,5%w/v 
Casaminoacids (DifcoTM), different growth media were formulated containing the 
same mineral medium supplemented with each amino acid as sole carbon source.  
In contrast to many -proteobacteria, P. haloplanktis TAC125  does not possess a 
phosphoenolpyruvate-dependent phosphotransferase system for the transport and  
first metabolic step of carbohydrate degradation (Medigue et al., 2005) but the 
genome analysis reveals the presence of all metabolic pathways for amino acids 
biosynthesis and degradation. This evidence makes theoretically possible P. 
scFvOx 
B 
Figure 14: Schematic representation of ScFvOx (A) and VHH D6.1 (B) expression cassettes. SD, Shine Dalgarno sequence; 
Prom, psychrophilic L-malate inducible promoter; term, psychrophilic terminator; PsD, DsbA signal peptide; VL, variable light 
chain; VH, variable heavy chain. 
A 
B 
 
VHH 
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haloplanktis TAC125 growth even in presence of a single amino acid as sole carbon 
source.  
A total of 15 synthetic media 
were formulated according to 
Casaminoacids composition (BD 
Bionutrients™ Technical 
Manual). Indeed, due to acid 
hydrolysis of  caseins, several 
amino acids are absent or 
present in concentrations lower 
than 0,5% w/w in Casaminoacids 
and were not tested for P. 
haloplanktis TAC125 growth. In 
order to avoid a carbon/nitrogen 
unbalance, the concentration of each amino acid in synthetic media was calculated 
keeping the total nitrogen concentration at the same value contained in the 
Casaminoacids medium when supplemented at 0,5% w/v (0,038M)  (Tab.4). P. 
haloplanktis TAC125 growth was tested in shaken flask cultures at the optimal 
growth temperature of 15°C. Surprisingly, no significant growth was observed in most 
of the analysed media (data not shown) and only 4 amino acids were selected for 
further analysis (Fig.15).  
Compared to the growth 
parameters observed in 
Casaminoacids medium, 
media containing L-
glutamate and L-aspartate 
showed about two folds 
increase of specific growth 
rate and  biomass yield 
(Tab. 5). P. haloplanktis 
TAC125 fast growth on 
acidic amino acids is 
probably due to the 
presence of an efficient 
uptake system and their 
rapid metabolism through  
transamination to TCA cycle intermediates. Growth parameters are also improved in 
L-alanine containing medium. L-alanine is rapidly metabolised through 
transamination to piruvate and several genes are annotated as putative Na+-alanine 
symporter in P. haloplanktis TAC125 genome. More interestingly, biomass yield in 
the medium containing L-leucine as carbon source was almost three folds increased 
compared to that obtained in the same 
amount of Casaminacids while specific 
growth rate are comparable. L-leucine 
catabolism is complex and genes 
predicted to encode for metabolic 
enzymes involved in different 
pathways for branched amino acids 
degradation are present in P. 
haloplanktis TAC125 genome. 
Carbon source Mol/L Carbon source Mol/L 
L-alanine 0,0385 L-Lysine 0,0192 
L-arginine 0,0096 L-methionine 0,0385 
L-aspartate 0,0385 L-phenylalanine 0,0385 
L-glutamate 0,0304 L-proline 0,0385 
Glycine 0,0385 L-serine 0,0385 
L-histidine 0,0130 L-threonine 0,0385 
L-isoleucine 0,0385 L-valine 0,0385 
L-leucine 0,0385 Ref. CAA 0,0400 
Carbon source max Final biomass g L
-1
 
L-Ala 0,202 2,1 ± 0,3 
L-Asp 0,252 3,6 ± 0,4 
L-Glu 0,340 4,4 ± 0,2 
L-Leu 0,126 5,6 ± 0,3 
Ref. CAA 0,194 2,2 ± 0,2 
Table 4: Sinthetic media composition 
Figure 15: P. haloplanktis TAC125 growth profiles in selected synthetic media 
Table 5: Growth parameters in selected  media  
26 
 
Furthermore no clear information are available regarding branched amino acids 
uptake systems in P. haloplanktis TAC125. 
 
Recombinant psychropilic -galactosidase production in synthetic media 
The next step for a new defined medium development for recombinant proteins 
production in P. haloplanktis TAC125 was to assess the transcriptional efficiency of 
the psychrophilic expression system in selected synthetic media. For this purpose, a 
recombinant strain of P. haloplanktis TAC125 was used harbouring the plasmid 
pUCRP- -gal in which the gene encoding a psychrophilic -galactosidase is under 
the control of L-malate inducible promoter. -galactosidase  was chosen as reporter 
enzyme because its production is easily detected and quantified by enzymatic 
assays. Recombinant cells were cultivated in shaken flasks at 15°C in different 
synthetic media supplemented with L-malate and samples were collected from each 
culture at late exponential growth phase. Interestingly, specific -galactosidase 
activity detected in protein extracts of cells grown in L-leucine-containing medium 
was about five folds higher than that obtained in Casaminoacids medium while a 
huge decrease in -galactosidase production was observed in all other tested media 
(Fig. 16).  
The observed inhibition effect on 
recombinant protein production 
particularly in L-aspartate and L-
glutamate containing media is likely to 
occur at transcriptional level. Indeed, L-
malate induction involves a two 
component system (Papa et al., 2009) 
where a periplasmic binding protein is 
responsible for L-malate sensing and, 
as a consequence of ligand binding, an 
altered state of the cis-acting gene 
regulation element is directed to the 
appropriate gene(s) by the protein's 
DNA binding activity The structural 
analogy between the acidic amino acids 
and the L-malate can be the reason for 
the observed inhibition of L-malate 
activation on the outer membrane 
porine PSHAb0363 promoter. When 
acidic amino acids are used in 
combination with L-malate a cross 
regulation can occur where L-malate 
uptake results to be repressed. Further 
investigation has been carried out in 
order to clarify the transcriptional 
regulation of PSHAb0363 promoter in L-glutamate containing media and it will be 
reported in the next sections.   
Transcription activation by L-malate is also inhibited when L-glutamate and/or L-
aspartate are used in combination with L-leucine (Fig. 17) even if specific growth rate 
is increased compared to that observed in L-leucine containing medium (data not 
shown). 
 
Figure 16: -galactosidase production yield in selected media 
Figure 17: -galactosidase production yield in combined 
synthetic media  
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Effect of L-leucine concentration on P. haloplanktis TAC125 growth  
According to previous results, L-leucine represents a key component for the 
development of a new synthetic medium optimised for recombinant protein 
production in P. haloplanktis TAC125. In order to improve the biomass yield, different 
media containing increasing amount of L-leucine as carbon source were tested for P. 
haloplanktis TAC125 growth in a lab-scale STR bioreactor. Surprisingly, as shown in 
Figure 18, a clear inhibition effect is observed on P. haloplanktis TAC125 growth 
when higher L-leucine concentration is added in the medium in the range tested (0,5-
1,0% w/v). This effect is likely to occur at the level of substrate uptake system. 
Different systems have been 
described for branched amino 
acids uptake in bacteria. Among 
them, the regulation mechanism 
of the ATP-dependent high 
affinity branched amino acids 
transport system LIV-I in 
Escherichia coli has been deeply 
investigated and it was found that 
the rate of transport responds 
only to changes in concentrations 
of leucine in the medium. In the 
presence of high concentrations 
of leucine the transport activity is 
repressed (Penrose et al., 1968; 
Rahmaniam et al., 1973; Oxender and Quay 1976; Quay and Oxender 1976) by the 
indirect action of a leucine-responsive regulatory protein Lrp on livJ and livKHMGF 
operon encoding all the components of the high affinity branched amino acids 
transport system (Haney et al., 1992; Landgraf et al., 1999). Actually it is not possible 
to univocally identify the liv gene cluster in P. haloplanktis TAC125 genome by an in 
silico analysis. However, the presence of several genes encoding putative ATP 
Binding Cassette (ABC) transporters and two lrp homologues (PSHAa1717 and 
PSHAa2263) and the experimentally observed inhibition on P. haloplanktis TAC125 
growth by L-leucine addition in culture media suggest the presence of a mechanism 
similar to LIV-I for branched amino acids uptake in the psychrophilic bacterium. If L-
leucine concentration could not be increased in the new developed medium, other 
carbon sources should be tested in combination with L-Leu in order to improve the 
biomass yield and growth kinetic of P. haloplanktis TAC125. Moreover a very long 
lag phase is observed in P. haloplanktis TAC125 growth on L-leucine alone even if it 
is added in lowest concentration. Quay and co-workers in 1976 proposed an 
alternative explanation for E. coli growth inhibition in leucine-containing minimal 
medium. Based on the observation of a huge decrease of intracellular levels of L-
valine and L-Isoleucine during growth starvation, they hypothesised that mechanism 
of leucine sensitivity involved transport-mediated exchange of intracellular isoleucine 
and valine for leucine (Quay et al., 1976). In this situation, when leucine is the only 
carbon source available,  LIV-I or any other similar system functionally uptakes 
extracellular leucine in exchange for intracellular isoleucine and valine that can 
become limiting for cellular protein synthesis. This leads to a period of restricted 
growth, corresponding to the long lag phase observed in P. haloplanktis TAC125 
growth in leucine-containing media. When leucine concentration in the medium 
further decreases, ilv operon, also regulated by Lrp, can be completely derepressed 
Figure 18: P. haloplanktis TAC125 growth profiles in synthetic media 
containing increasing L-leucine concentrations. 
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and the biosynthetic enzymes for isolecine and valine encoded by ilv genes are 
produced sufficiently to compensate the isoleucine and leucine consumption by 
protein synthesis and loss from the cell for solutes exchange and the growth can 
proceed normally.  
According to this model, a new synthetic medium was developed containing L-
leucine in combination with L-isoleucine and L-valine in stoichiometric ratio. 
 
Analysis of P. haloplanktis TAC125 growth and recombinant -galactosidase 
production in branched amino acids (LIV) synthetic medium 
A new medium containing L-leucine, L-isoleucine and L-valine in 1:1:2 ratio, hereafter 
called LIV medium, was developed and it was tested for P. haloplanktis TAC125 
growth in lab-scale STR bioreactor. As shown in Fig. 19, the new medium leads to a 
very short lag phase and a slight increase of specific growth rate and biomass yield           
compared to the previously optimised L-leucine containing medium. Furthermore,  
recombinant -galactosidase production results to be above two folds increased in 
the new growth conditions.  
The observed results confirm the hypothesis that major factor in leucine sensitivity is 
ability of the transport system to carry out exchange of pool amino acids for 
extracellular leucine. The presence of all three branched amino acids in culture 
medium in stoichiometric ratio overcomes the loss of intracellular isoleucine and 
valine that was limiting for bacterial growth and for recombinant protein synthesis.  
When a substrate consumption analysis was performed (Fig. 20) it revealed a 
significant residual amino acid concentration in the spent medium at the end of 
exponential growth leading to a low Yx/s (≤0,30). The amino acidic substrates are 
rapidly consumed during the first 20 hours of cultivation, corresponding to 
exponential bacterial growth at maximum specific growth rate, while L-malic acid 
concentration remains almost constant. From 20 to 48 hours of cultivation the amino 
acids concentration in the extracellular medium slightly decreases while a rapid 
consumption of L-malic acid is observed which results to be completely depleted 
from the culture medium at about 24 hours of cultivation.  This doesn’t seem to affect 
bacterial growth whose specific growth rate follows the rate of amino acids 
consumption. Furthermore a strong ammonia accumulation was observed at same 
rate of biomass production. This is not surprising considering that amino acids are 
Figure 19: P. haloplanktis TAC125 growth profiles, kinetics, biomass and recombinant protein production yield in L-leucine 
and LIV synthetic media. -galactosidase induction was performed by L-malate  0,4%addition at t=0. 
29 
 
also nitrogen sources and the LIV medium is unbalanced containing an excess of 
organic nitrogen. The role of ammonia accumulation in P. haloplanktis TAC125 
growth inhibition was experimentally investigated (data not shown) and it was 
demonstrated that up to 150 mM ammonia does not affect P. haloplanktis TAC125 
growth. According to the data collected, an explanation for the lower Yx/s in the new 
optimised medium must be searched out more deeply in bacterial physiology in this 
behaviour. 
 
Set-up of chemostat cultivation process 
The obtained results paved the way to the possibility to set up a chemostat process 
where a feeding medium containing L-leucine as sole carbone source will be used 
after a batch cultivation in LIV medium. Due to the residual concentration of 
substrates observed at the end of the exponential growth of P. haloplanktis TAC125 
in LIV medium and to the hypothesis of a total derepression of ilv operon in those 
conditions, the addition of leucine only after exponential growth in LIV medium should 
lead to bacterial growth at steady state. 
P. haloplanktis TAC125  was grown in LIV medium at 15°C in STR bioreactor until 
the highest biomass yield was reached (about 48 h of cultivation). The L-leucine 
containing medium 
was fed to the culture 
at a dilution rate of 
0,05 h-1, calculated 
on the base of the 
maximum specific 
growth rate observed 
in batch cultivation in 
LIV medium. As 
shown in Figure 21, 
in selected 
conditions a steady 
state is established 
in which the cell 
density remains 
constant for at least 
five resident times. 
Figure 20: Substrate consumption analysis, biomass and ammonia accumulation during P. haloplanktis TAC125 batch 
cultivation in bioreactor. 
 
Figure 21: Growth and oxygen consumption profiles of P. haloplanktis TAC 125 in 
chemostat cultivation at 15°C. The black arrow indicates the end of batch phase in LIV 
medium and the beginning of the feeding with L-Leu. Resident times are indicated on 
the graph.  
Feeding 
1  3  5  
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Section 3: Process scale up: recombinant antibody fragments production in 
bioreactor 
After the construction of an ad hoc genetic expression system for each model protein 
and the development of a fermentation process optimised for recombinant proteins 
production by the selected psychrophilic expression system, the recombinant 
production of antibody fragments by P. haloplanktis TAC125 has been evaluated in 
bioreactor.  
The production of the three model proteins Fab 3H6, ScFvOx and VHH D6.1 has 
been performed at 15°C and pH 7 in LIV medium in presence of L-malate 0,4% as 
inducer and dissolved oxygen concentration was kept always above 30% by 
adjusting air flow inlet and stirring speed.  
Different cultivation operational strategies have been screened for each production 
process in order to maximize recombinant proteins yield.  
 
Fab fragment recombinant production  
○ Batch cultivation: 
The analysis of Fab 3H6 production was performed by ELISA experiments on total 
soluble protein extracts from P. haloplanktis TAC125-pUCRP-fab samples collected 
at different times of cultivation. As shown in Figure 22, recombinant Fab 3H6 nicely 
accumulates during fermentation reaching the highest production yield of 3,99 ± 0,11 
mg L-1 in late exponential phase corresponding to about 48 h of cultivation thus 
demonstrating that our model protein Fab 3H6 is produced in soluble form by the 
psychrophilic expression system in the optimised conditions. The highest rate of Fab 
3H6 accumulation is observed between 20 and 25 hours of cultivation corresponding 
to the range in which the inducer L-malate is rapidly consumed (Fig. 22).The 
observed yield of soluble Fab 3H6 is quite high compared to that obtained by other 
conventional microbial recombinant hosts (Gach et al., 2007). Furthermore, a high 
YP/X  of 0,89 ± 0,15 mg gbiomass
-1 was also observed suggesting that a further 
optimisation of culture media and/or cultivation strategies could represent a valid 
approach to increase the yields of recombinant Fab fragments production. 
Figure 22: Fab 3H6 titer, biomass yield,  oxygen and L-malate consumption profiles in P. haloplanktis TAC125 pUCRP-fab 
batch cultivation in LIV medium at 15°C. 
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Analysis of Fab 3H6 cellular localisation and quaternary structure was performed by 
Western blotting experiments on periplasmic and cytoplasmic extraxts from samples 
collected at different times of cultivation, using specific anti-light chain antibodies in 
non-reducing conditions (Fig. 23). The analysis revealed a specific signal 
corresponding to Fab 3H6 in 
heterodimeric form (≈50kDa) exclusively 
in periplasmic fractions, demonstrating 
that soluble Fab 3H6 is not only 
effectively produced but also correctly 
and totally translocated into the 
periplasmic space. Moreover, the 
apparent molecular weight of the 
detected signal (≈50 kDa) and the 
complete absence of signals 
corresponding to free light chains (≈25 
kDa) suggest that the recombinant 
product is fully assembled in 
heterodimeric quaternary structure.  
 
○ Continuous cultivation: 
Fab 3H6 recombinant production was also performed by a chemostat cultivation 
process. After 48 hours of batch growth in LIV medium the culture was fed with a 
medium containing L-leucine as sole carbon source at a dilution rate of 0,05 h-1. 
As shown in Figure 24, in the selected conditions, the steady state was achieved for 
at least 5 resident times in which both the cell density and the product titer remain 
constant. By the developed process a specific Fab 3H6 productivity of 0,19±0,02 mg 
L-1 h-1 was achieved with a constant production yield of about 3,8 mg L-1.  
Data collected demonstrated that a continuous fermentation process can be suitable 
for soluble production of  recombinant Fab fragments at low temperatures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fab 3H6 
~50kDa 
Ref.    P    C      P    C     P     C     P     C     
Figure 23: anti human  light chain immunodetection on 
periplasmic (P) and cytoplasmic (C) fractions of bacterial 
samples collected at different times of cultivation. The black 
arrow indicates the increasing time of sampling. Ref, positive 
control, pure Fab 3H6 100ng.   
Figure 23: Growth, Fab titer and oxygen consumption profiles during P. haloplanktis TAC125 pUCRP-fab chemostat 
cultivation. Resident times are indicated on the graph. 
1  3  5  
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ABSTRACT 
While efficient heterologous protein production has proven to be feasible in general terms, 
the production of complex proteins has turned out to have a low success rate. A lot of 
molecular, biochemical and biological information about different host cells has been 
progressively accumulated, but such data has been gained through a variety of non-
comparable approaches, leading to a poor base for generalisation. 
Therefore, this study aimed at a comparative analysis of five different host species with 
proven capacities for protein expression to adress functional, structural and regulatory 
processes involved in expression of complex proteins. Another aim was to investigate the 
efficiency of folding, solubility and secretion and the physiological response in different host 
organisms at different critical environmental conditions.  
Expression of a heterodimeric antibody Fab fragment was assessed in five microbial host 
systems, namely Saccharomyces cerevisiae, Pichia pastoris, Trichoderma reesei, 
Escherichia coli and Pseudoalteromonas haloplanktis. The comparative analysis of the 
specific production and the effect of cultivation temperature and oxygenation as examples for 
production-relevant environmental parameters highlight fundamental differences but also 
common features of these protein production platforms. The current study highlights P. 
haloplanktis as a high potential candidate for the expression of recombinant proteins. 
Furthermore it could be shown that lowering temperature had a positive effect on 
heterologous protein secretion in 3 out of 4 analyzed microorganisms. 
Keywords 
Saccharomyces cerevisiae, Pichia pastoris, Trichoderma reesei, Escherichia coli, Pseudoalteromonas 
haloplanktis, comparison, antibody Fab fragment, 3H6, heterologous protein production, 
environmental conditions 
 
Introduction 
Microbial host cells, most notably Escherichia coli and Saccharomyces cerevisiae, represent 
the most common model and host organisms for basic research and recombinant protein 
production. Of the few protein based biopharmaceuticals on the market, the majority is still 
produced in these two host organisms (10). Apart from these two working horses of 
Submitted to Applied Enviromental Microbiology-2009 
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biotechnological research, many different organisms are currently used or tested for the 
production of technically and therapeutically relevant proteins, including bacterial and fungal 
host cells, insect and mammalian cell lines and transgenic plants. Since post-translational 
modifications (PTMs), such as glycosylation (6), play a major role for product quality and 
suitability for human administration, higher eukaryotic expression systems are commonly 
applied, because they can often produce human or human-like PTMs and generally achieve 
high product titers. Furthermore, the production of large proteins is often difficult in microbial, 
especially bacterial hosts (10). Nevertheless, detailed research has enabled substantial 
progress in producing PTMs such as glycosylation in bacterial cells (54) and fungal hosts 
such as Pichia pastoris (18, 20, 29, 41). Large proteins such as full length antibodies have 
also already been successfully produced in microbial hosts (35, 42, 48). In addition to these 
advances and the strong molecular biology knowledge background of microbial hosts, there 
are also the benefits of simple growth requirements on defined mineral growth media, high 
growth rates and consequently short fermentation and process times. Thus there is 
motivation to further develop and improve microbial host systems.  
In the current study, different microbial host systems for recombinant protein production were 
compared. A complex model protein, the Fab 3H6 (12, 26), was expressed and secreted 
either into the periplasm or into the culture broth in S. cerevisiae. P. pastoris, Trichoderma 
reesei, E. coli and Pseudoalteromonas haloplanktis. These organisms represent well 
established platforms for heterologous  
protein production in academia and industry or highly prospective new host systems, as in 
the case of P. haloplanktis (39). The general characteristics of these organisms are 
summarized in Table. 1. There are big differences in the capability to express specific  
proteins even among yeast species, indicating the importance to identify differences as well 
as common features even in more closely related species. For each species a commonly 
used vector system with an inducible or a constitutive promoter for recombinant protein 
production in combination with chemostat cultivation was applied. Generally, secretion of the 
recombinant product into the periplasm or culture supernatant results in relatively pure 
protein and facilitates downstream processing, although periplasmic secretion of  
recombinant polypeptides in bacteria such as E. coli may result in relatively low protein 
concentrations and filamentous fungi such as T. reesei secrete a vast amount of host protein 
into the culture supernatant (33). Codon optimization for the specific host organism may also  
host organism 
cytoplasmic 
production 
secretory 
production 
periplasmic 
production 
disulfide 
bond 
formation 
glycosylation 
S. cerevisiae 
Yes – may 
result in poor 
product titers 
Yes  - generally 
low titers 
Na Yes 
Yes – protein 
often 
hyperglycosylated 
P. pastoris Yes  
Yes – generally 
lower titers than 
for intracellulary 
production 
Na Yes 
Yes – smaller 
glycan-structures 
than S. cerevisiae 
T. reesei Yes Yes Na Yes Yes  
E. coli 
Yes – often 
highly pure 
protein in the 
form of 
inclusion 
bodies (IBs) 
Yes – but 
inefficient and 
the underlying 
mechanisms 
are poorly 
understood 
Yes  
Not for 
intracellulary 
produced 
proteins, but 
can occur in 
the periplasm 
No 
P. haloplanktis Yes Yes Yes 
Can occur in 
the periplasm 
No 
Table 1. Host organisms used in this study and their general protein production 
characteristics. na - not applicable 
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be applied to increase the product yield (7). In the current study non-codon optimized 3H6 
Fab was used to facilitate comparison of the organisms and because codon optimization 
would not have been applicable to all organisms.  
It is often still unpredictable which host systems will be the most suitable for the production of 
a particular protein, thus a trial and error approach is necessary to find the best suited host 
cell. The results of this study confirm that there is a great variability in the production of Fab 
3H6 among different host organisms. Furthermore microorganisms encounter diverse stress 
conditions during fermentation processes, which may interfere with process performance 
(34). These environmental stresses and the consequently triggered physiological reactions, 
including changes of the protein folding/secretion machinery, are highly interrelated (16), 
thus strongly supporting the investigation of environmental factors influencing protein 
expression and secretion. Of all the possible stresses, temperature, oxidative stress, 
osmolarity and pH appear particularly important. Therefore the impact of temperature and 
oxygenation on recombinant protein production was analysed at steady-state using 
chemostat cultivation. As microorganisms encounter rather long-term suboptimal conditions 
during production processes rather than short-term perturbations, the analysis of 
environmental factors at steady-state conditions was the method of choice. Furthermore 
growth rate related effects can be avoided by applying chemostat cultivation (45).  
The results obtained in the current study highlight common features and differences in the 
response to key fermentation parameters and the resulting product yields in different 
microbial species.  
 
Materials and Methods 
Strain construction 
Saccharomyces cerevisiae – The 3H6 heavy and light chain (12) coding sequences were 
both integrated on a pYX integrative expression vector. For constitutive expression the S. 
cerevisiae TPI (triose phosphate isomerase) promoter was used and the S. cerevisiae α-
factor leader sequence served as secretion signal (4). A polyA sequence served as 
terminator. HIS3 and URA3 were used as selection markers and expression vectors were 
integrated into the genome of  the reference S. cerevisiae CEN.PK strain (52). 
Pichia pastoris – Heavy and light chain coding sequences were both inserted into a single 
pGAPzαA expression vector. Both chains were expressed under the control of the GAP 
(glyceraldehyde-3-phosphate dehydrogenase) -promoter and the AOX terminator (2). The S. 
cerevisiae α-factor secretion signal was used to target the protein into the supernatant. The 
plasmid was linearized by restriction digest and integrated into the genomic GAP promoter 
locus of P. pastoris X-33.  
Trichoderma reesei – Two expression cassettes were constructed, where the 3H6 light and 
heavy chain fragments were between the cbh1 promoter and terminator. The cbh1 signal 
sequence was fused with the antibody chain sequences. The expression cassettes were 
subsequently cloned to a final expression plasmid where the light and heavy chain cassettes 
were in tandem, followed by the acetamidase selection marker gene and a cbh1 3´flanking 
region fragment. The fragment carrying these elements was transformed into the T. reesei 
strain RutC-30 (36). The Fab production strain studied in this work had the Fab fragment 
expression cassettes and the acetamidase gene integrated into the cbh1 locus.  
Escherichia coli – 3H6 Fab heavy and light chain expression cassettes were present on the 
pET27b vector, using T7 promotor and terminator sequences and the pelB secretion signal 
for secretion into the periplasm. E. coli HMS174(DE3) was transformed with the obtained 
plasmid.  
Pseudoalteromonas haloplanktis – An artificial operon was constructed for 3H6 heavy and 
light chain recombinant expression in P. haloplanktis strain TAC125. The operon was cloned 
in the psychrophilic vector pUCRP containing a strong L-malate inducible promoter (38) and 
each gene was fused to a psychrophilic signal peptide encoding sequence for periplasmic 
secretion. 6xHis tag was fused at the C-terminus of recombinant 3H6 heavy chain.  
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Secretion / Periplasmic expression of the 3H6 Fab fragment was verified by Western Blotting 
and quantified by ELISA (see section Analytical procedures for details) in all the hosts. 
Growth conditions 
Generally, cultivations were all performed in triplicate and for temperature and oxygenation 
experiments, the combinations for the temperature and oxygenation regimes were different 
for each chemostat to avoid the effect of evolutionary adaption. Samples were taken at 
steady state, indicated either by constant RQ and biomass yield or as in the case of T. reesei 
also by monitoring the expression of 13 genes(rpl16a, hen6, hsp70, rps16b, gcn4, chs1, 
acs1, bgl2, bga1, egl1, vpa1, antibody light chain, antibody heavy chain, and nth1) using 
TRAC analysis (44).  
Detailed media recipes for all model-organisms of this study can be found in Supplemental 
data 1. 
Saccharomyces cerevisiae – Shake flask cultivations of S. cerevisiae were performed in 
mineral medium with 2% (w/v) glucose as carbon source (batch medium, Supplemental data 
1). Fermentation was performed in a BIOSTAT B (B-Braun) bioreactor as follows: after a 
batch phase of approximately 24 hours (initial OD660 was 20), chemostat cultivation was 
performed on 2% (w/w) glucose and 0.05% ethanol (w/w) as carbon sources under fully 
aerobic conditions at pH 5.0 and at a dilution rate of D = 0.1h-1 and a working volume of 
1.25L with an expected yeast dry mass of 10g L-1. Ethanol was added to avoid culture 
oscillation (40). The total gas flow was kept constant for all experiments at 1 vvm (volume 
gas per volume batch medium and minute) and the agitation was set at 1000 rpm. 
Chemostat cultivation was performed at 3 different temperatures: 23, 26 and 30°C. For 
cultivation at different oxygenation conditions, chemostat medium was used, with 2% (w/w) 
glucose, at a dilution rate of D = 0.1h-1. No ethanol was added in the oxygen experiment 
because no culture oscillations were observed without ethanol in the growth medium. The 
temperature was set at 26°C and the air concentration in the inlet gas stream was changed 
in a stepwise manner by partial replacement with an equivalent volume of nitrogen. The 
corresponding oxygen concentrations in the inlet air were 20.97 %, 5% and 2 %, resulting in 
normoxic, oxygen limiting and respiro-fermentative (hypoxic) conditions, respectively. The 
dissolved oxygen tension (DOT) in oxygen limiting condition was about 2-5%, in hypoxic 
conditions it was zero, whereas in fully aerobic conditions it was about 80%.  
Pichia pastoris – Shake flask cultivations of P. pastoris were performed in YPD medium (2% 
(w/v) peptone, 1% (w/v) yeast extract, 2% (w/v) glucose). Bioreactor cultures were performed 
in a MBR 3L Bioreactor at a working volume of 1.5L as follows. After a batch phase of 
approximately 24 hours on mineral medium with glycerol as carbon source, chemostat 
cultivation was performed on mineral medium and glucose as carbon source under fully 
aerobic conditions (20% dissolved oxygen, DO), pH 5.0 and at a dilution rate of D = 0.1h-1 
with an expected yeast dry mass of 25g L-1. Chemostat cultivation was performed at 20, 25 
and 30°C, respectively. For cultivation at different oxygenation conditions, the chemostat 
medium was used, the temperature was set to 25 °C and the oxygen concentrations in the 
inlet air were: 20.97% (normoxic condition), 10.91% (oxygen limitation) and 8.39% (hypoxic 
condition). The total gas flow was kept constant for all experiments at 1.5 vvm with a 
headspace overpressure of 0.2 bar, 700 rpm and 25 C. In both limited and hypoxic 
conditions the dissolved oxygen tension (DOT) was zero, whereas in fully aerobic conditions 
DOT was about 45%. 
Trichoderma reesei –  T. reesei was grown in Braun Biostat CT2 bioreactors (B. Braun 
Biotech International GmbH) with a working volume of 2 L, with 0.5 vvm aeration at 800 rpm 
and pH 4.8 ± 0.1. Cultures were inoculated with 200 ml (10% final culture volume) 
filamentous pre-cultures inoculated with 1 x 106 conidia ml-1 and grown for approximately 72 
h at 28°C in 50 ml volumes in 250 ml flasks which were shaken at 200 rpm. Nitrogen, oxygen 
and carbon dioxide were monitored online with an OmniStar mass spectrometer (Pfeiffer 
Vacuum, Germany). Chemostats were maintained at D = 0.03 h-1. Cultivations were carried 
out at 28, 24 and 21.5°C.  
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Escherichia coli – Chemostat cultivations were performed in a 2L bench-top bioreactor 
(Biostat B, Braun Biotech, Melsungen, Germany) as follows. During the batch phase, the 
temperature was set to 33ºC and the dissolved oxygen concentration was maintained above 
20% saturation by cascade automatic control of the stirrer speed between 700 and 1000 rpm 
and the air-flow between 1.5 and 4 L min-1. pH was controlled at 7.0. After approximately 10 
h of batch growth, continuous medium flow was started at a dilution rate of D = 0.10 h-1. 
Induction was performed by addition of IPTG after the continuous process began. IPTG 
concentration was maintained constant at 25 μM throughout the process. Chemostat 
cultivations were carried out in glucose limited cultures at 37, 33 and 30 C. Fully aerobic 
conditions were maintained by means of constant aeration and stirring. 
Pseudoalteromonas haloplanktis – Shake flask cultivations of P. haloplanktis were performed 
in complex TYP medium (1.6% (w/v) bacto-triptone, 1.6% (w/v) yeast extract, 1% (w/v) NaCl 
pH 7.5). Fermentation was performed in a STR 3L Bioreactor (Applikon) connected to an ADI 
1030 Bio Controller (Applikon) in SCHATZ mineral medium (38) containing L-leucine 0.5% 
(w/v), L-isoleucine 0.5% (w/v) and L-valine 1% (w/v) as carbon sources and supplemented 
with ampicillin 100 g ml-1 for plasmid selection and L-malate 0.4% (w/v) for promoter 
induction. After a batch phase of approximately 48 hours, chemostat cultivation was 
performed on same medium under fully aerobic conditions ( 30% DOT) at a dilution rate of D 
= 0.05h-1 and a working volume of 1.0L. Chemostat cultivation was performed at 15°C 
(µmax=100%).  
Analytical procedures 
Biomass determination - For biomass determination adequate sample volumes were washed 
in demineralised water and either dried to constant weight in pre-weight beakers at 105°C 
until constant weight (2) or collected and dried on pre-weighed filter discs and dried at 110°C 
until constant weight (43). 
Periplasmic protein preparation for bacterial hosts - Bacterial pellets were resuspended in 
1/20 of culture volume of borate buffer (Na2B4O7  200mM,  NaCl 130mM, EDTA 5mM, pH 8) 
and incubated 18h at 4°C. The suspension was centrifuged at 8000rpm for 15min at 4°C and 
the supernatant used for ELISA. 
Product quantification by ELISA – A sandwich ELISA was performed as described in 
previous studies (12, 14). 
Western Blot Analysis – For Western Blot analysis, samples were subjected to standard 
polyacrylamide gel electrophoresis (SDS-PAGE) under non-reducing conditions to avoid 
reduction of disulfide-bonds and blotted onto a nitrocellulose membrane (Biorad). After 
blocking the membrane in PBS 2% (w/v) dry milk for at least 2 hours, 3H6 Fab was detected 
using either anti-human IgG (light chains) or anti-human Fab specific alkaline phosphatase 
conjugate (Sigma). Blots were developed using the AP-substrate kit (Biorad). 
 
Results 
Fab 3H6 could be successfully produced and in all bacterial and fungal host cells. A band of 
approximately 50 kDa in size was obtained in all host organisms and indicated full length Fab 
3H6 (Figure 1). Additionally, it can be seen that besides the correctly assembled 
heterodimeric Fab 3H6, free unassembled light chains, of approximately 25 kDa in size, were 
released in nearly all host organisms, to a different extent with exception of P. haloplanktis. 
Furhermore a small fraction of degradation products was detectable in P. pastoris and E. coli 
cultures. Moreover, during E. coli chemostat cultivation, presence of the 3H6 Fab was not 
only observed in the periplasmic space but also in the culture broth (Figure 1).                             
Productivities at temperatures optimal for growth For comparative purposes, the standard 
operating conditions for each microorganism were defined as an aerobic carbon limited 
continuous culture with a temperature setpoint at which µmax was 100%. However, it should 
be noted that chemostat cultivations were not performed at a dilution rate corresponding to 
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µmax but at a dilution rate that corresponds to 
≤ 60 % µmax depending on the host 
organism. Cultivations were not performed 
at µmax to allow subsequent cultivation at 
different temperatures that would not 
support growth at µmax and to enable the 
analysis of the impact of growth temperature 
on specific production in a growth rate 
independent manner. Final product titers 
differed between different host organisms, 
but also specific production varied between 
the expression hosts (Table 2). P. 
haloplanktis and P. pastoris were able to 
produce the 3H6 Fab very effectively and 
showed the highest specific production, 
followed by S. cerevisiae and E. coli. For T. 
reesei product yields were low compared to 
the other 4 organisms.  
Table 2. Final product titers and specific Fab production (Y P/X) at optimal growth temperature, grown in carbon limited 
chemostat cultures at constant dilution rates (D). * For E. coli the combined (periplasmic + extracellular product) values 
are shown. +/- represents the standard error of the mean. 
 
 
 
 
 
   
The Effect of Temperature on biomass yield and specific production Temperatures below the 
optimal growth value have already been reported to have a beneficial effect on heterologous 
protein production, and specifically on the Fab 3H6 secretion in P. pastoris (3, 9, 15, 27, 47). 
Therefore we investigated if decreased temperature had an impact on 3H6 Fab production in 
the other host species as well. Therefore, continuous cultivations were performed at 3 
different temperatures and data were collected after steady-state was reached. For each 
host organism temperature setpoints, referring to 60, 80 and 100% of µmax were chosen. The 
impact of temperature was analysed for S. cerevisiae, P. pastoris, T. reesei and E. coli, 
whereas no data are available for P. haloplanktis.Interestingly the biomass yield during 
chemostat cultivation was affected by growth temperature in some of the host organisms 
(Table 3). T. reesei and 
P. pastoris had a higher  
biomass yield at lower 
growth temperature, 
whereas S. cerevisiae 
had a lower biomass 
yield at the lower 
temperature. No 
significant differences 
were observed for E. coli. 
Furthermore, growth 
temperature had a 
significant effect on 
specific production during 
host organism growth temperature 
[°C] 
D[h-1] product titer 
[mg L
-1
] 
Y P/X 
[mg g biomass 
-1
] 
S. cerevisiae 30 0.10 0.22 +/- 0.05 0.02 +/- 0.005 
P. pastoris 30 0.10 5.4 +/- 0.2  0.21 +-/ 0.01 
T. reesei 28 0.03 3.3 10
-3
 +/- 2 10
-4
 9.4 10
-4
 +/- 7 10
-4
 
E. coli * 37 0.10 0.21 +/-0.043 0.017+/- 0.003 
P. haloplanktis  15 0.05 4.14 +/- 0.16 0.93 +/- 0.05 
 Y x/s 
Host organism T = 100% µmax T = 80% µmax T = 60% µmax 
S. cerevisiae 0.48 +/- 0.006 0.46 +/- 0.012 0.41 +/- 0.010 
P. pastoris 0.52 +/- 0.01 0.53 +/- 0.01 0.55 +/- 0.01 
T. reesei 0.355 +/- 0.006 0.378 +/- 0.006 0.437 +/- 0.018 
E. coli 0.37 +/- 0.004 0.38 +/- 0.012 0.37 +/-0.015 
P. haloplanktis 0.22 +/- 0.00 nd nd 
Fig.1 : Representative, non - quantitative Western Blot 
images to verify the successful production of antibody 3H6 
Fab fragment. Molecular weight marker (M), S. cerevisiae 
culture supernatant (A), P. pastoris culture supernatant (B), 
T. reesei culture supernatant (C), E. coli periplasma 
preparation (D), E. coli culture supernatant (E) and P. 
haloplanktis periplasma preparation (F). 
 
Table 3: Biomass yield coefficient Y X/S [g g
-1
 biomass per carbon source] in carbon 
limited chemostat cultures at constant dilution rate at different growth 
temperatures. T represents the temperature at which the indicated percentage of 
µmax could be reached in batch culture. +/- represents the standard error of the 
mean. nd no data available. 
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chemostat cultivation in 3 out of 4 host 
organisms. As can be seen in Figure 2, 
E. coli showed a 2.4-fold increase while 
P. pastoris and T. reesei a showed a 2-
fold increase in specific production when 
the growth temperature was decreased 
to a setpoint equivalent to 80% of µmax in 
batch culture. At the temperature 
setpoint, which referred to 60% of µmax in 
batch culture, these 3 organisms showed 
an even higher increase in specific 
production (3 fold for P. pastoris and E. 
coli and 2.5 fold for T. reesei compared 
to the maximum temperature setpoint, 
respectively). In contrast, S. cerevisiae 
showed no change of specific production 
with temperature. 
Additionally an interesting effect was 
observed in E. coli. As already 
mentioned, during E. coli cultivations 
product leakage into the culture broth occurred. 3H6 Fab was found both in the periplasma 
and in the culture medium. It was observed that the amounts found in both fractions varied 
with temperature and hence with the amount of Fab produced (data not shown). At the 
lowest Fab 3H6 concentration, more protein was found in the periplasma but as the amount 
of Fab increased, it was mainly found in the culture broth. 
As mentioned above for P. pastoris and E. coli a small amount of apparently degraded Fab 
was detectable on Western Blots. However the amount of degraded Fab did not accumulate 
or decrease at growth at different temperatures (data not shown). 
 
The Effect of Oxygenation on biomass yield and specific productivity   
It has already been reported in a previous study that decreased oxygen supply during 
chemostat cultivation of P. pastoris can lead to an increased specific productivity (2). A 2.5 
fold increase in specific productivity was achieved by shifting from normoxic to hypoxic 
growth conditions. Based on these data, an oxygen limited fed batch strategy was developed 
(2).  This shift was also accompanied by a 2-fold decrease in biomass yield and increased 
ethanol formation.  
However, to check whether this is a general effect that also appears in other yeasts, the 
same experiment was performed with S. cerevisiae. The obtained data showed that no 
positive effect on specific production could be achieved by decreasing oxygen availability in 
S. cerevisiae (Table 4). As for P. pastoris a reduction of oxygen supply resulted in a nearly 2- 
 
fold reduction of biomass yield and ethanol accumulation in S. cerevisiae, but the specific 
Fab production showed no changes at any of the three oxygenation set points. 
organism oxygenation 
Y X/S 
[g g carbon source 
-1
] 
Y P/X 
[mg g biomass 
-1
] 
ethanol in culture 
broth [g L
-1
] 
S. cerevisiae N 0.46 +/- 0.01 0.027 +/- 0.0046 0.004 +/- 0.0004 
 L 0.45 +/- 0.00 0.029 +/- 0.0046 0.008 +/- 0.0004 
 H 0.31 +/- 0.01 0.023 +/- 0.0039 2.16   +/- 0.11 
P. pastoris N 0.48 +/- 0.01 0.27 +/- 0.02 0.31   +/- 0.17 
 L 0.45 +/- 0.02 0.36 +/- 0.06 0.71   +/- 0.19 
 H 0.25 +/- 0.01 0.69 +/- 0.02 5.72   +/- 0.14 
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Fig.2: Relative specific production in carbon-limited chemostat 
cultures (D ≤ 60% µmax) at different temperatures for S. cerevisiae 
(●), T. reesei (▲), P. pastoris  (■) and E. coli (♦).The relative 
temperature values indicate the temperatures at which µmax in 
batch culture would be reduced, relative to growth at the optimal 
temperature, by the percentages indicated. 
 
 
Table 4. The effect of oxygen provision on biomass yield, Fab 3H6 yield and ethanol production of recombinant P. 
pastoris (2) and S. cerevisiae, grown in glucose - limited  chemostat cultures at D = 0.1h
-1
. N – normoxic conditions, L 
– limited oxygenation, H – hypoxic conditions. +/- represents the standard error of the mean. 
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No data are available for E. coli and T. reesei. For E. coli no stable cultivations could be 
established at decreased oxygen concentration because of excessive foaming at oxygen-
limited conditions. Hypoxic conditions could not be applied due to the fact that media such as 
the one used in this study, do not support anaerobic cultivations. Standard media for aerobic 
cultivation of E. coli lack the co-factors selenium, nickel and molybdenum which are 
necessary for the formate hydrogen lyase complex (FLC). The FLC itself is induced under 
anaerobic conditions and serves to remove formate, which acts toxic on cells at high 
concentrations (49). 
 
Discussion 
The complex protein, Fab 3H6 was produced in 5 microbial host organisms with different 
success. The results demonstrate variation in the specific production between different 
expression hosts and platforms (Table 2). P. haloplantkis showed the highest specific 
production, demonstrating its potential as novel high yield protein expression host. 
Nevertheless, further optimization is required to improve P. haloplanktis growth rate, biomass 
yield and also to reduce medium complexity. Without these optimizations elaborate effort 
might be necessary to perform large scale cultivations.  
The methylotrophic yeast P. pastoris, which showed the second highest specific production, 
has already been used for a long time as a well suited host for heterologous protein 
production. Apart from its advantages to grow on methanol and also to grow to extremely 
high cell densities (>100g L-1 yeast dry mass), many proteins have already been produced at 
high titers in this yeast (12, 13, 57). The pGAP expression system may have contributed to 
the high specific production of Fab 3H6 in P. pastoris. Integration into the host genome 
results in a stable expression phenotype and application of high antibiotic concentrations (e.g 
100µg mL-1 Zeocin) enables the selection of multicopy clones with high gene copy number 
and consequently high recombinant protein mRNA levels (53).  
S. cerevisiae showed rather moderate product levels, which may be partially explained by 
the pYX integrative vector systems, which generally may result in lower gene copy number / 
mRNA level, than the P. pastoris pGAP vector. Furthermore, S. cerevisiae is generally 
known as a non high performance secretor. However, the 3H6 Fab is a glycosylated protein 
(12) and P. pastoris and S. cerevisiae differ in the extent to which they glycosylate proteins 
(Table 1). Extensive clone characterization at the level of transcript and gene copy number 
will be necessary to better understand the reasons for these differences between S. 
cerevisiae and P. pastoris.  
E. coli also showed low levels of heterologous Fab, similar to the amounts produced in S. 
cerevisiae, but it is well established that large proteins with an MW of >50kDa are difficult to 
express in bacterial host systems without extensive host/vector fine tuning. Specific 
production in E. coli might be increased by strictly controlling the ratio of heavy and light 
chain mRNA levels (48). In contrast, in the current study no strain engineering was applied 
and the heavy and light chain mRNA ratio was expected to be near 1:1 as they were both 
expressed under the control of the same promoter. 
Interestingly T. reesei showed the lowest specific production although other proteins could be 
produced at high yields in this filamentous fungus (24, 25). TRAC analysis for T. reesei 
revealed that mRNA levels for both chains were very low (data not shown). Therefore, a 
bottleneck at the transcript level might exist. Low levels of Fab secretion (< 1 mg L-1) in T. 
reesei have been reported previously. A more than a 50-fold increase in Fab production was 
achieved by fusing the heavy chain to T. reesei cellobiohydrolase CBHI, a strategy 
commonly applied for heterologous protein production in filamentous fungi (37). This fusion-
strategy was not applied in the present study to enable the comparison with the other host 
organisms, but not producing a fusion protein most likely contributed to the low secretion 
levels of the recombinant Fab in T. reesei. 
Generally, codon optimization might also increase product yields. Codon optimization has 
already been successfully applied in various host organisms to increase production of 
heterologous proteins (5, 7, 11, 31, 51). Nevertheless, it has been shown previously that 
codon optimization had no effect on the production of Fab 3H6 in P. pastoris (12). 
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Furthermore, codon usage analysis revealed that there are no significant differences in the 
general codon preferences of P. pastoris and S. cerevisiae (Supplemental data 3), indicating 
that for S. cerevisiae no improvement can be expected by codon optimization. In contrast 
codon usage analysis for E. coli revealed that many codons of the 3H6 Fab heavy and light 
expression cassettes represent less frequent codons in this bacterial host (Supplemental 
data 3). A great effect of codon optimization on productivity have been observed for E. coli 
(7), including our own unpublished data on Fab 3H6 expression, which showed that the 
productivity was increased by a factor of >10 when codon optimized sequences were used. 
With no data at hand for T. reesei and P. haloplanktis it remains unclear whether codon 
optimization can have a positive effect on Fab 3H6 secretion in these hosts. 
Product formation and secretion correlates with cellular growth (19). Generally, higher growth 
rates may increase the specific production in all organisms due to higher ribosomal / 
translational activity. In S. cerevisiae and P. pastoris, systems which use glycolytic or TCA-
cycle derived promoters, increased specific production may be also achieved at higher 
growth rate due to increased transcript levels of the heterologous protein. 
Reducing the cultivation temperature showed a positive effect on specific production in 3 out 
of 4 species analysed, namely E. coli, P. pastoris and T. reesei but had no significant effect 
on specific production in S. cerevisiae. An increase of cell viability and lower amount of 
proteases in the culture broth was considered to be responsible for the increased product 
yield in P. pastoris (21, 30). For example, a temperature controlled methanol fed-batch 
strategy was developed for P. pastoris to increase product yield by reducing cellular lysis and 
contamination with intracellular proteases (21). Along with the increased specific production 
at decreased temperature T. reesei and P. pastoris responded with an increase of biomass 
yield at temperatures below the optimal growth temperature, whereas no such increased 
biomass yield was observed in E. coli and S. cerevisiae. In S. cerevisiae a decrease of 
temperature resulted in a decrease of biomass yield, although a positive effect of a reduction 
of growth temperature below the so-called optimum growth temperature has already been 
reported in several studies for a wide variety of microorgansisms (23, 27, 32, 56). It was 
concluded, that reduced protein folding stress and therefore lower maintenance energy were 
responsible for the increase in biomass yield. This conclusion is in good agreement with 
transcript data and proteome data available for S.cerevisiae and P. pastoris. It has been 
reported that environmental stress response (ESR) gene transcription was reduced and 
ribosome biogenesis related gene transcription increased at low temperature steady state 
growth of S. cerevisiae (50). Proteome data for P. pastoris showed that transcript and protein 
levels for stress induced chaperones such as SSA4 were reduced during chemostat 
cultivation at 20°C, whereas no change of mRNA levels for recombinant Fab 3H6 was 
observed (8, 15). Taken together it seems plausible that physiological changes related to 
protein folding and energy demand lead to increased specific production and / or increased 
biomass yield in T. reesei, P. pastoris and E.coli. The fact that S. cerevisiae showed no 
temperature dependent change (in the tested range) of biomass yield, although it was 
observed in batch culture studies (32) and no change of specific production occurred, may 
highlight strain dependency of the physiological response to temperature. Furthermore, 
differences in protein folding and processing between S. cerevisiae compared to T. reesei (1) 
or P. pastoris (17) have been reported, which may also account for the different behaviour 
observed in this study. The behaviour of S. cerevisiae may also be simply dependent on the 
low production level of Fab 3H6 resulting in no protein folding / secretion bottleneck that can 
be relieved by decreased temperature like in the other species.  
E. coli additionally responded with increased leakage of recombinant Fab into the culture 
broth at lower temperature. This effect has already been described in previous studies (46), 
but it remains unclear, whether this effect was caused by increased recombinant protein 
amount itself or if low temperature triggered physiological changes that enhanced product 
leakage into the culture broth.  
Nevertheless, this work demonstrates that producing recombinant proteins at temperatures 
below the optimal growth temperature improves protein production in many if not all hosts, 
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although the reasons for this are not well understood and are beyond the scope of this 
investigation. 
Although oxygen availability and its strong effect on cellular physiology have been analysed 
for several species (22, 28, 43, 55), its potential impact on heterologous protein production 
and secretion had not been reported until recently (2). In oxygen-limited conditions 
metabolism is respirofermentative rather than purely respirative, as reflected in increased 
ethanol levels in S. cerevisiae and P. pastoris (Table 4). Increased transcript levels of the 
3H6 Fab heavy and light chain during hypoxic cultivation conditions in P. pastoris 
(unpublished data) might contribute to the increased productivity as during 
respirofermentative growth the flux and transcript levels for the glycolytic machinery 
increased, also boosting heterologous protein mRNA levels under the control of the GAP 
promoter. Still, this has to be further investigated, especially as there occurred no 
improvement of specific production in S. cerevisiae, although similar physiological events 
(22), happen in this yeast during growth at depleted oxygenation conditions. As in P. 
pastoris, the flux through glycolysis increases as the amount of oxygen available for the 
cellular metabolism is reduced (unpublished data). However, in S. cerevisiae (22) the 
mRNAs of genes involved in glycolysis are not increased in a comparable experimental 
setup (55). The different response of these two yeast species may highlight substantial 
differences in cellular control regimes, indicating massive regulation at the transcript level in 
P. pastoris and largely post-transcriptional regulation in S. cerevisiae. Nevertheless, it is still 
unclear whether recombinant protein transcript levels can be considered the sole explanation 
for increased production of 3H6 Fab in P. pastoris.  
The presented data show that common features as well as differences exist in the well-
established protein production factories used in this study. Although eukaryotic systems are 
thought to be better equipped for the production of complex, disulfide bonded proteins such 
as Fab fragments we could show that also prokaryotic systems such as P. haloplanktis have 
a great potential as host systems as high production could be achieved without elaborate 
strain and vector engineering. In contrast, the filamentous fungus T. reesei showed only a 
weak performance at the secretion of the 3H6 Fab, without applying the commonly used 
method of generating fusion proteins to enhance heterologous protein production.  
However, to analyse the host / platform dependencies of protein production more closely, 
other secreted model proteins, various vector systems and strains should be included in 
future studies. Additionally, with affordable high through-put transcript and proteome analysis 
available nowadays, proteome and transcript profiling will be applied to fully understand the 
influence of environmental factors on heterologous protein secretion and to shed more light 
onto the discrepancies that appeared among different host organisms.  
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Single chain antibody fragment production   
○ Batch cultivation: 
The anti 2-phenyl-5-oxazolone single chain antibody fragment ScFvOx production 
was firstly carried out by batch cultivation in LIV medium in optimised conditions. The 
production yield was evaluated by ELISA assays in presence of the hapten 2-phenyl-
5-oxazolone on total soluble extracts from samples collected at different times of 
cultivation. As show in Figure 24, growth profiles of P. haloplanktis TAC125 pUCRP-
scfv strain show a longer lag phase compared to that observed for the wild type and 
the Fab 3H6 producing strains. During the first 25 hours bacterial growth proceeds at 
a lower rate while just a few amount of recombinant ScFvOx is detected. After 30 
hours of cultivation a huge increase of bacterial growth rate and ScFvOx production 
titer are observed reaching the highest yield after about 48h.                          
By our optimised psychrophilic expression system, a maximum yield of of 4,69 ± 0,12 
mg L-1 of soluble and biologically active ScFvOx was obtained which is the highest 
reported so far by conventional prokaryotic expression systems even after inclusion 
bodies refolding (Patil et al., 2008). Moreover, performances of our optimized 
process led to a high specific productivity (YP/X= 
0,94±0,03 mg gX-1) suggesting that a further 
increase in specific biomass yield would lead to 
higher ScFvOx production titers.   
Cellular localisation of recombinant ScFvOx was 
also investigated by cellular fractionation and 
SDS PAGE analysis of total soluble protein 
extracts, cytoplasmic and periplasmic fractions 
(Fig. 25). The analysis revealed that a band 
corresponding to recombinant ScFvOx-c-Myc-
6xHis (about 35kDa) is present only in total and 
periplasmic extracts of recombinant P. 
haloplanktis TAC125 cells. The latter 
observation demonstrates that ScFvOx antibody 
fragment is not only nicely produced in soluble 
and active form but it is also efficiently and 
Figure 24: ScFvOx  titer, biomass yield and oxygen  consumption profiles in P. haloplanktis TAC125 pUCRP-scfv batch 
cultivation in LIV medium at 15°C. 
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Figure 25: SDS-PAGE analysis of recombinant 
ScFvOx cellular localisation on cytoplasmic (C), 
periplasmic (P) and total (T) protein extracts of 
P. haloplanktis TAC125 pUCRP-scfv cells.  Total 
soluble proteins of P. haloplanktis wild type 
strain was used as negative control (NC). Mk, 
molecular weight ladder. 
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totally translocated in the periplasmic compartment.  
Recombinant ScFvOx was affinity purified from 
total cellular extracts collected after 48h of batch 
cultivation in optimised conditions by using the 
C-terminal 6xHis tag (Fig. 26). The binding 
activity of purified ScFvOx was verified by 
ELISA assay in  the presence of the hapten 2-
phenyl-5-oxazolone. The analysis revealed a 
yield of 4,05 ± 0,18 mg L-1 of pure biologically 
active ScFvOx. Data collected indicate that, 
apart from a slight loss due to the purification 
step, all the recombinant product obtained by 
the optimised psychrophilic expression system 
is correctly folded and biologically competent. 
 
○ Continuous cultivation: 
ScFvOx production at low temperatures was also performed by a continuous 
cultivation strategy. In particular, a C-limited chemostat cultivation process was set-
up by using the optimised LIV medium for either batch growth phase and feeding. By 
a dilution rate of 0,05 h-1, the steady state was achieved for at least 5 resident times 
in which both the cell density and the product titer remain constant (Fig. 27). By the 
developed process a specific active ScFvOx productivity of 0,23 ± 0,05 mg L-1 h-1 
was achieved with a constant production yield of about 4,5 mg L-1.  
VHH antibody fragment production   
The anti- human fibroblast growth factor receptor 1 (FGFR1) VHH D6.1 production 
was performed by P. haloplanktis TAC125 pUCRP-vhh batch cultivation in LIV 
medium in optimised conditions. Registered growth profiles (Fig. 28) are comparable 
to those observed for P. haloplanktis TAC125 wild type strain. 
Analysis of production and cellular localisation of recombinant anti hFGFR1 
VHHD6.1 was carried out by semi-quantitative Western blotting analysis on total 
soluble protein extracts and periplasmic fractions of samples collected at different 
Figure 27: ScFvOx  titer, biomass yield and oxygen  consumption profiles in P. haloplanktis TAC125 pUCRP-scfv 
chemostat cultivation. 
Figure 26: SDS-PAGE analysis of ScFvOx affinity 
purification. T, total soluble extract; U, 
unbound proteins fraction; W, wash fraction; 
E1, elution 250mM imidazole; E2, elution 
500mM imidazole; mk, molecular weight 
protein ladder.  
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times of cultivation (Fig. 29). 
Immunodetection performed 
with anti c-Myc antibodies 
revealed VHHD6.1 soluble 
production during all 
fermentation and its correct 
periplasmic localisation 
during early (22h) and 
middle (29h)  exponential 
growth phase. In contrast, 
no recombinant VHHD6.1 
was found in periplasmic 
fraction extracted from 
samples collected at late 
exponential growth phase (42h) and stationary phase (60h) while production titers 
seem to increase during exponential growth reaching the highest yield at late 
exponential phase (42h). Furthermore, another specific signal showing an apparent 
molecular weight of about 30 kDa was detected in total soluble protein extracts 
probably corresponding to VHHD6.1 dimers. It is not surprising since a strong 
tendency of multimerisation has been reported for this and other formats of antibody 
fragments in vivo when their local concentration in recombinant host cells reaches a 
critical value (Hollinger and Hudson, 2005).  
It is worth to notice that as far as 
the high molecular weight signal 
relative intensity increases the 
secretion efficiency of 
recombinant product into 
periplasmic space seems to 
decrease. One explanation can 
be found in VHHs dimerisation 
kinetics that could be faster than 
the product recruitment by the 
periplasmic secretion system. On 
the other hand, VHH dimers 
formation could be a consequence of its cytoplasmic localisation. If protein secretion 
does not occur, its correct folding can not be achieved and hydrophobic interactions 
can take place among partly folded intermediates thus causing protein molecules 
aggregation in soluble dimeric complexes.  
Although the co-translational SRP-mediated secretion system was successfully 
employed for Fab and ScFv formats model proteins, VHHD6.1 translocation across 
the inner membrane results to be somehow inhibited at high cell densities. Further 
investigation has to be carried out in order to find out the reason of this phenomenon 
and the best strategy to overcome it. 
Recombinant anti hFGFR1 VHHD6.1 was partially purified from total soluble cell 
extracts by small scale His tag affinity chromatography (Fig. 30). Surprisingly, the 
purified product showed an apparent molecular weight of about 30 kDa 
corresponding to dimeric VHHD6.1. The total absence of purified proteins of the 
expected mass of about 15 kDa confirms the huge tendency of aggregation shown 
by this antibody fragment format even in soluble form. Moreover, the purified product 
resulted to be very poorly stable in solution when stored either at 4°C and -20°C 
Figure 29: Western blotting analysis of VHHD6.1 soluble production and 
cellular localisation on total protein extracts (T) and periplasmic fraction 
(P) of recombinant P. haloplanktis TAC125 pUCRP-vhh cells collected at 
different times of batch cultivation. 
Figure 28: P. haloplanktis TAC125 pUCRP-vhh growth profiles in batch 
cultivation in LIV medium at 15°C 
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(data not shown). The low protein stability prevented the 
quantification of its production yield and the evaluation of 
its binding activity. Further experiments are still ongoing in 
collaboration with Dr. A. De Marco of Ifom-IEO campus in 
Milan in order to clarify the recombinant VHH structure 
and to stabilise the product in order to be able to get 
information regarding its binding activity.  
 
 
Conclusions  
The number of candidate proteins used as biopharmaceuticals or in industrial 
processes is rapidly increasing in recent years and, in particular, the 
biopharmaceutical market is currently dominated by monoclonal antibodies and 
antibody fragments (Evans and Das 2005). However, efficient expression of genes in 
homologous/heterologous expression systems and rapid purification steps are 
actually major bottlenecks for industrial production of recombinant antibody-based 
biopharmaceuticals. In fact, although many recombinant proteins have been 
successfully produced by common prokaryotic (Escherichia coli) and eukaryotic 
(yeasts and CHO cells) hosts, these conventional systems have often proved to be 
unproductive due to the peculiar properties of the protein to be produced. One of the 
main limitations experienced while producing proteins in conventional mesophilic 
expression systems is the need to operate at their optimal growth temperature 
(usually above 30 ºC) for the production process. Since temperature has a general 
negative impact on protein folding due to the strong temperature dependence of 
hydrophobic interactions that mainly drive their aggregation in form of inclusion 
bodies, the production of recombinant proteins at low temperatures represents an 
exciting model to improve the quality of the products. Recombinant protein 
production in psychrophilic bacteria, i.e. at temperature as low as 4°C, may minimise 
undesired hydrophobic interactions during protein folding, desirably resulting in 
enhancing the yield of soluble and correctly folded products. In this context , a few 
cold adapted species are under early but intense exploration as cold cell factories, 
among them, Pseudoalteromonas haloplanktis being a representative example. The 
efficiency of cold-adapted expression systems was tested by fully soluble and 
biologically competent production of  several thermal-labile and aggregation-prone 
products (Parrilli et al., 2008). 
The aim of this work was the development of a new process for recombinant 
production of soluble antibody fragments by the psychrophilic bacterium P. 
haloplanktis TAC125. To test the versatility of the new developed process, the 
production of three aggregation prone model proteins was evaluated representing 
examples of different formats of antibody fragments: Fab, ScFv and VHH. 
The first part of this work was the development of an ad hoc expression system for 
antibody fragments genes based on the available genetic tools for recombinant 
genes expression at low temperatures. A rational approach was applied for the 
choice of promoter, molecular signal for periplasmic protein addressing and fusion 
tags for immunodetection and purification of products. Moreover an artificial operon 
was designed and constructed for Fab fragment production in heterodimeric form.  
Figure 30: SDS-PAGE analysis of VHHD6.1 affinity purification. T, total soluble 
cell extract; U, unbound proteins fraction; E1, elution 250mM imidazole; E2, 
elution 500mM imidazole; mk, molecular weight protein ladder. 
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By an experimental approach, a new defined minimal medium was developed to 
maximise bacterial growth parameters like specific growth rate and biomass yield  
and promoter transcription efficiency. 
The production of model antibody fragments has been evaluated in lab-scale 
bioreactor and the effect of different cultivation operational strategies on production 
yields has been investigated.  
Up to 4,0 mg L-1 of soluble and heterodimeric Fab 3H6 production were obtained by 
recombinant P. haloplanktis TAC125 batch cultivation in optimised conditions. The 
production yield was also stabilised in C-limited chemostat cultivation reaching a 
constant volumetric productivity of about 0,2 mg L-1 h-1. Moreover Fab 3H6 
production by continuous cultivation was also performed in comparison with other 
conventional microbial hosts including yeasts, filamentous fungi and bacteria in the 
framework of the European project GENOPHYS. The analysis revealed that Fab 3H6 
is produced very effectively by the psychrophilic expression system in optimised 
conditions leading to highest production yields together with Pichia pastoris 
expression system and to the highest specific productivity (Dragosit et al., submitted). 
Similar results were obtained for single chain antibody fragment model protein 
ScFvOx. About 5 mg L-1 of soluble and biologically active recombinant protein were 
obtained by recombinant P. haloplanktis TAC125 batch cultivation in optimised 
conditions. A volumetric productivity of above 0,2 mg L-1 h-1 of soluble and 
biologically active ScFvOx was stabilised in C-limited chemostat cultivation in 
optimised conditions.  
The production of recombinant VHHD6.1 heavy chain antibody fragment was also 
investigated in the optimised psychrophilic expression system. By batch cultivation in 
optimised conditions soluble and periplasmic production of recombinant VHHD6.1 
was achieved. Nevertheless, the low stability in solution of recombinant product  has 
prevented the analysis of its binding activity. 
It is worth to mention that when a codon usage analysis was performed on a set of 
genes highly expressed in P. haloplanktis TAC125 
(http://www1.unifi.it/scibio/bioinfo/caiap/results/cut/Pseudoalteromonas_haloplanktis_TAC125_
35%20set.cut) a number of rare codons were identified and most of them were found in 
antibody fragments coding genes (data not shown) reflecting the different origin of 
recombinant genes from the host strain. The presence of rare codons in recombinant 
genes, especially if consecutive,  may lead to amino acid misincorporation and/or 
truncation of the polypeptide, thus affecting the recombinant protein expression 
levels and quality (Rosano and Ceccarelli, 2009). A codon optimisation of 
recombinant antibody fragments coding genes can therefore be a good choice to 
further improve products yields.  
In conclusion, all tested antibody fragments were successfully produced in soluble 
and catalytically competent form. Our results demonstrated that the production of 
recombinant proteins in psychrophilic bacteria is not only a mature and reliable 
technology but it is also a successful strategy to overcome the product solubility 
problems often occurring in conventional systems such as in E. coli. In this context, 
P. haloplanktis TAC125 and the gene expression systems set up have a valuable 
biotechnological potential as non-conventional systems for the production of “difficult” 
proteins.and biopharmaceuticals such as recombinant antibodies and antibody 
fragments. 
 
 
 
50 
 
Part II: New Products 
 
Section 1: New regulated promoters identification for recombinant gene 
expression at low temperatures. 
Recombinant protein production at low temperatures is right now a mature and 
reliable technology. As previously described, there are already several tools available 
for recombinant genes expressions in the psychrophilic host P. haloplanktis TAC125. 
However, an effective cold expression system needs to be finely tuned possibly using 
ad hoc promoters. Indeed, physical separation between bacterial  growth phase and 
expression of the desired proteins can not only improve the productivity of the entire 
system but can also play an important role in the production of proteins toxic for the 
host cells. These goals can only be achieved by using regulated promoters and 
efficient induction strategies. 
Recently, by a proteomic approach, a two-component system has been isolated and 
characterized. The regulatory system (PSHAb0361–PSHAb0362) is involved in the 
transcriptional regulation of the gene coding for an outer membrane porin 
(PSHAb0363) and it is strongly induced by the presence of L-malate in the medium 
(Papa et al., 2008). The regulative region including the two-component system 
located upstream the PSHAb0363 gene has been used to construct the first inducible 
psychrophilic expression vector, named pUCRP, that is under the control of L-malate 
(Papa et al., 2007).  
The L-malate inducible expression system was successfully used in this work for 
recombinant production of soluble antibody fragments in P. haloplanktis TAC125. 
Nevertheless, good performances of the regulated promoter can be only achieved 
when branched amino acids are used as sole carbon sources for bacterial growth. 
The use of such substrates is unprofitable for a large scale production process due to 
their high cost and their very poor solubility in water. Moreover, the inducer itself, the 
L-malate, is also expensive and, since it is also consumed as carbon source by the 
psychrophilic bacterium, it is required in significantly high amounts (up to 4 g L-1) to 
ensure sufficient induction of recombinant gene expression during all the cultivation.   
As described in Part I-Section 2, a screening for suitable carbon sources for P. 
haloplanktis TAC125 growth revealed that the psychrophilic bacterium fast duplicates 
in minimal media containing amino acids like L-glutamate, L-aspartate and L-alanine. 
In particular,  the synthetic medium containing L-glutamate as sole carbon source led 
to the highest bacterial specific growth rate either at the optimal (15°C) growth 
temperature (Tab. 5) and at temperatures as low as 4°C (data not shown). Moreover, 
the price of sodium glutamate, which is commonly used as food additive and flavour 
enhancer, is much more affordable than that of branched amino acids and it has a 
very high solubility in water (up to 74% w/v at RT).  
Unfortunately, none of the psychrophilic promoters available so far shows high 
transcriptional efficiency in minimal media when L-glutamate is used as sole carbon 
source (data not shown).  
In this section the identification of P. haloplanktis TAC125 potentially regulated genes 
and the evaluation of their transcription rates in L-glutamate containing defined 
medium is described in the presence of inexpensive compounds or physical stimuli 
as inducers. The identification of new regulated psychrophilic promoters with high 
transcriptional efficiency in cheap minimal media could pave the way to the use of the 
novel psychrophilic expression system  even at industrial level. 
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Analysis of L-malate inducible promoter activity in different minimal media 
In order to verify if the low production yields obtained in L-glutamate containing 
medium by the L-malate inducible expression system was really due to a low 
promoter efficiency in those conditions a relative quantification of PSHAb0363 
transcription level was performed by Real Time PCR experiments. P. haloplanktis 
TAC125 wild type cells were grown in L-glutamate and in branched amino acids (LIV) 
containing media with or without L-malate. The inducer was added at t=0 at the 
concentration optimised for recombinant antibody fragments production (0,4% w/v). 
The analysis was performed on cDNA synthesised from total RNA extracted after 
24h of cultivation in shaken flasks at 15°C.  As shown in Figure 31, L-malate addition 
to the L-glutamate containing medium does not affect PSHAb0363 transcription thus 
confirming negative interference of L-glutamate or one of its catabolic derivatives on 
PSHAb0363 promoter transcriptional activation. On the contrary, in LIV medium, a 75 
folds increase in PSHAb0363 mRNA copy number is observed when L-malate is 
added to the culture. Data collected confirm that the L-malate regulated expression 
system for recombinant proteins production at low temperatures can be effectively 
used only when branched amino acids are used as carbon sources for bacterial 
cultivation and therefore the identification of new regulated promoters is needed in 
order to set up a feasible process for large scale recombinant proteins production in 
psychrophilic bacteria.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In silico analysis of P. haloplanktis TAC125 regulons involved in primary metabolism 
An in silico analysis of P. haloplanktis TAC125 genome was firstly carried out in order 
to identify genes and/or operons whose transcription is expected to be up-regulated 
in the presence of particular carbon sources.  
In bacteria, genes involved in primary metabolism processes are generally finely 
regulated in response to the nutrients availability. Marine bacteria are facing a 
medium generally unbalanced in terms of carbon, nitrogen, and phosphorous supply 
(Moran et al. 2004). Excess of several easily metabolised carbon sources present 
simultaneously is unlikely, making catabolite repression the exception rather than the 
rule. Indeed, P. haloplanktis TAC125 is lacking the cAMP-CAP complex that 
regulates carbon availability in related organisms such as Vibrio and Shewanella 
-                           + -                          + 
Figure 31: Real Time PCR relative quantification of P. haloplanktis TAC125 PSHAb0363 mRNA in L-glutamate and LIV media 
in the presence (+) or absence (-) of L-malate. RQ: relative quantification. 
L-Glu LIV 
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(Medigue et al., 2005). Furthermore, in contrast to many γ-proteobacteria, it does not 
possess the glycolytic pathway and a PTS system for the transport and first 
metabolic step of carbohydrate degradation. This accounts for its lack of growth on 
glucose, likely to be phosphorylated by glucokinase (PSHAa1364).  
P. haloplanktis TAC125 main metabolic pathway for pyruvate supply in the cell  is the 
Entner-Doudoroff pathway according to the use of gluconate as a preferred carbon 
source (Medigue et al., 2005). Furthermore P. haloplanktis TAC125 is also able to 
grow on galactose thus indicating the presence of a functional Leloir pathway. 
According to the latter observations, the regulation of genes involved in gluconate 
and galactose catabolism in P. haloplanktis TAC125 was investigated. 
 
o Gluconate catabolism 
  
Figure 32: The superpathway of gluconate degradation including the Entner-Doudoroff pathway I. (Klemm et al., 1996) 
The initial steps of gluconate metabolism in E. coli are its entry into the cell and its 
subsequent phosphorylation to 6-phosphogluconate. Then, two enzymes of the 
Entner-Doudoroff pathway, 6-phosphogluconate dehydratase (EC 4.2.1 .12) and 6-
phospho-2-dehydrogluconate aldolase (EC 4.1 .2.14), convert 6-phosphogluconate 
to pyruvate and glyceraldehyde 3-phosphate (Fig. 32).  
Two sets of genes are involved in transport and phosporylation of gluconate in E. 
coli. The main system, GntI, contains gntT and gntU, encoding high- and low-affinity 
gluconate transporters respectively, and gntK, a thermoresistant gluconokinase 
(Porco et al., 1998). The GntII system, which was discovered in a GntI deletion 
mutant, contains gntW and gntV, encoding another high-affinity gluconate transporter 
and a thermosensitive gluconokinase (Istúriz et al., 1986). Thus, in E. coli there are 
four known gluconate transporters, including GntP another gluconate permease 
Entner-Doudorof Pathway I 
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(Klemm et al., 1996). Previous genetic studies indicated that the GntI system is, 
together with the EDP genes edd and eda, negatively regulated by the gntR gene 
product (Izu et al., 1997). GntR belongs to the GalR-LacI family of regulators and it is 
highly conserved between bacteria (Haydon and Guest, 1991). In Figure 33 is shown 
the schematic representation of gntKU regulon. The gntR gene product which is 
constitutively expressed, binds to the operator site on gntKU promoter when 
gluconate is not present.  
Figure 33: E. coli gntKU gene local context. GntR and IdnR boxes indicate repressor binding sites and CRP box indicates 
cyclic AMP receptor protein activator binding site. Arrows and loops indicate promoters and terminators sites respectively. 
EcoCyc: Nucl. Acid. Res. 37:D464-70 2009 
Gene orthologs for all enzymatic functions required in Entner-Doudoroff pathway are 
present in P. haloplanktis TAC125 genome. In particular, orthologs of gntR and  
gntU, PSHAb0478 and PSHAb0479 respectively, were found in P. haloplanktis 
TAC125 chromosome II (Fig. 34). However structural organisation of GntI locus is not 
conserved in P. haloplanktis TAC125. The gluconate permease encoding gene is 
indeed a separate transcriptional unit in the psychrophilic bacterium and the gntK 
gene is replaced by a idnK homologue encoding a putative D-gluconate kinase active 
at low temperature. When an in silico analysis on PSHAb0479 promoter was 
performed it didn’t revealed the presence of conserved consensus sequence for the 
operator site in the permease transcription unit. However the  PSHAb0479 gene was 
selected for further investigation on its transcription regulation in the presence of D-
gluconic acid.  
 
 
Figure 34: Multi-genome alignment of gntU local gene context.  Genes colour indicates orthologous groups. 
 
o Galactose catabolism 
D-galactose catabolism goes through Leloir pathway (Fig. 35). The enzymes of the 
Leloir pathway catalyze the conversion of D-galactose  to the more metabolically 
useful version of the sugar, D-glucose-6-phosphate. In most organisms five enzymes 
are required to catalyze this conversion: a galactose-1-epimerase, a galactokinase, a 
galactose-1-phosphate uridylyltransferase, a UDP-glucose 4-epimerase, and a β-
phosphoglucomutase. D-glucose-6-phosphate in E. coli goes to glycolytic pathway 
while in P. haloplanktis TAC125 it is converted in 6-phosphogluconate which is 
recruited by the Entner-Doudoroff pathway. 
In E. coli, the genes responsible for D-galactose metabolism (the galactose operon 
galETKM) and for high affinity transport of methylgalactosides, glucose, and 
gntK gntU gntR yhhW 
yhgN 
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galactose (the mglBAC operon) (Fig. 36 A and B) are controlled by a repressor, 
GalR, and an isorepressor, GalS (Weickert and Adhya, 1993). Both operons are 
induced by D-galactose or by its nonmetabolizable analog, D-fucose. For GalR, 
inducer binding results in a loss of repressor affinity for DNA (Majumdar and Adhya, 
1987). The same mechanism is presumed to mediate mgl induction, which is under  
Figure 35: The Leloir pathway. Frey et al., 1996 
Figure 36: galETKM (A) ang mglBAC (B) gene local context. GalR and GalS boxes indicate repressor binding sites and green 
box indicates cyclic AMP receptor protein activator binding site. Arrows and loops indicate promoters and terminators sites 
respectively. EcoCyc: Nucl. Acid. Res. 37:D464-70 2009 
 
A 
galT galK galM galE 
B 
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the control of GalS (Weickert and Adhya, 1992a). GalR and GalS have overlapping 
regulatory specificities, as indicated by ultrainduction of the gal operon. Both belong 
to the GalR-LacI family of regulators (Weickert and Adhya, 1992b). While galS is 
negatively autoregulated and positively regulated by cyclic AMP (cAMP) receptor 
protein (CRP), galR is constitutively expressed. 
In P. haloplanktis TAC125 genome either the mgl operon and the galS regulator are 
not present. On the other hand a galR orthologue was found showing 42,7% identity  
to EcgalR (Tab. 5). Moreover, P. haloplanktis TAC125 gal operon shows a different 
organisation compared to E. coli (Fig. 37). The galE gene (PSHAa0469) is not 
included in the cluster and a new gene appears between galK and galM, 
PSHAa1768. It is predicted to encode a putative sodium/hexose cotransport protein 
but it shows only 20% identity with EcgalP.  
When the intergenic distances between P. haloplanktis TAC125 gal genes are 
considered, it appears that only galT and galK are included in gal operon. Those two 
genes are indeed overlapped (-1bp distance) showing the typical structure of P. 
haloplanktis TAC125 translationally coupled genes intergenic regions. A promoter 
scan was performed on galM and PSHAa1768 upstream regions (Bprom, Softberry) 
and it revealed the presence of consensus sequences for the constitutive 
transcription of the analysed genes (data not shown). Although the same analysis 
carried on galT upstream region did not reveal the presence of canonical consensus 
sequences for GalR binding, we considered worth to investigate on the 
transcriptional regulation of P. haloplanktis TAC125 galTK operon in the presence of 
D-galactose. 
 
Transcriptional analysis of gluconate permease PSHAb0479 
The relative amount of gluconate permease PSHAb0479 mRNA in P. haloplanktis 
TAC125 cells was evaluated during growth in defined medium containing L-
glutamate as carbon source in the presence/absence of 0,5% w/v D-gluconic acid. 
Real Time PCR analysis on cDNA synthesised from total RNA extracted after about 
24h of shaken flask cultivation at 15°C revealed that the addition of D-gluconic acid in 
the culture medium induces up to 20 folds increase of PSHAb0479 transcription (Fig. 
38). This finding confirms the presence of a functional D-gluconate dependent 
Organism  Gene  Gene Product  
E. coli K-12 substr. 
MG1655  
galR  GalR transcriptional dual regulator  
P. haloplanktis TAC125  PSHAa1771  putative GalR repressor of contiguous operon, likely to bind a 
galactoside  
Table 5: Cross-species comparison of galR orthologs (MetaCyc) 
Figure 37: Multi-genome alignment of galT and galE local gene context.  Genes colour indicates orthologous groups. 
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regulation mechanism for the 
transcription of genes involved in the 
uptake of gluconate in P. 
haloplanktis TAC125. Moreover, the 
psychrophilic gluconate permease 
promoter represents an interesting 
tool for the construction of new 
regulated expression vectors for 
recombinant proteins production at 
low temperatures. Indeed, sodium 
gluconate is a user friendly 
compound, highly soluble and quite 
inexpensive. Furthermore, D-
gluconate is also a good substrate 
for P. haloplanktis TAC125 growth 
and therefore the new promoter 
could be alternatively used  for 
constitutive expression of 
recombinant proteins in media 
containing D-gluconate as carbon 
source.   
 
 
Transcriptional analysis of galTK operon 
The effect of D-galactose on P. haloplanktis TAC125 galTK operon transcription was 
evaluated by Real Time PCR relative quantification of galT mRNA after 24h growth in 
defined medium containing L-glutamate as carbon source at 15°C in the 
presence/absence of 0,5% w/v D-galactose.  The analysis was performed on cDNA 
synthesised from total RNA. Surprisingly the analysis revealed that the amount of 
galT mRNA in the cell doesn’t significantly change when galactose is added in the 
culture medium (Fig. 39). The ability of the psychrophilic bacterium to grow in media 
containing D-galactose as sole carbon source indicates that the transcription of 
galTK operon in P. haloplanktis 
TAC125 is constitutively 
derepressed. The lack of GalS 
isorepressor and the different 
distribution of gal genes in P. 
haloplanktis TAC125 genome 
suggest that the transcriptional 
regulation of genes involved in 
galactose metabolism has been 
counter selected by the evolution of 
the psychrophilic bacterium. 
Moreover the in silico analysis of P. 
haloplanktis TAC125 galR promoter 
(Bprom, Softberry) underlined the 
presence of a conserved CRP 
binding site. The lack of cAMP-CAP 
complex in P. haloplanktis TAC125 
can be the reason of insufficient 
+ - 
Figure 38: Real Time PCR relative quantification of P. 
haloplanktis TAC125 gluconate permease PSHAb0479 mRNA in 
the presence (+) or absence (-) of D-gluconic acid. RQ: relative 
quantification 
Figure 39: Real Time PCR relative quantification of P. haloplanktis 
TAC125 galT (PSHAa1770) mRNA in the presence (+) or absence (-) 
of D-galactose. RQ: relative quantification 
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expression of GalR repressor which causes constitutive transcription of the genes 
responsible for galactose catabolism. However the transcriptional efficiency of galTK 
promoter can still be further investigated for constitutive expression of recombinant 
genes in P. haloplanktis TAC125. 
 
Alginate dependent transcription of PSHAa1748 alginate lyase 
An in silico analysis of P. 
haloplanktis TAC125 genome 
revealed the presence of three 
putative alginate lyase coding 
genes. Previous experiments 
demonstrated that two genes are 
always expressed while the 
PSHAa1748 mRNA was only 
detected by non quantitative RT-
PCR when alginate was added to 
the culture medium (unpublished 
results). The induction efficiency of 
alginate on  P. haloplanktis TAC125 
alginate lyase PSHAa1748 
promoter was then investigated by 
Real Time PCR relative 
quantification. The analysis was 
carried on PSHAa1748 cDNA 
synthesised from total RNA 
extracted after about 24h of shaken 
flask cultivation at 15°C in L-
glutamate deefined medium in the 
presence/absence of 0,3% w/v 
alginic acid. As shown in Figure 40, 
the addition of alginic acid leads to about 10 folds increase in PSHAa1748 gene 
expression. This makes the PSHAa1748 promoter a promising candidate for the 
construction of a new regulated psychrophilic expression system. However, although 
alginate is a quite inexpensive compound, it is very poorly soluble in water and highly 
viscous limiting its use at high concentrations. Therefore, alginic acid utilisation as 
inducer for recombinant gene expression in P. haloplanktis TAC125 should be 
carefully optimised to ensure good induction efficiency even at low concentrations. 
 
Temperature downshift induction: analysis of psychrophilic Trigger Factor differential 
expression 
The peculiar ability of P. haloplanktis TAC125 to grow in a wide range of 
temperatures (0-25°C) suggests that a molecular adaptation to temperature changes 
should occur even at transcriptional level. The identification of P. haloplanktis 
TAC125 promoters whose activity is specifically induced at low temperatures could 
represents an attractive feature for the construction of an effective cold-inducible 
expression system for recombinant protein production in P. haloplanktis TAC125. 
Previous experiments focused on the understanding of cell adaptation to the life at 
low temperatures by proteomics did not underline the presence of  specific sets of 
proteins (such as Cold Shock Proteins, Csp) whose expression is up- or down-
regulated at low temperatures (unpublished data).  More recently, a differential 
Figure 40: Real Time PCR relative quantification of P. haloplanktis 
TAC125 alginate lyase PSHAa1748 mRNA in the presence (+) or 
absence (-) of alginic acid. RQ: relative quantification 
-                            + 
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proteomic analysis of P. haloplanktis TAC125 grown at 4 and 18°C revealed that a 
particular protein, identified as the Trigger Factor (TF), results to be up to 50 folds 
over-expressed in response to temperature downshift (D’Amico S., personal 
communication).  
TF is a peptidyl-prolyl cis/trans isomerase that acts as a molecular chaperone by 
maintaining the newly synthesized protein in an open conformation. In prokaryotes, 
the ribosome-associated Trigger Factor is the first chaperone that newly synthesized 
polypeptides encounter when they emerge from the ribosomal exit tunnel (Hoffmann 
et al., 2006). In E. coli, Trigger Factor is induced upon cold shock and enhances its 
viability at low temperatures (Kandror and Goldberg, 1997). 
We analysed differential expression of P. haloplanktis TAC125 tig gene, encoding the 
psychrophilic Trigger Factor, at different temperature (4 and 15°C) in order to identify 
a new potential cold-inducible psychrophilic promoter to be used for recombinant 
gene expression at low temperatures.  
The quantification of P. haloplanktis TAC125 TF relative expression at different 
temperatures was carried out by 
Real Time PCR experiments on 
cDNA synthesised from total RNA 
extracted after about 24h of shaken 
flask cultivation in L-glutamate 
defined medium at 15°C and 4°C. 
Unfortunately, the analysis revealed 
that the amount of tig mRNA does 
not significantly change between the 
two tested temperatures (Fig. 41). 
The obtained result indicates that 
the observed up-regulation of TF 
protein expression at low 
temperatures probably occur at a 
translational or post-translational 
level and therefore other targets 
have to be searched out for the 
identification new psychrophilic 
regulated promoters induced by 
temperature downshift.    
 
 
Section 2: Extracellular protein secretion in P. haloplanktis TAC125 
Protein secretion into the extra-cellular environment is one of most desirable strategy 
to allow a rapid and not expensive recovery of recombinant proteins. Secretion to the 
culture medium has several advantages over intracellular recombinant protein 
production. These advantages include simplified downstream processing, enhanced 
biological activity, higher product stability and solubility, and N-terminal authenticity of 
the expressed peptide (Cornelis, 2000; Makrides, 1996; Mergulhaõ et al., 2004). If 
the product is secreted to the culture medium, cell disruption is not required for 
recovery. As bacteria usually do not secrete amounts of proteins higher then they 
have in the intracellular space, recovery of a recombinant gene product can be 
greatly simplified by a secretion strategy that minimises contamination from host 
proteins.  
Figure 41: Real Time PCR relative quantification of P. haloplanktis 
TAC125 Trigger Factor PSHAa2063 mRNA at different temperatures. 
RQ: relative quantification 
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The realisation of a "cold" recombinant secretion system in the Antarctic Gram-
negative bacterium P. haloplanktis TAC125 has been previously reported (Cusano et 
al., 2006b). This system efficiently conjugates the obvious advantages of 
extracellular protein targeting with the positive effect of low temperature on the 
recombinant product solubility. Indeed, low expression temperature can facilitate the 
correct folding of "difficult" products (Sahdev et al., 2008)  and the use of P. 
haloplanktis TAC125 as expression system  allowed the efficient production of some 
"intractable" proteins in soluble and active form at temperature as low as 4°C (Parrilli 
et al., 2008). The cold-adapted secretion system makes use of the psychrophilic -
amylase from P. haloplanktis TAB23 (Feller et al., 1992) as secretion carrier. Three 
chimerical proteins, made of the psychrophilic -amylase fused to an intracellular 
protein, were translocated in the extracellular medium with a secretion yield always 
above 80% (Cusano et al., 2006b). The system also allowed the correct disulphide 
bond formation of chimera components, secreting a fully active passenger (Cusano 
et al., 2006b).  
A deep understanding of the molecular mechanism driving extracellular protein 
secretion in the psychrophilic bacterium can pave the way to strain engineering 
strategies aimed at the construction of a P. haloplanktis TAC125 stain with improved 
secretion ability and reduced extracellular proteases content which can affect the 
quality of recombinant products (Cusano et al., 2006b). By an in silico analysis of P. 
haloplanktis TAC125 genome it is possible to indentify the presence of only one 
canonical secretion system, a Type II secretion machinery (T2SS), homologous to 
the General Secretory Pathway (GSP) already described in many other Gram-
negative bacteria (Sandkvist, 2001). Moreover, experimental evidences suggested 
that in P. haloplanktis TAC125 the secretion of the cold -amylase depends on a still 
uncharacterised pathway.  
The last part of this work has been focused on the study of P. haloplanktis TAC125 
secretion systems. Starting from the molecular and phenotypic characterisation of the 
canonical T2SS, we developed a P. haloplanktis TAC125 mutant strain with reduced 
extracellular proteolytic activity. Moreover the existence of a functional still 
uncharacterised Psychrophilic Secretion System (PSS) responsible for the cold -
amylase extracellular localisation was demonstrated and the first key component of 
this secretion machinery, the protein PssA, was identified.    
 
Results of this section are reported into the following published articles: 
 
General Secretory Pathway from marine Antarctic Pseudoalteromonas haloplanktis 
TAC125 
E. Parrilli, M. Giuliani, M.L. Tutino. Marine Genomics  2008, 1(3-4): 123-128 
 
Cell engineering of Pseudoalteromonas haloplanktis TAC125: construction of a 
mutant strain with reduced exo-proteolytic activity 
E. Parrilli, A.M. Cusano, M. Giuliani and M.L. Tutino. Microbial Cell Factories 2006, 
5 (Suppl 1):P36  
 
PhPssA is required for alpha-amylase secretion in Antarctic Pseudoalteromonas 
haloplanktis  
E. Parrilli, M. Giuliani, C. Pezzella, A. Danchin, G. Marino, M.L. Tutino. 
Microbiology 2010, DOI 10.1099/mic.0.032342-0- In press 
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Protein secretionType II secretion system (T2SS) is one of six protein secretion machineries that
permit the export of proteins fromwithin the bacterial cell to the extra-cellular milieu and/or into target host
cells. The ability to secrete proteins in the extra-cellular medium is a key aspect of the physiology of Gram-
negative bacteria. Indeed, secreted proteins provide the means, among others, by which microorganisms
interact and modify the surrounding environment. This is a crucial aspect for microorganisms capable to
survive in hostile extreme habitats, such as Antarctica. The sequencing and the annotation of marine
Antarctic Pseudoalteromonas haloplanktis TAC125 (P. haloplanktis TAC125) genome paved the way to
investigate on the molecular mechanisms of Type II dependent protein secretion in this bacterium. The
present work reports a detailed in silico description and a functional analysis of P. haloplanktis TAC125 T2SS
pathway, which features were compared with other already characterized T2SS machineries. The cold
adapted Type II secretion cluster resulted to be characterized by the notably presence of a downstream and
physically associated gene (called gspXX) which was found only in two other Alteromonadales T2SS gene
clusters. A transcriptional analysis of some P. haloplanktis TAC125 T2SS genes demonstrated that the
psychrophilic cluster was constitutively transcribed during the cell growth and that gspXX gene is co-
transcribed with another gene of the cluster. These data support the inclusion of gspXX into the cold-adapted
Type II secretion system cluster and point towards the existence of a novel and previously not described
component of the T2SS machinery. This evidence opens new questions concerning the role played by GspXX
protein in the architecture/function of the P. haloplanktis TAC125 T2SS machinery.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The external layer of the cell envelope of Gram-negative bacteria is
an essential barrier against undesirable compounds and a place of
intense trafﬁcking of proteins and signals. This layer allows the
exchange of various small nutrient molecules between the cells and
the environment. Nevertheless, it is a compartment of trafﬁc for large
proteins such as enzymes and toxins.
Numerous studies dealing with the molecular mechanism of
protein secretion have revealed that Gram-negative bacteria evolved
different strategies to achieve this process. Among them, the Type II
protein secretion system (T2SS), also known as the General Secretory
Pathway (GSP), is part of a two steps process in which proteins are
ﬁrst translocated across the inner membrane by the Sec (de Keyzer eteneral Secretory Pathway; TAT,
l sulphate polyacrylamide gel
anica e Biochimica, Università
elo via Cinthia 4, 80126, Napoli,
l rights reserved.al., 2003) or TAT (Voulhoux et al., 2001) pathway and then, are
transported from the periplasm to the exterior by an outer membrane
secretin (Filloux, 2004; Cianciotto, 2005; Sandkvist, 2001).
Dependingon the species, between 12 and 15 genes (often called gsp
genes) have now been identiﬁed as essential for Type II secretion, and
the homologous genes and gene products have been designated, for
most species, by the letters A through O and S. Although the T2SS serves
as an outer membrane translocase, essential components of this system
are found in four distinct sub cellular locations. Together, these proteins
forma trans-envelope complex that spans the entire length of periplasm
and penetrates both the outer and the cytoplasmic membranes.
GspD (also known as secretin) is embedded in outer membrane
where it works as gated secretion pore (Marciano et al., 1999; Filloux,
2004). A pilus-like structure comprising one major (GspG) and four
minor (GspH, -I, -J, -K) pseudopilins (Nunn and Lory, 1993; Bleves et al.,
1998; Sauvonnet et al., 2000) extends between cytoplasmic and outer
membrane (Hu et al., 2002). The presumably retractable assembly of
pseudopilins might facilitate protein secretion by acting as a piston
(Sandkvist, 2001).
Four cytoplasmic membrane proteins GspL, GspM, GspF and GspC
form a hierarchically structured complex (Tsai et al., 2002; Filloux,
Table 1
Plasmids and oligonucleotides primers used in this work.
Plasmids
pUCC Vector deriving from the pUCLoriT/oriR plasmid,
containing the T/R box, the transcription
termination signal from PhTAC125 aspC gene
and chloramphenicol resistance gene
(Tutino
et al., 2002)
pUCRP Vector deriving from the pUC18 plasmid, containing
the T/R box and the transcription termination signal
from PhTAC125 aspC gene and PSHAb0363 promoter
region
(Papa et al.,
2007)
pUCRDgspE Plasmid containing the gspE gene under the control
of PSHAb0363 promoter
(This work)
Oligonucleotides
Oligo
gspESalI-NdeIfw
5′-TCAGCTGCATATGACTAAGGCGATTG-3′
Oligo gspEXbaI-
PmeIrev
5′-AATCTAGAGTTTAAACAAACCGCCAAG-3′
Oligo 1 5′-TTGCATGCATGCGCATCATCCGG-3′
Oligo 2 5′-AAGAGCTCCTTCACTGAGCATCG-3′
Oligo 3 5′-TTTCTAGAATCCTATTGTGTCACCAC-3′
Oligo 4 5′-AAGAGCTCAATCGTCCGTTTACCG-3′
Oligo 5 5′-TTGAGCTCGCAGATGTGAGCTTTGG-3′
Oligo 6 5′-AAGAATTCTTTTAGGGTTGCATCAGC-3′
Oligo 7 5′-TTGCATGCGTTTTAATGCAATTACCC-3
Oligo 8 5′-AAGAGCTCTAATTTGATGGTATAGCG-3
124 E. Parrilli et al. / Marine Genomics 1 (2009) 123–1282004). Being able to mediate multiple protein–protein interactions, this
inner membrane (IM) complex may function as an energy- or signal-
transmittingmodule to couple the variousmolecular events required for
exoprotein secretion. The function of the GspC protein is unknown. Its
principal feature is the presence of a PDZ (Pallen and Ponting, 1997)
domain in the C-terminal region of the protein. PDZ domains mediate a
variety of protein–protein interactions. It is widely thought that PDZ
domain-containing proteins mediate the organization of multi-mole-
cular complexes at sites of membrane specialization. Direct interactions
have been demonstrated between GspC and GspD (Lee et al., 2000), as
well as betweenGspC and themajor pseudopilin GspG (Lee et al., 2005).
Classically, within the Type II secretion, GspM was shown to be crucial
for the stability of GspL (Michel et al., 1998). The stabilization process is
reciprocal because the abundance of GspM in the cell depends on GspL,
indicating that these two Gsp components interact with each other. In
addition, GspL is known to interact with the cytosolic secretion ATPase
GspE (Sandkvist et al.,1995). GspE is essential for the T2SS functionality
(Sandkvist et al., 1995) since likely it works as the energy-generating
component for the T2SS.
Beyond these core components, there are several other proteins
that are not conserved among the majority of genera, including GspN,
GspA, GspB, GspO and GspS. Possible functions have been suggested
for some of them. For instance, GspN protein is, like GspC, a bitopic IM
protein and the Xantomonas campestris GspN was proposed to take
part to the formation of the GspL–GspM complex (Lee et al., 2001; Tsai
et al., 2002). GspO is a specialized peptidase localized in the inner
membrane, likely involved in the N-terminal processing of the
pseudopilins, while GspS might assist the placement of the secretin
GspD in the outer membrane (Peabody et al., 2003; Filloux, 2004).
GspA and GspB form a complex within the cytoplasmicmembrane,
the role of this complex remains elusive looking at the panel of
putative proposed functions, which include energy transduction,
stabilization or increased expression of the Gsp complex and piloting
the secretin to the OM (Filloux, 2004).
Historically, the study of T2SS started from bacteria with
pathogenic capabilities; however, recent studies have shown that
GSP functionality may also confer an ecologic advantage to bacteria
growing in speciﬁc environments. Presently, there are genetic and
functional data to indicate the relevance of T2SS in bacteria that are
strictly environmental non-pathogens. Indeed, many non-pathogenic
organisms secrete proteins, such as cellulases and other degradative
enzymes, that help them adapt to their lifestyle.
For example, the T2SS pathway plays a fundamental role in the
lifestyle of the eukaryote-associated bacterium Pseudoalteromonas
tunicata D2, as the production of secondary metabolites with inhibitory
activity against bacteria and other organisms is directly correlated with
the existence of a functional GSP system in this bacterium (Egan et al.,
2002). Recently, it has also been shown that T2SS might promote the
persistence of the Legionella pneumophila in aquatic habitats by
facilitating both intracellular growth in fresh water amoebae and
extra-cellular growth at ‘low’ temperatures (Soderberg et al., 2004).
Recent reports on several Shewanella species have signiﬁcantly
contributed to increase our knowledge on the different functions
undertaken by the T2SS system, further shifting the focus of the T2SS
research from pathogenicity to ecology. Shewanella putrefaciens is able
to reduce Fe(III) andMn(IV) as part of the anaerobic respiratory process
due to a metal reductase complex that uses the GSP pathway to be
transported across the outer membrane (DiChristina et al., 2002). In
different Shewanella species, theGSP pathway is directly associatedwith
the transport of enzymes that carry out important biogeochemical
functions in the marine environment. For example, Shewanella
oneidensis strain MR-1 produces conductive pilus-like appendages
(nanowires) used to transfer electrons between cells and metal-oxide
surfaces under oxygen limitation (Gorby et al., 2006).
The evidence that the Type II secretion pathway is directly involved
in exporting enzymes with different ecological functions suggests thatthe GSP pathway has a signiﬁcant role in the ecology of environmental
bacteria. As often observed in Pseudoalteromonadales, the Antarctic
bacterium Pseudoalteromonas haloplanktis TAC125 (P. haloplanktis
TAC125) (Médigue et al., 2005) has a very good secretory ability, likely
related to the basic nutritional consequences of protein secretion if the
enzymes to be exported are hydrolases, i.e. enzymes able to broaden
up the nutritive substrate proﬁle. The sequencing and the annotation
of P. haloplanktis TAC125 genome (Médigue et al., 2005) paved the
way to investigate on the molecular mechanisms of protein secretion
in this Antarctic bacterium. The annotation of P. haloplanktis TAC125
genome highlighted the presence of a gene cluster coding for a Type II
secretion machinery which functionality have been recently reported
(Parrilli et al., 2008). The present work is aimed at a detailed in silico
description and a functional analysis of P. haloplanktis TAC125 GSP
pathway, which features have been compared with other already
characterized T2SS machineries.
2. Materials and methods
2.1. Strains and plasmids
P. haloplanktis TAC125 (Médigue et al., 2005) was isolated from
Antarctic sea water. Escherichia coli DH5α (Hanahan, 1983) was used
as host for the gene cloning. E. coli strain S17-1(λpir) was used as
donor in intergeneric conjugation experiments (Tascon et al., 1993).
2.2. Growth conditions and analytical procedures
P. haloplanktis TAC125 was grown in aerobic conditions at 15 °C in
TYP broth (16 g/l yeast extract, 16 g/l bacto tryptone, 10 g/l marine
mix) at pH 7.5, supplemented with ampicillin 200 µg/ml, or
chloramphenicol 25 µg/ml if transformed when required. Antarctic
bacteria transformation was achieved by intergeneric conjugation as
previously reported (Duilio et al., 2004).
E. coli cells were routinely grown in Terriﬁc broth (Sambrook and
Russell, 2001) at 37 °C. When required, antibiotics were added at the
following concentrations in liquid cultures: 100 µg/ml of ampicillin, or
cloramphenicol at 50 µg/ml ﬁnal concentration. Genetic manipulations
were carried out as previously described (Sambrook and Russell, 2001).
P. haloplanktis TAC125 DNA genomic puriﬁcationwas performed by
ChargeSwitch gDNA Mini Bacteria Kit (Invitrogen).
125E. Parrilli et al. / Marine Genomics 1 (2009) 123–128Protein samples were analyzed by Polyacrylamide Gel Electro-
phoresis (SDS-PAGE) (12% acrylamide, w/v) according to standard
methods (Sambrook and Russell, 2001).
2.3. Construction of vector pUCRDgspE
pUCRDgspE was constructed starting from pUCC vector, a plasmid
deriving from the pUCLOriT/R plasmid (Tutino et al., 2002), contain-
ing the T/R box, the transcription termination signal from PhTAC125
aspC gene and chloramphenicol resistance gene. In this vector was
cloned the gspE gene under the control of L-malate inducible
promoter. DNA fragment containing promoter region of PSHAb0363
gene(P363) was extracted from pUCRP (Papa et al., 2007) vector by a
double HindIII and NdeI digestion. The gspE gene was ampliﬁed to
introduce NdeI and PmeI restriction sites (primers oligo gspESalI-
NdeIfw and oligo gspEXbaI-PmeIrev see Table 1) and the PCR product
was subjected to a double NdeI and PmeI digestion. Promoter region
and gspE gene were introduced in pUCC vector digested using HindIII
and SmaI restriction enzymes.
2.4. RNA isolation and RT-PCR analysis
P. haloplanktis TAC125 cells were grown at 15 °C in TYPmedium and
total RNA was extracted according to Tosco et al. (2003). RNA was
reverse transcribed using SuperScript II RNase H-Reverse Transcriptase
(Invitrogen) according to the manufacturer's instructions. cDNAs were
ampliﬁed using as primers speciﬁc oligonucleotides (Table 1) designed
on P. haloplanktis TAC125 genome sequence, and Taq polymerase
(Promega, Madison, WI, USA) according to the manufacturer's instruc-
tions. The reactionmixturewasampliﬁed (denaturation at95 °C for45s;
annealing at 58 °C for 45 s; extension at 72 °C for 1 min, 35 cycles).
2.5. Zymographic assay
P. haloplanktis TAC125wild type and gspEmutant strainswere grown
in standard conditions and culture samples were collected. Samples
were centrifuged at 10000 ×g for 5min at 4 °C and the upper phasewas
collected for further analysis. The collected culture media were tenfold
concentrated by Centricon (AMICON, exclusion size 5 kDa), and 12 µl
were loaded onto a non reducing sodium dodecyl sulfate-polyacryla-
mide gel electrophoresis (SDS-PAGE) containing gelatin (1.5 mgml−1).
After electrophoresis, gel was soaked twicewith 2.5% Triton X-100 (v/v)
solution for a total of 60min to remove SDS. The gel was then incubated
in a developing buffer (50mMTris–HCl, pH 7.5, containing 5mMCaCl2)
for 18 h at 15 °C, rinsed with water, and stained with Coomassie blue
R250. Areas of gelatin digestion corresponding to proteolytic activies
were visualized as unstained regions in the gel.Fig. 1. Schematic representation of Pseudoalteromonas haloplanktis TAC125, P. tunicata D2,
Schewanella oneidensis Type II secretion clusters. Genes (from A to O and S) are represente
the same color. The P. aeruginosa and E. chrysanthemi T2SS gene clusters have a different
introduced to indicate that genes are not adjacent. (For interpretation of the references to c3. Results and discussion
3.1. In silico analysis of gsp cluster from P. haloplanktis TAC125
P. haloplanktis TAC125 General Secretory Pathway is located on its
larger chromosome and it is made up of twelve genes organized into a
cluster including gspC-N (Fig. 1). Respect to Type II secretion pathways
present in other Gram-negative bacteria, the psychrophilic GSP
contains all genes codifying functions necessary for the secretion
system activity i.e.: the gene encoding the secretion ATPase GspE and
pseudopilin genes gspG, -H, -I, -J, -K. P. haloplanktis TAC125 genome
also contains the genes encoding the cytoplasmatic platform
components (gspC, -F, -L, -M) and the secretin (gspD), but it is devoid
of genes encoding GspA, -B, -O, -S proteins.
As for the absence of gspO gene in Type II secretion cluster, in those
specieswhere theOgene is not physicallyassociated to the rest of the Type
II secretiongenes, it is often foundclusteredwitha subsetof genes required
for Type IVpilus biogenesis. In these species theprepilinpeptidase exhibits
a dual function, i.e. it is required for processing andmethylation of both the
Type IV prepilin subunits as well as the prepilin-like components encoded
by the Type II secretion genes gspG, -H, -I, -J, and -K (Strom et al., 1993;
Pugsley and Dupuy, 1992). It is therefore likely that in P. haloplanktis the
role of the prepilin peptidase is played by the protein codiﬁed by
PSHAa0380genewhich is located ina conservedPhTAC125genomeregion
coding for a canonical Type IV pilus biogenesis system (Médigue et al.,
2005).
A databank search looking at the distribution of the gspN gene in
T2SS containing genomes highlighted that this gene is present only
in a reduced number of GSP clusters, thus conﬁrming the likely
dispensability of its encoded protein, which function still remains
not understood. Interestingly, as shown in Fig. 1, PhTAC125 contains a
gspN gene and 21 bp downstream of its stop codon, an open reading
frame is found, in the same direction of the gsp cluster. This coding
sequence, annotated as PSHAa0243 gene, is characterized by a
canonical SD sequence (5′-AAAGAG) centered at −8 from the ATG
start codon and encodes a hypothetical protein of 195 aa (hereafter
called GspXX). The position of this gene is suggestive of a potential
involvement of its encoded product in the cold-adapted GSP
function, and it makes atypical the P. haloplanktis TAC125 gsp cluster.
Other two Alteromonadales, P. tunicata D2 (NZ_AAOH00000000)
and Alteromonadales bacterium TW-7 (NZ_AAVS00000000), present
a similar Type II gene cluster organization (Fig. 1), that includes a
gene homologue to PSHAa0243 (Evans et al., 2008). The GspXX
protein contains highly conserved regions, one of which is the YgfB-
YecA domain (IPRO11978), so called because it was found for the ﬁrst
time in the E. coli proteins YgfB and YecA. This domain, which
function is still unknown, characterizes several other proteins andAlteromonadales bacterium TW-7, Pseudomonas aeruginosa, Erwinia chrysanthemi, and
d by arrowheads to indicate their orientation, and homologous functions are ﬁlled by
designation, and have been called xcp and out gene clusters, respectively. Spaces are
olour in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 2
Identity percentages between P. haloplanktis TAC125 GSP proteins and their homologues
in selected bacteria.
Pseudomonas
aeruginosa
Erwinia
chrysanthemi
Shewanella
oneidensis
Pseudoalteromonas
tunicata D2
Alteromonadales
bacterium TW-7
GspC – 28 37 51 76
GspD 35 48 55 75 89
GspE 64 63 72 80 90
GspF 47 55. 58 76 89
GspG 50 58 57 75 94
GspH 36 22 35 59 82
GspI 36 39 35 62 80
GspJ 30 34 31 64 87
GspK 28 34 37 52 81
GspL 25 25 33 49 75
GspM 20 27 33 46 80
GspN – 23 26 41 85
GspXX – – – 34 76
126 E. Parrilli et al. / Marine Genomics 1 (2009) 123–128consists of two tightly associated 3-helical bundles with different
twists (Galkin et al., 2004).
Fig. 1 also presented the genetic organization of T2SS gene cluster
in S. oneidensis, Pseudomonas aeruginosa and Erwinia chrysanthemi.
These micro-organisms have been selected due to the close phyloge-
netic relationship with P. haloplanktis TAC125 (S. oneidensis) or
because their T2SS systems have been extensively characterized.
Each P. haloplanktis TAC125 gsp gene product was pair wise
compared to thehomologousprotein (if present) from theother selected
micro-organisms, and the resulting identity percentages are reported in
Table 2. As a whole, the identity percentages reﬂect the phylogenetic
relatedness between P. haloplanktis TAC125 and the compared bacteria,
where Tw-7 is the closest one. Some Gsp proteins (i.e. GspC, -L and -M)
resulted to be less conserved, while GspE, -F, and -G turned out to be
proportionally more invariant. These observations are in good agree-
mentwith those previously reported in literature (Sandkvist et al.,1995).
3.2. P. haloplanktis TAC125 genome encodes a functional GSP protein
secretion system
In a recent paper (Parrilli et al., 2008), we described the construc-
tion of a P. haloplanktis TAC125 genomic mutant strain in which GSP-
dependent secretion was completely abolished. This mutant was
obtained by insertional mutagenesis of gspE gene that encodes a
specialized ATPase whose inactivation in other Gram-negative
bacteria resulted in the total loss of T2SS functionality (SandkvistFig. 2.12% SDS-PAGE analysis of tenfold concentratedculture supernatants ofP. haloplanktis
TAC125wild type (wt) and gspEmutant cells (gspEmutant) grown in richmedium at 15 °C.et al., 1995). When grown at 4 °C, the P. haloplanktis TAC125 gspE
mutant strain resulted to secrete a reduced number of proteases with
respect to the wild type strain (Parrilli et al., 2008), thus demonstrat-
ing the cold-adapted GSP functionality at 4 °C.
In order to asses the GSP functionality in different environmental
conditions, the P. haloplanktis TAC125 gspEmutant strain grown at 15 °C
in richmedium, and concentrated culture supernatants of P. haloplanktis
TAC125 wild type and gspEmutant were analyzed by SDS-PAGE (Fig. 2).
The analysis of the extra-cellular protein content demonstrated that also
in these growth conditions the gspE mutant actually secretes lower
amounts of proteins with respect to the wild type strain (Fig. 2). Extra-
cellular protein secretion is however not completely abolished in the
gspEmutant strain, thus supporting the functionality of other secretion
pathways different from T2SS in P. haloplanktis TAC125.
The extra-cellular protease secretion in P. haloplanktis TAC125 gspE
mutant strain was investigated by gelatin zymography of concentrated
culture supernatants. As shown in Fig. 3, the gspE mutant sample
contains a notably reduced number of proteolytic activities as compared
to the protease content of wild type sample.
To exclude that the inability of P. haloplanktis TAC125 gspE mutant
cells to secrete proteases was due to a polar effect on expression of
gspE neighboring genes, a complementation experiment was carried
out. The complementing plasmid, pUCRDgspE, was constructed to
restore the GspE function in P. haloplanktis TAC125-gspE cells. This
plasmid contains the DNA sequence encoding gspE gene under the
control of a regulated promoter (Papa et al., 2007), which function is
induced by L-malate.
The mutant strain was transformed with pUCRDgspE plasmid and
the recombinant cells were grown at 15 °C in rich medium in the
presence of 0.1% malate. The extra-cellular protease secretion in P.
haloplanktis TAC125 gspE (pUCRDgspE) complemented strain was
investigated by gelatin zymography of concentrated culture super-
natants. As shown in Fig. 3, the secretion of the psychrophilic proteases
is partially restored in P. haloplanktis TAC125 gspE complemented cells.
The partial recovery of protease secretion is likely a consequence of the
altered stoichiometry of Type II protein complex components.
3.3. Transcriptional analysis of GSP cluster from P. haloplanktis TAC125
As previously discussed, GSP system is one of the most widespread
protein secretion systems in Gram-negative bacteria (Cianciotto, 2005).
This observation may reﬂect an early appearance of this system during
bacteria evolution, associated to its efﬁciency in protein translocation.Fig. 3. Zymography of ten fold concentrated supernatants withdrawn from P.
haloplanktis TAC125 wild type, P. haloplanktis TAC125 gspE mutant, and P. haloplanktis
TAC125 gspE mutant-(pUCRDgspE) cultures at middle exponential phase. In this
experiment the zymographic developing time was 18 h, a condition that assures the
detection of all proteases contained in the sample.
Fig. 4. Non quantitative Reverse Transcriptase RT-PCR analysis of gspC, gspE, and gspN genes in P. haloplanktis TAC125 cells. 1, RT-PCR analysis of sample withdrawn at 15 h; 2, RT-PCR
analysis of sample withdrawn at 47 h; 3, positive control, PCR reaction carried out on P. haloplanktis TAC125 genomic DNA; 4, negative control, PCR reaction carried on P. haloplanktis
TAC125 DNA-free total RNA; 5, PCR negative control; M, broad range DNA ladder. The Fig. contains schematic representations of the expected PCR products, where black arrows
indicate the annealing position of oligonucleotide primers (see Table 1) used for PCR experiments.
127E. Parrilli et al. / Marine Genomics 1 (2009) 123–128Although extremely conserved in structure/genetic organization,
T2SS functionality can be subjected to a wide array of regulatory
networks, often associated to the speciﬁc role to be exerted by the
secreted passenger(s). Therefore, reports can be found in literature
either on constitutively expressed T2SSmachineries or onGSP secretionFig. 5. Non quantitative Reverse Transcriptase RT-PCR analysis of gspXX gene. Panel gspXX: 1, RT-P
positive control, PCR reaction carried out onP haloplanktisTAC125 genomicDNA;4, negative contr
M, broad range DNA ladder. Panel gspXX–gspN: non quantitative Reverse Transcriptase RT-PCR an
Theﬁgure containsschematic representationsof expectedPCRproductswhereblackarrows indicasystems which function is actually regulated in a growth-phase-
dependent manner as a result of quorum sensing or auto induction
mechanisms (Sandkvist, 2001).
In order to asses if in P. haloplanktis TAC125 the gsp genes
expression is growth-phase-dependent, a Reverse Transcriptase (RT)-CR analysis of samplewithdrawn at 15 h; 2 RT-PCR analysis of samplewithdrawn at 47 h; 3,
ol, PCR reaction carried onP haloplanktisTAC125DNA-free total RNA; 5 PCRnegative control;
alysis of the region between gspN and gspXX genes. Lanes 1 toM, see legend of Panel gspXX.
te theannealingpositionof oligonucleotidesprimers (seeTable1)used for PCRexperiments.
128 E. Parrilli et al. / Marine Genomics 1 (2009) 123–128PCR analysis was performed. Total RNA was extracted from cell
samples withdrawn at exponential (15 h) and stationary (47 h)
growth phases and was used to evaluate the transcription of gspC,
gspE, and gspN. As shown in Fig. 4 (lanes 1 and 2), all the tested gsp
genes resulted to be constitutively expressed in P. haloplanktis TAC125
cells. These results suggest that GSP functionality may be required
over the development of psychrophilic bacterial culture.
The same approach was used to investigate the expression of gspXX
gene. TheReverse Transcriptase (RT)-PCR analysis shown in Fig. 5, panel
gspXX, demonstrates that the gene is actually expressed in the tested
conditions, and that its expression is growth-phase-independent.
As previously observed, the relative position of gspXX and gspN
genes suggests that they could be co-transcribed. A transcriptional
analysis performed using oligonucleotides designed to amplify the
region between the two genes (Fig. 5, panel gspN–gspXX) was carried
out. The presence of a PCR product of the expected size and sequence
demonstrated that gspXX and gspN genes are co-transcribed in these
experimental conditions. This evidence supports the inclusion of
gspXX into the cold-adapted gsp cluster, and opens new questions
concerning the role played by GspXX protein in the architecture/
function of the psychrophilic T2SS machinery.
4. Conclusion
The present paper reports a detailed in silico description of P.
haloplanktis TAC125 T2SS gene cluster, the ﬁrst one isolated from an
Antarctic marine bacterium. This cluster is characterized by the notably
presence of a downstream and physically associated gene (called gspXX)
which was found only in two other Alteromonadales gsp gene clusters.
The cold-adaptedGSPmachinerywasdemonstrated to be responsible for
the extra-cellular addressing of a large number of P. haloplanktis TAC125
proteins, proteases amongst others. Transcriptional regulation of T2SS
gene expression was also investigated, and it turned out that the tested
psychrophilic gsp genes were constitutively transcribed during the cell
growth. Furthermore, the gspXX transcription was veriﬁed, and the
inclusionof this gene into the cold-adaptedgsp clusterwas demonstrated
by the co-transcription of the gspN–gspXX genes. These data pointed
towards the existenceof anovel andpreviouslynotdescribed component
of theGSPmachinery,which role shouldbe investigated topossibly relate
its presence with the adaptation to marine psychrophilic lifestyle.
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Background
We have already shown that using cold-adapted bacteria
as host vectors, some "intractable" proteins can be effi-
ciently produced at temperature as low as 4°C [1,2]. Fur-
thermore, we set up a "cold" gene-expression system
implemented for the secretion of recombinant proteins in
the Antarctic Gram-negative bacterium Pseudoalteromonas
haloplanktis TAC125 (PhTAC125). Such a system could
effectively conjugate the positive effect of low temperature
on the recombinant product solubility with the obvious
advantages linked to extra-cellular protein targeting. This
novel system makes use of the psychrophilic α-amylase
from PhTAB23 [3] as secretion carrier. Several chimerical
proteins were produced and used to test the versatility and
efficiency of the novel secretion system. All the chimerical
proteins were efficiently produced and secreted (Cusano
AM, Ph. D thesis 2005 Università di Napoli "Federico II").
However, bacteria belonging to Pseudoalteromonas genus
are reported to secrete a wide range of exo-proteins, espe-
cially proteases. This feature could hamper both applica-
bility and efficiency of the cold-adapted secretion system,
due to the possible recombinant product degradation.
The PhTAC125 genome sequence [4] was recently deter-
mined. The in silico genome analysis highlighted the pres-
ence of a putative Type II secretion system (T2SS), while
the extra-cellular targeting of the cold α-amylase depends
on a still uncharacterized secretion pathway [4].
Results
Construction of the PhTAC125 suicide vector
Figure 1 shows the Vs suicide vector constructed to gener-
ate PhTAC125 genomic mutants. It is characterised by the
presence of: i) the pJB3-derived oriT (1), a DNA fragment
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Schematic representation of the PhTAC125 Vs suicide vectorFigure 1
Schematic representation of the PhTAC125 Vs suicide vec-
tor. mcs, Multiple cloning site; oriT, origin of conjugative 
transfer [1]; oriC and AmpR, origin of replication and beta-
lactamase encoding gene from the pUC18 vector; P13, syn-
thetic psychrophilic promoter; pheSGly294, E. coli gene encod-
ing a mutated version of the α subunit of Phe-tRNA synthase.
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Microbial Cell Factories 2006, 5(Suppl 1):P36responsible for the initiation of the conjugative transfer
between an Escherichia coli λpir strain (donor) and the psy-
chrophilic cells (acceptor); ii) the E.coli blaM gene, encod-
ing a mesophilic β-lactamase which is used as selection
gene to isolate the first site-specific integration event; iii)
pheSGly294, which encodes a mutated version of the E. coli
α subunit of Phe-tRNA synthase [5], which renders bacte-
ria sensitive to p-chlorophenylalanine. This phenylalanine
analog is used as counterselective agent for the isolation of
those strains in which a second recombination event
occurred. To assure a proper level of pheSGly294 expression,
its transcription was subjected to the control of a psy-
chrophilic synthetic promoter (P13).
Construction of a PhTAC125 gsp- [ΔgspCN] strain
To inactivate the T2SS pathway in PhTAC125 (Figure 2), a
deletion strategy was applied. Two genomic fragments
were PCR amplified by using specific oligonucleotides as
primers. They correspond to the 5' 360 bp portion of gspC
and 3' 300 bp portion of gspN respectively. The fragments
were suitably digested and cloned into the Vs vector. The
resulting vector (VsCN) was mobilized by intergeneric
conjugation [1] into PhTAC125, and the cells were plated
at 4°C on TYP solid medium containing 30 μg/ml carbe-
nicellin to select those in which a single recombination
event occurred. Second recombination event was induced
by repeated plating of mutant psychrophilic cells at 4°C
on minimum solid medium containing 20 mM p-ClPhe.
The occurrence of the correct deletion was checked by
sequencing the specific PCR fragments.
Phenotypic characterization of PhTAC125 gsp- strain
The global exo-proteolytic activity of the PhTAC125 gsp-
strain was analyzed by in gel zymography and compared
to that of the wild type strain. As shown in figure 3, culture
supernatant of gsp- strain contains a reduced number of
exo-proteases.
Conclusion
We report here a cell engineering approach to the con-
struction of a Ph TAC125 strain with reduced exo-protease
activity. By applying a gene-placements strategy, we
obtained a mutant strain in which the gene cluster encod-
ing the T2SS was almost totally deleted. While the growth
behavior and some physiological features of the gsp-
mutant are indistinguishable from the wild type ones, the
deleted strain displays a remarkable reduction in the pro-
Gelatin zymography of PhTAC125 wt and gsp- supernatantsFigure 3
Gelatin zymography of PhTAC125 wt and gsp- supernatants. 
Psychrophilic cells were grown in TYP medium at 4°C till late 
exponential phase. Culture supernatants were recovered by 
culture centrifugation, 10 times concentrated and loaded 
onto a 10% SDS-PAGE containing bovine gelatin. After the 
electrophoresis run, the gel was washed to remove the Na-
SDS and incubated in the development solution overnight at 
15°C. Finally the gel is stained with Comassie blue and 
destained. Molecular weight markers were marked in kDa.
118.0
85.0
47.0
36.0
26.0
      wt             gsp-
Genetic organization of the PhTAC125 gsp cluster and gspCN deletionFigure 2
Genetic organization of the PhTAC125 gsp cluster and gspCN deletion. The PhTAC125 gsp- mutant was generated by deleting a 
genomic region corresponding to that displayed into the dotted rectangle.
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tease content in the culture supernatant. This aspect
makes the PhTAC125gsp- mutant a promising host for the
recombinant secretion into the host extra-cellular
medium of proteins with biotechnological potential.
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Extracellular protein secretion is an essential feature in bacterial physiology. The ability to
efficiently secrete diverse hydrolytic enzymes represents a key nutritional strategy for all bacteria,
including micro-organisms living in extreme and hostile habitats, such as cold environments.
However, little is known about protein secretion mechanisms in psychrophilic bacteria. In this
study, the recombinant secretion; of a cold-adapted a-amylase in the Antarctic Gram-negative
Pseudoalteromonas haloplanktis TAC125 was investigated. By a combination of several
molecular techniques, the function of the pssA gene was related to a-amylase secretion in this
psychrophilic bacterium. Deletion of the pssA gene completely abolished amylase secretion
without affecting the extracellular targeting of other substrates mediated by canonical secretion
systems. The pssA gene product, PssA, is a multidomain lipoprotein, predicted to be localized in
the bacterial outer membrane, and displaying three TPR (tetratricopeptide repeat) domains and
two LysM modules. Based on functional annotation of these domains, combined with the
experimental results reported herein, we suggest a role for PssA as a molecular adaptor, in charge
of recruiting other cellular components required for specific a-amylase secretion. To the best of
our knowledge, no proteins exhibiting the same domain organization have previously been linked
to protein secretion.
INTRODUCTION
Protein export systems are present in all living organisms.
Bacteria have evolved several complex systems for protein
export. Didermic< bacteria face a special challenge in this
regard, since secreted proteins must cross the inner
membrane, the periplasmic space, and the outer mem-
brane. Secretion of proteins takes place via a variety of
mechanisms, from simple one-component systems to
complex multi-component pathways (Desvaux et al.,
2009; Johnson et al., 2006).
This wide diversity in the structure of protein secretion
systems can be interpreted in the light of the central role
played by extracellular protein secretion in bacterial
physiology. Secreted proteins provide the means by which
micro-organisms interact with and modify their surround-
ing environment, also a crucial aspect necessary for survival
in hostile extreme habitats, such as Antarctica. Although
several cold-adapted exoenzymes have been characterized,
the small amount of information available on the
mechanisms responsible for their extracellular addressing
has come from our laboratory (Cusano et al., 2006a, b;
Parrilli et al., 2008b, 2009; Tutino et al., 2001). The
development of a cold-adapted expression system (Parrilli
et al., 2008a) paved the way to investigate the cellular
machineries devoted to protein secretion in Antarctic
bacterial hosts. The a-amylase from Pseudoalteromonas
haloplanktis TAB23 (Feller et al., 1992) =was chosen as a
model enzyme. This enzyme is synthesized as a preproen-
zyme, composed of a signal peptide, the mature enzyme
(49 kDa), and a C-terminal propeptide (21 kDa), which
constitutes a structurally independent domain that neither
exhibits any foldase function nor affects the amylase
catalytic activity (Feller et al., 1998). The export of the a-
amylase precursor through the inner membrane likely
occurs via the Sec pathway (Cao & Saier, 2003; Feller et al.,
1998). Once in the periplasmic space, a-amylase undergoes
folding into its catalytically competent form >(Feller et al.,
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1998). Subsequently, secretion machinery drives its extra-
cellular translocation. The proenzyme is found in the P.
haloplanktis TAB23 culture supernatant as a precursor until
the late exponential growth phase, when the action of an
extracellular protease removes the C-terminal domain
(Feller et al., 1998). Although the C-terminal propeptide
sequence is not homologous to that of b-autotransporters
(Henderson et al., 2004), in a previous paper (Feller et al.,
1998) it was suggested that it may function as a protein
secretion helper when amylase is produced in Escherichia
coli. However, different results were obtained when the
secretion of recombinant a-amylase? and its truncated
version, devoid of the C-terminal domain, was investigated
either in the enzyme source strain, P. haloplanktis TAB23,
or in another Antarctic bacterium, P. haloplanktis TAC125
(Tutino et al., 2002). It was demonstrated that the C-
terminal propeptide is not mandatory for a-amylase
secretion and that the presence of the C-terminal domain
does not interfere either with the secretion kinetics or with
the maximal secretion and production yield (Tutino et al.,
2002).
In the light of the above results, we decided to study the
secretion of the truncated a-amylase (hereafter, ‘a-amylase’
indicates the protein without C-terminal domain). This
approach was chosen to simplify data analysis and
interpretation, since it allows ruling out the occurrence
of C-terminal-domain-mediated effects on protein secre-
tion, if any. a-Amylase secretion was studied in P.
haloplanktis TAC125. Several reasons prompted us to use
this bacterium as recombinant host: (i) it is the first
Antarctic micro-organism whose genome has been
sequenced and annotated (Me´digue et al., 2005); (ii) in
this bacterium, recombinant a-amylase secretion occurs in
a way similar to that in the source strain (Tutino et al.,
2001, 2002); (iii) P. haloplanktis TAC125 is devoid of
endogenous a-amylase activity (Tutino et al., 2001); and
(iv) the cold-adapted a-amylase was successfully used as
secretion carrier in a cold gene-expression system for
secretion of heterologous proteins in P. haloplanktis
TAC125 (Cusano et al., 2006b; Parrilli et al., 2008b).
The in silico analysis of the P. haloplanktis TAC125 genome
(Me´digue et al., 2005) demonstrated that the bacterium
possesses, besides specialized machineries for secretion of
type IV pili and curli components, only one other secretion
system: a type II secretion system (T2SS) (Parrilli et al.,
2009) homologous to already described T2SSs in many
other Gram-negative bacteria (Johnson et al., 2006). This
secretion system is not involved in recombinant a-amylase
secretion in P. haloplanktis TAC125 (Parrilli et al., 2008b).
Indeed, a P. haloplanktis TAC125 mutant strain in which
the T2SS was knocked out was able to specifically secrete
the cold-adapted a-amylase like the wild-type strain
(Parrilli et al., 2008b), thus suggesting the occurrence of
an as yet uncharacterized secretion pathway.
In this paper we report the identification of a cold-adapted
protein required for a-amylase secretion in P. haloplanktis
TAC125.
METHODS
Bacterial strains and growth condition. P. haloplanktis TAC125
(Me´digue et al., 2005) was isolated from Antarctic sea water. E. coli
DH5a (Hanahan, 1983) was used as host for the gene cloning. E. coli
EPI100 @[F2 mcrA D(mrr-hsdRMS-mcrBC) w80dlacZDM15 DlacX74
recA1 endA1 araD139 D(ara, leu)7697 galU galK l2 rpsL nupG] was
used as host for the cosmid library screening and for in vitro
complementation.
P. haloplanktis TAC125 was grown in aerobic conditions at 15 uC in
TYP broth Aat pH 7.5, supplemented with ampicillin (200 mg ml21) or
chloramphenicol (50 mg ml21) if transformed. E. coli was routinely
grown in Luria–Bertani broth (Sambrook & Russell, 2001) at 20 uC or
at 37 uC supplemented with ampicillin (100 mg ml21), chlorampheni-
col (50 mg ml21) or kanamycin (50 mg ml21) if transformed.
Transformation of P. haloplanktis was achieved by intergeneric
conjugation B(Parrilli et al., 2008a).
Construction and screening of cosmid library. Construction of a
cosmid library of P. haloplanktis TAC125 genomic DNA was
performed as described in the pWEB cosmid cloning kit
EPICENTRE brochure. The number of cosmid clones required to
ensure that any given P. haloplanktis TAC125 DNA sequence is
contained within the library is 420; the calculated total number of
independent clones contained within the constructed PhTAC125
cosmid library was 616. The cosmid clones were transformed by
electroporation with pBBRamyDCt and plated on selective LB plates
containing 100 mg ampicillin ml21, 50 mg chloramphenicol ml21 and
1% soluble starch. The plates were incubated at 20 uC and colonies
able to secrete amylase were detected by the amylase activity test
(Filloux et al., 1985). The selected clones were grown in liquid culture
at 20 uC in LB medium with 100 mg ampicillin ml21 and 50 mg
chloramphenicol ml21. The amylase activity was tested on the culture
medium of each clone. The amylase secretion yield Cof clones
displaying higher amylase activity was evaluated by assaying amylase
and b-lactamase activity in the extracellular medium and corres-
ponding intracellular extracts.
General techniques for plasmid construction. EXStandard methods
were employed for DNA manipulation and isolation, amplification by
PCR, and DNA sequencing (Sambrook & Russell, 2001; Ausubel et al.,
1994).
Construction of pBBRamyDCt vector. To produce the P.
haloplanktis TAB23 a-amylase lacking its C-terminal propeptide in E.
coli EPI100 cells an expression vector, pBBRamyDCt, was synthesized.
The DNA fragment containing the amyDCt gene under control of the
lacZ promoter was excised by TfiI/XbaI double digestion of paH12wt*
(Feller et al., 1998) followed by enzymic reaction to fill protruding ends.
The DNA fragment was inserted into AccI-digested pBBR122 (Antoine
& Locht, 1992) after fill-in of protruding ends.
Construction of cosmid subclones. Subclone 1. 12-26 cosmid
DNA was digested with BglII and derived DNA fragments were loaded
in a 0.7% agarose gel EOand separated by electrophoresis. The 9201 bp
DNA fragment was purified from the gel and cloned into pUC18
vector (Norrander et al., 1983) previously digested with BglII.
Subcone 2. To obtain a subclone containing the cosmid region
between the PSHAb0127 and PSHAb0133 genes, 12-26 cosmid DNA
was digested with Bst1107I and the protruding ends obtained were
subjected to intramolecular ligation.
Subclone 3. 12-26 cosmid DNA was digested with AvaI and the DNA
fragments obtained were loaded in a 0.7% agarose gel and separated
by electrophoresis. The 9268 bp DNA fragment was purified from the
gel and cloned into pGEM vector previously digested with AvaI.
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Subclone 4. PSHAb0139 and PSHAb0140 were amplified from P.
haloplanktis TAC125 genomic DNA in two separate PCRs. Primers
used to amplify the first fragment of 1102 bp were designed to
introduce a SphI restriction site and to cover the natural PvuII
restriction site (oligo 140PvuII forward and oligo 140SphI reverse; see
Supplementary Table S1, available with the online version of this
paper). Primers used to amplify the second fragment of 1646 bp were
designed to introduce an EcoRI restriction site and to cover the
natural PvuII restriction site (oligo 139EcoRI forward and oligo
140PvuII reverse; see Supplementary Table S1). The two fragments
were digested with PvuII/SphI and EcoRI/PvuII respectively and
ligated into pUC18 (SphI/EcoRI).
Subclone 5. The 12-26 cosmid DNA was digested with BamHI and
the DNA fragments obtained were loaded in a 0.7% agarose gel and
separated by electrophoresis. The 13580 bp DNA fragment was
purified from the gel and cloned into pUC18 vector previously
digested with BamHI.
Construction of pFCamyDCt-pssA vector. To complement pssA
function in P. haloplanktis TAC125-DpssA mutant cells the expression
vector pFCamyDCt-pssA was constructed. The 2504 bp region
including the pssA gene and its upstream region was excised by FspI
digestion of subclone 4 and then ligated into the a-amylase
psychrophilic expression vector pFCamy (Cusano et al., 2006b)
digested by BglII after enzymic fill-in of protruding ends.
Amplification of the P. haloplanktis TAB23 pssA gene
homologue. Two internal primers 43F and 43R (Supplementary
Table S1), designed to amplify a 595 bp fragment of the pssA gene,
were used to perform a PCR amplification on the P. haloplanktis
TAB23 genome. The sequence of the amplified fragment was
determined and aligned in the BLAST nucleotide database.
Protein electrophoresis and immunoblotting. Protein samples
were analysed by SDS-PAGE (12%, w/v, acrylamide) according to
standard methods (Ausubel et al., 1994). For immunoblotting, the
proteins were transferred to a PVDF membrane (Millipore). For
immunodetection of proteins, P. haloplanktis TAB23 anti-a-amylase
(Feller et al., 1998) or anti-b-lactamase antisera were diluted in
blocking buffer (phosphate-buffered saline, 5% skimmed milk).
Peroxidase-conjugated anti-rabbit IgG (Sigma-Aldrich) was used as
secondary antibody. Proteins were detected by chemiluminescence
(Pierce).
Zymographic assay. P. haloplanktis TAC125 wild-type and P.
haloplanktis TAC125-DpssA mutant strains were grown at 15 uC in
standard conditions and the zymographic assay was performed as
previously reported (Parrilli et al., 2008b).
Enzymic assays. a-Amylase activity was assayed by using the
Boehringer-Roche kit AMYL under the conditions previously
reported (Feller et al., 1998). b-Lactamase activity was assayed
according to O’Callaghan et al. (1972).
RESULTS
Isolation of a cosmid clone containing the
P. haloplanktis TAC125 genomic fragment
responsible for the recombinant a-amylase
secretion
To identify the genes encoding the secretion machinery
responsible for the extracellular addressing of the cold-
adapted a-amylase in P. haloplanktis TAC125, an in vivo
heterologous complementation assay was set up.
Since E. coli cannot secrete the cold-adapted a-amylase
devoid of its C-terminal propeptide (Feller et al., 1998),
this bacterium was used as a host for screening the P.
haloplanktis TAC125 genomic DNA cosmid library, look-
ing for cold-adapted gene product(s) allowing secretion of
the a-amylase in the mesophilic host. The use of a cosmid
library was appropriate because secretion pathway genes
are usually organized in large gene clusters.
The cosmid library of randomly generated P. haloplanktis
TAC125 genomic DNA fragments (~40 kb long) was
obtained using pWEB cosmid cloning kit and the
recombinant cosmids were transferred into recipient cells
already containing an expression vector for production of
the a-amylase (pBBRamyDCt). The pBBRamyDCt plasmid
was synthesized by cloning the amyDCt gene in the
pBBR122 vector. This broad-host-range vector was chosen
since its replication is compatible with the replication of
the pWEB vector, while it carries two selection genes,
which confer resistance to chloramphenicol and kanamy-
cin, respectively. E. coli cells co-transformed with
pBBRamyDCt and pWEB cosmid library clones were plated
at 20 uC on a selective solid medium containing starch. In
these conditions, an amylolytic halo will only surround
colonies that can secrete an amylase activity in the
extracellular medium.
About 600 clones were screened on plates, evaluating the
size of the colonies versus the haloes, and 60 clones
displaying wider amylolytic haloes were grown in liquid
culture at 20 uC. Amylase activity was tested in the culture
medium of each clone. Nine clones displaying higher
amylase activity were subjected to further analysis. The
amylase and b-lactamase activities were assayed in the
extracellular medium and corresponding intracellular
extracts of the nine clones (data not shown) to determine
the amylase secretion yield (expressed as the percentage of
total enzymic activity detected in the extracellular med-
ium). The localization of the periplasmic b-lactamase was
monitored to rule out that the extracellular targeting of the
recombinant cold-adapted a-amylase was due to host outer
membrane leakage. One clone (E. coli clone 12-26) passed
this last screening step, being able to secrete the a-amylase
into the culture medium with a secretion yield of about
35%, under conditions where we did not detect significant
amounts of b-lactamase (Table 1). Therefore, the produc-
tion of the heterologous cold-adapted proteins encoded by
the 12-26 cosmid insert did not alter the stability of E. coli
cell envelope, but conferred amylase secretion ability to the
E. coli cells (Table 1).
The sequencing of the P. haloplanktis TAC125 genomic
DNA insert contained in the 12-26 cosmid locates this
fragment as the region between bp positions 152464 and
189746 of P. haloplanktis TAC125 chromosome b, contain-
ing the CDSs from PSHAb0127 and PSHAb0152 (see
Supplementary Fig. S1A, Supplementary Table EPS2, and
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The selected DNA portion does not code either for a T2SS
component or for any proteins of the already characterized
secretion pathways. It encodes a few proteins of known
function and several proteins of unknown function
(Supplementary Table S2).
Construction of 12-26 cosmid subclones and test
for their ability to promote a-amylase secretion
To find out which of the genes were involved in a-amylase
secretion, several subclones of the 12-26 cosmid insert were
constructed. Different portions of the P. haloplanktis
TAC125 genomic DNA region between CDS PSHAb0127
and PSHAb0152 were cloned using different strategies.
These subclones are illustrated in Supplementary Fig. S1B.
Subclone 1 includes a 9201 bp fragment that contains a
portion of CDS PSHAb0127, full PSHAb0128 and
PSHAb0129 genes, and a large section of CDS
PSHAb0130. The 9268 bp DNA fragment cloned in
subclone 2 includes the region between CDS PSHAb129
and CDS PSHAb134 in addition to a portion of CDS
PSHAb135. In subclone 3, the region between the
PSHAb0127 and PSHAb0133 genes is present. Subclone 4
contains a genomic DNA fragment that includes CDS
PSHAb0139 and CDS PSHAb0140. In Subclone 5, a
13 580 bp DNA fragment includes the region between
PSHAb0141 and PSHAb0152. Attempts to clone the DNA
region comprising PSHAb0135 to PSHAb0138 failed,
although several cloning strategies were applied.
E. coli/pBBRamyDCt cells were transformed with each
subclone, and recombinant cells were grown in liquid
culture at 20 uC. Amylase activity was tested in the culture
medium of each clone. The a-amylase was detected only in
the extracellular medium of E. coli cells transformed with
subclone 4. Extracellular medium and corresponding
cellular extract of E. coli/pBBRamyDCt+Subclone 4
recombinant cells were analysed by Western blotting using
anti-PhTAB23 a-amylase serum (Fig. 1a) and anti-b-
lactamase serum (Fig. 1b). The a-amylase was present in
both extracellular and intracellular extract of E. coli/
pBBRamyDCt+Subclone 4 cells, whereas the periplasmic
b-lactamase remained confined to the intracellular extract
of recombinant E. coli cells. These results indicate that
subclone 4 confers to E. coli cells the ability to secrete the a-
amylase.
Subclone 4 includes a DNA fragment that contains two
CDSs, PSHAb0139 and PSHAb0140 (hereafter called pssA)
(Supplementary Fig. S1B). In silico analysis revealed that
PSHAb0139 codes for a putative transcriptional regulator,
and this gene displays 28.27% identity with the homolog-
ous E. coli gene yfgA (Supplementary Table S2). The
protein encoded by CDS PSHAb0140 (hereafter called
PssA) is a 577 aa lipoprotein and the sequence analysis of
its leader peptide (LipoP prediction: http://
www.cbs.dtu.dk/services/LipoP; Juncker et al., 2003) pre-
dicted that it is transported to and inserted into the inner
face of the outer membrane via the Lol lipoprotein sorting
pathway (Tokuda & Matsuyama, 2004). Moreover, in silico
analysis of the PssA amino acid sequence with the InterPro
software (http://www.ebi.ac.uk/InterProScan; Zdobnov &
Apweiler, 2001) predicted the presence of three tetra-
tricopeptide repeat (TPR) domains (IPR001440), encom-
passing amino acid positions 40 and 160 of the protein,
and of two LysM peptidoglycan-binding domains
(IPR002482) at the C-terminal side. No significant
similarities were found between the central domain of the
protein and proteins present in international protein
databases.
PssA protein, labelled as putative lytic cell-wall-binding
lipoprotein (Supplementary Table S2), has no homologue
in the E. coli proteome. As shown in Supplementary Fig.
S1C, the gene cluster surrounding pssA is conserved in
beta- and gamma-proteobacteria. Furthermore, in the
genomes of many Gram-negative bacteria the CDSs
ranging between PSHAb0134 and PSHAb0142 are in
synteny (filled rectangles in Supplementary Fig. S1C), with
the sole exception of pssA.
%paper no. mic032342 charlesworth ref: mic032342&
Table 1. Extracellular a-amylase and b-lactamase activities in E. coli EPI100/pBBRamyDCt cells transformed with the 12-26 cosmid
(E. coli/pBBRamyDCt+12-26) at different growth phases
Enzyme activities are expressed as percentages of the total activity recovered in cells and culture supernatants. As control, the same values referring
to E. coli cells co-transformed with pBBRamyDCt and a non-secreting cosmid clone (13-64 cosmid) are reported. Each experiment was carried out
in triplicate; means±SD are shown FO.
Growth
phase
E. coli/pBBRamyDCt+12-26 E. coli/pBBRamyDCt+13-64 E. coli/pBBRamyDCt+ pUC18
a-Amy b-Lac a-Amy b-Lac a-Amy b-Lac
Early 39% (1.4±0.1 IU) 5% (15.8±4 IU) 9% (0.28±0.1 IU) 4% (22.4±5 IU) 9% (0.33±0.3 IU) 5% (294±8 IU)
Exponential 25% (3.3±0.1 IU) 16% (62.7±5 IU) 8% (0.33±0.1 IU) 5% (20.6±2 IU) 12% (0.69±0.1 IU) 10% (448±5 IU)
Stationary 34% (7.3±0.4 IU) 15% (48.3±3 IU) 7% (0.71±0.3 IU) 5% (19.1±3 IU) 13% (1.52±0.3 IU) 15% (862±4 IU)
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Identification of pssA gene orthologues in
P. haloplanktis TAB23 and other Gram-negative
bacteria
A PCR experiment (data not shown) carried out on P.
haloplanktis TAB23 genomic DNA using internal primers
designed on the pssA sequence led to the specific
amplification of a 595 bp DNA fragment. The sequence
of the amplified fragment showed 99% identity with the
pssA sequence, indicating the presence of a PssA-coding
gene homologue in the a-amylase source strain.
The PssA sequence was used as template for a homology
search in protein databases, and gene products having a
similar domain organization to PssA were found in three
marine bacteria only: Colwellia psychrerythraea (Methe´
et al., 2005), Pseudoalteromonas tunicata D2, (GenBank
AAOH00000000) and an unclassified Alteromonadales
strain named TW-7 (GenBank AAVS00000000).
Construction and phenotype analysis of the P.
haloplanktis TAC125-DpssA mutant
To assess the role of PssA protein in a-amylase secretion, a
P. haloplanktis TAC125 mutant was constructed in which
the pssA gene was knocked out.
Functional inactivation of the P. haloplanktis TAC125 pssA
gene was achieved by two-step gene deletion mutagenesis.
The mutation was obtained by using a suicide vector
(pVS), suitably constructed for P. haloplanktis TAC125
(Parrilli et al., 2006, 2008b). The DpssA mutated gene is
characterized by a 607 bp deletion that results in a
sequence frame shift.
Total RNA was extracted from the P. haloplanktis TAC125-
DpssA deletion mutant and subjected to reverse transcrip-
tase RT-PCR analysis to evaluate transcription of the pssA
and PSHAb0139 genes. The deletion mutagenesis carried
out in P. haloplanktis TAC125-DpssA abolished pssA gene
transcription while it did not affect PSHAb0139 gene
expression (data not shown). The growth behaviour of P.
haloplanktis TAC125-DpssA in standard conditions
remained comparable to that of the wild-type strain (data
not shown), suggesting that inactivation of the pssA gene
does not affect cell viability.
To evaluate whether inactivation of the pssA gene may alter
the general secretion ability of the bacterium in a non-
specific way, for instance by interfering with a process that
could indirectly impair all protein secretion mechanisms,
the secretion of extracellular proteases by P. haloplanktis
TAC125-DpssA was evaluated. This group of extracellular
enzymes was analysed since it was previously demonstra-
ted (Parrilli et al., 2008b, 2009) that the majority of
extracellular proteases in P. haloplanktis TAC125 are
secreted by the type II secretory pathway. Extracellular
protease secretion in P. haloplanktis TAC125-DpssA was
investigated by gelatin zymography of culture supernatant.
As shown in Fig. 2, the extracellular medium of the P.
haloplanktis TAC125-DpssA mutant contains a number of
proteolytic activities similar to those detected in the wild-
type.
PssA is necessary for a-amylase secretion in P.
haloplanktis TAC125
Secretion of cold-adapted a-amylase by P. haloplanktis
TAC125-DpssA was investigated. The mutant strain was
transformed with pFCamyDCt, a vector previously con-
structed for the recombinant secretion of a-amylase in P.
haloplanktis (Cusano et al., 2006b). The recombinant
mutant strain was grown at 15 uC and the a-amylase
secretion was evaluated by Western blot analysis of
intracellular and extracellular protein samples withdrawn
at different growth phases. As shown in Fig. 3(a), the a-
amylase was present only in the intracellular extracts,
demonstrating that the inactivation of the pssA gene
completely abolishes the secretion of this enzyme in P.
haloplanktis TAC125-DpssA.
To exclude the possibility that the inability of P.
haloplanktis TAC125-DpssA cells to secrete the recombin-
ant a-amylase was due to a polar effect on expression of
pssA neighbouring genes, a complementation experiment
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Fig. 1. Analysis of a-amylase localization in E.
coli/pBBRamyDCt cells transformed with sub-
clone 4. Samples from E. coli/pBBRamyDCt
transformed with pUC18 or 12-26 cosmid
were used as negative and positive controls
respectively. (a) Western blot analysis with
anti-P. haloplanktis a-amylase polyclonal anti-
serum of extracellular samples (S) and corres-
ponding cellular extract (P). (b) Western blot
analysis with anti-E. coli b-lactamase polyclo-
nal antiserum of extracellular supernatant (S)
and corresponding cellular extract (P).
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was carried out. The complementing plasmid,
pFCamyDCt-pssA, was constructed to restore PssA func-
tion in P. haloplanktis TAC125-DpssA cells. This plasmid
contains both the amyDCt gene and the DNA sequence
encoding pssA and its upstream region (150 bp long), in
which the presence of a putative promoter sequence was
predicted (SoftBerry BPROM software: http://linux1.soft-
berry.com/berry.phtml)EQ . The mutant strain was trans-
formed with pFCamyDCt-pssA and the recombinant cells
were grown in standard conditions. Intracellular and
extracellular protein samples were withdrawn at different
growth phases, and subjected to Western blotting analysis
with anti-P. haloplanktis a-amylase (Fig. 3b) and anti-E.
coli b-lactamase sera (Fig. 3c). As shown in Fig. 3(b, c), the
a-amylase was detected in the extracellular samples, while
the b-lactamase was always fully associated with the
intracellular extracts, thus demonstrating that the secretion
of the a-amylase is partially restored in P. haloplanktis
TAC125-DpssA/pFCamy-pssA complemented cells.
DISCUSSION
Over the last several years our group has been involved in
unravelling the molecular mechanism involved in the
secretion of the cold-adapted a-amylase from the marine
Antarctic bacterium P. haloplanktis TAB23. This a-amylase
is still one of the most cold-tolerant proteins intensively
studied to clarify the structure/function relationships
which underlie enzyme cold-adaptation (D’Amico et al.,
2006). This cold-adapted enzyme is likely translocated by a
Sec system in the periplasmic space, where it attains its
catalytically competent folded stateER (Feller et al., 1998), and
then an as yet unidentified secretion machinery catalyses its
extracellular translocation.
The development of genetic tools for manipulation of
Antarctica bacteria (Parrilli et al., 2008a) allowed us to
demonstrate that the C-terminal propeptide is not
mandatory for a-amylase recombinant secretion either in
the source strain or in the related strain P. haloplanktis
TAC125 (Tutino et al., 2002). Indeed, the propeptide can
be replaced by other protein domains without affecting the
secretion of the chimeric proteins (Cusano et al., 2006b;
Parrilli et al., 2008b). Therefore it can be assumed that the
mature a-amylase (i.e. devoid of the C-terminal propep-
tide) contains some molecular signals responsible for its
specific secretion. To investigate the nature and structure
of these secretion signals, mature a-amylase was subjected
to a deletion mutagenesis analysis (Cusano et al., 2006a).
Features necessary for exoenzyme secretion were localized
in a a-amylase domain, and a likely 3D recognition
between a-amylase and the cognate cold-adapted secretion
machinery was suggested (Cusano et al., 2006a).
These results may point towards the involvement of a T2SS
secretion pathway (Johnson et al., 2006), which is the only
canonical secretion system identified in silico in the P.
haloplanktis TAC125 genome. However our recent results
demonstrated that the extracellular targeting of the cold-
adapted a-amylase does not depend on the T2SS in P.
haloplanktis TAC125 (Parrilli et al., 2008b).
To identify cellular components involved in the secretion
of a-amylase, a P. haloplanktis TAC125 genomic DNA
cosmid library was constructed and screened in E. coli. By
this in vivo complementation experiment a P. haloplanktis
TAC125 genomic fragment was selected, which did not
encode any of the components of previously characterized
secretion pathways. Data reported in this paper allowed us
to identify a protein (PssA) required for the secretion of a-
amylase in P. haloplanktis TAC125. The presence of a PssA
homologue was demonstrated only in P. haloplanktis
TAB23, i.e. the a-amylase source strain, and in three
marine bacteria.
In silico analysis suggests that PssA is a lipoprotein that
may be anchored into the inner face of the outer
membrane. The PssA protein is predicted to contain three
TPR domains; the TPR is an imperfect 34 aa repeat that is
found as a protein–protein interaction module that
mediates the assembly of multiprotein complexes ( ESBlatch
& La¨ssle, 1999; D’Andrea & Regan, 2003; Das et al., 1998).
Recently, two lipoproteins equipped with TPR domains
have been related to the functionality of the bacterial type
IV pilus biogenesis system, which closely resemble the T2SS
(Peabody et al., 2003), and reported data (Carbonnelle
et al., 2005; Nudleman et al., 2005) indicate that TPR-
containing lipoproteins have the potential to interact with
and/or form an outer-membrane multiprotein complex.
The PssA protein contains also two LysM domains in its C-
terminal region ET. This protein module was originally
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Fig. 2. Protease zymography of P. haloplanktis TAC125 wild-type
(wt) and P. haloplanktis TAC125-DpssA mutant (DpssA) culture
supernatants. Samples were withdrawn at the mid-exponential
phase and concentrated tenfold. The zymographic developing time
was 18 h, a condition that ensures the detection of all proteases
contained in the sample.
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identified in enzymes that degrade bacterial cell walls but it
is also present in many other bacterial proteins (Birkeland,
1994). The available data suggest that the LysM domain is a
general peptidoglycan-binding module (Bateman &
Bycroft, 2000).
In summary, PssA is a putative multidomain lipoprotein
predicted to be localized in the inner leaflet of the outer
membrane and displaying three TPR domains and two
LysM modules. To the best of our knowledge, no proteins
exhibiting the same domain organization have previously
been related to protein secretion systems. Based on the
functional annotation of TPR and LysM domains,
combined with experimental evidence reported in the
present work, a model for the role of PssA protein is
suggested (Fig. 4) in which PssA interacts with other
proteins and/or with itself while bound to the peptidogly-
can, allowing the specific secretion of cold-adapted a-
amylase. According to the proposed model, the lack of
PssA completely abolishes a-amylase secretion.
Symmetrically, PssA overproduction may alter the secre-
tion complex stoichiometry, affecting amylase secretion
efficiency. A similar effect was reported when some
proteins of a multicomponent secretion system were
overproduced (Ball et al., 1999). This may account for
the partial recovery of amylase secretion in the comple-
mented strain (Fig. 3b), where pssA was supplied in
multiple copies.
Surprisingly, the production of the PssA protein permits
recombinant E. coli/pBBRamyDCt+Subclone 4 cells to
secrete the cold-adapted a-amylase. The most plausible
explanation of this result is that PssA can recruit some E.
coli proteins, forming a protein complex able to recognize
and secrete the a-amylase. Data presented in this paper do
not allow speculation on structural similarities and/or
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Fig. 3. Western blot analysis of extracellular
samples (S) and corresponding cellular
extracts (P) collected at different growth
phases of P. haloplanktis TAC125-DpssA/
pFCamyDCt (a), P. haloplanktis TAC125-
DpssA/pFCamyDCt-pssA (b, c) and P. halo-
planktis TAC125/pFCamyDCt (positive con-
trols; d, e). In (a), (b) and (d), Western blot
analysis was carried out by using anti-P.
haloplanktis a-amylase polyclonal antiserum,
while in (c) and (e) anti-E. coli b-lactamase
polyclonal antiserum was used.
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differences between the protein complexes responsible for
amylase secretion in P. haloplanktis TAC125 and recom-
binant E. coli/pBBRamyDCt+Subclone 4 cells. This aspect
is currently under investigation and will be the subject of a
following paper.
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Conclusions 
The use of psychrophilic bacteria as hosts for recombinant proteins production is a 
promising strategy for improving the quality of recombinant products in terms of 
solubility and correct folding. By the use of the psychrophilic genetic expression 
systems available so far, many examples are reported of  soluble production 
―difficult‖ proteins from different origins in the Antarctic bacterium P. haloplanktis 
TAC125.  However, to achieve the goal of the utilisation the cold expression system 
for recombinant proteins production at industrial scale, the development of new 
genetic tools for recombinant genes expression at low temperatures is required in 
order to improve the performances of the psychrophilic expression system and to 
make it competitive with the well established microbial cell factories such as E. coli.  
The identification of new regulated psychrophilic promoters, for example, can be a 
useful strategy to improve protein production yields. Indeed, physical separation 
between bacterial  growth phase and recombinant protein expression by the use of a 
regulated promoter and an efficient induction strategy can improve the productivity of 
the entire system. By a rational strategy a set of potentially regulated genes were 
identified in P. haloplanktis TAC125 genome. Transcriptional analysis of target genes 
was performed in a cheap minimal medium in the presence of inexpensive 
compounds of physical stimuli as inducers. The analysis led to the identification of 
the gluconate permease PSHAb0479 which is up-regulated in the presence of D-
gluconic acid in the culture medium resulting in about 20 folds increase in 
corresponding mRNA levels. Moreover the alginate lyase PSHAa1748 resulted to be 
up to 10 folds over-expressed when alginic acid is added to the culture. The two 
identified promoters represent promising candidates for the construction of new 
regulated psychrophilic expression systems for recombinant proteins production at 
low temperatures.  
Another useful strategy to improve the yields of soluble products and to facilitate the 
downstream processes is the recombinant protein addressing into extracellular 
medium. The reduced extracellular proteins content can indeed significantly simplify 
the purification process and the lower local concentration of recombinant products 
can further overcome the aggregation phenomena and inclusion bodies formation. 
An efficient system for recombinant proteins extracellular secretion in P. haloplanktis 
TAC125 was already developed making use of a psychrophilic -amylase as 
secretion carrier. However only a few information are available so far about protein 
secretion mechanisms in psychrophilic bacteria. An in silico analysis of P. 
haloplanktis TAC125 genome reveals the presence of only one canonical secretion 
system, the T2SS GSP. Molecular and phenotypic characterisation of P. haloplanktis 
TAC125 GSP secretion system was performed and it revealed that GSP is 
responsible of the secretion of most of P. haloplanktis TAC125 extracellular 
proteases. This observation led to the construction of an engineered P. haloplanktis 
TAC125 strain where the GSP system was inactivated resulting in lower extracellular 
proteases content. Moreover, GSP system inactivation did not completely abolished 
proteins extracellular secretion in P. haloplanktis TAC125 indicating the presence of 
at least another still uncharacterised system also responsible for the secretion of the 
cold -amylase carrier protein. In order to improve the efficiency of the system used 
for extracellular secretion of recombinant proteins in P. haloplanktis TAC125 the 
mechanism involved in psychophilic -amylase secretion was investigated. By a 
combination of several molecular techniques, the function of pssA gene was related 
to -amylase secretion in the psychrophilic bacterium. pssA gene deletion completely 
abolished the amylase secretion without affecting the extracellular targeting of other 
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substrates mediated by canonical secretion systems. The pssA gene product, PssA, 
is a multidomain lipoprotein, predicted to be localised into the bacterial outer 
membrane, and displaying three TPR (Tetratrico Peptide Repeat) domains and two 
LysM modules. Relying on functional annotation of these domains combined with the 
experimental results obtained, we have suggested a role for PssA as a molecular 
adaptor in charge of recruiting other cellular components required for specific -
amylase secretion.  
Data collected have provided important information which can be used for the 
construction of engineered P. haloplanktis TAC125 strains with improved ability in 
recombinant proteins extracellular secretion.   
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MATERIALS AND METHODS 
Strains and plasmids 
Pseudoalteromonas haloplanktis TAC125 was isolated from Antarctic sea water 
(Medigue et al., 2005). Escherichia coli DH5α (Hanahan, 1983) was used as host for 
the gene cloning. E. coli strain S17-1(λpir) was used as donor in interspecific 
conjugation experiments (Tascon et al., 1993). 
Growth conditions 
P. haloplanktis TAC125 was grown at 15°C in aerobic conditions in TYP broth (16 g 
L-1 yeast extract, 16 g L-1 bacto tryptone, 10 g L-1 marine mix) at pH 7.5, 
supplemented with ampicillin 100 μg/ml when required. P. haloplanktis TAC125 
cultivation in synthetic media was performed in SCHATZ mineral medium (Papa et 
al., 2007) supplemented with different amino acidic carbon sources listed in table 4 
and with the addition of 100 μg/ml ampicillin and 0,4%w/v L-malate when required. 
Antibody fragments production was performed at 15°C in SCHATZ mineral medium 
supplemented with 0,5% w/v L-leucine, 0,5% w/v L-isoleucine and 1% w/v L-valine 
(LIV medium), 100 μg/ml ampicillin with additional 0,4%w/v L-malate as inducer. 
Experimental conditions for antibody fragments production processes are as follows. 
P. haloplanktis TAC125 batch and continuous cultivations in bioreactor were 
performed in LIV medium at 15°C in a STR 3L fermenter (Applikon) connected to an 
ADI 1030 Bio Controller (Applikon) with a working volume of 1L. The culture was 
mantained in fully aerobic conditions (DOT ≥ 30%) by  an airflow of 20 L h-1 and a 
stirring rate of 500 rpm. The culture pH was maintained at 7.00 by automatic addition 
of H2SO4 5% v/v. The cell biomass from a preinoculum, performed in shaken flask 
with the same medium and temperature used for the successive experiment in batch, 
was used to inoculate batch cultures. Chemostat cultivation was performed as 
described on SCHATZ medium supplemented  with 1xLIV or 0,5% w/v L-leucine at a 
dilution rate of D = 0.05 h-1 and a working volume of 1.0L. 
Antarctic bacteria transformation was achieved by intergeneric conjugation as 
previously reported (Duilio et al., 2004b). 
E. coli cells were routinely grown in LB broth (Sambrook and Russell, 2001) at 37°C. 
When required, 100 μg/ml of ampicillin was added in liquid and solid cultures. 
Cell growth was monitored by measuring the optical density (OD) at 600 nm using a 
UVIKON 922 spectrophotometer (Kontron). 
Genetic manipulations were carried out following standard procedures (Sambrook 
and Russell, 2001). 
All media component were purchased from Sigma-Aldrich. 
Plasmids construction 
DNA manipulation and analysis were performed according to Sambrook and Russell, 
2001. Plasmidic DNA extraction and fragments purification was carried out with the 
QUIAEX II kit from Qiagen. Restriction enzymes, T4 DNA ligase, alkaline 
phosphatase, Phusion DNA polymerase were supplied by Boehringer-Roche, 
Promega, Fermentas or Finnzyme. Plasmids and oligonucleotide primers used in this 
work are listed in Table 6. 
ScFvOx expression vectors construction – The scFvOx-c-myc gene was PCR 
amplified according to standard methods (Sambrook and Russell, 2001) from the 
source vector pScPelB, kindly provided by Dr B. Soehling, University of Halle 
(Germany) in order to introduce 5’ SmaI-SalI and 3’ EcoRI restriction sites by using 
primers Sc-SS-fw and Sc-tagE respectively (Tab 6). The amplified fragment was 
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cloned into pGEMTeasy (Promega) vector and its nucleotide sequence was checked 
by sequencing to rule out the occurrence of mutations during synthesis. 
For the construction of vectors pPM13psD-scFvOx-c-myc  and pPM13psA-scFvOx-c-
myc used for the screening of signal peptide for periplasmic secretion, the scFvOx-c-
myc gene was double digested with SalI/EcoRI and inserted into the corresponding 
sites of the psychrophilic periplasmic vectors pPM13psD and pPM13psA 
(unpublished results). For the construction of pFFamy-scFvOx-c-myc vector for 
ScFvOx extracellular secretion the scFvOx-c-myc gene was double digested with 
SmaI/EcoRI and ligated into pFFamy* vector (Cusano et al., 2006) previously 
digested with the same restriction enzymes. For pUCRP-scFv expression vector 
construction the psD-scFvOx-c-myc gene was PCR amplified according to standard 
methods (Sambrook and Russell, 2001) from the previously constructed pPM13psD-
scFvOx-c-myc  vector in order to introduce the 5’ NdeI and 3’ XhoI restriction sites 
and to remove the stop codon by using the primers PsD-N-fw and the c-Myc-X-rv 
respectively (Tab. 6). The amplified fragment was cloned into pGEMTeasy 
(Promega) vector and its nucleotide sequences was checked by sequencing to rule 
out the occurrence of mutations during synthesis. The gene fragment was then 
digested with NdeI/XhoI and cloned into a modified pUCRP vector (unpublished 
results) in-frame to a C-terminal 6xHis tag (Fig. 14).  
Fab 3H6 operon and expression vectors construction – Fab 3H6 lc and hc genes 
were fused to the sequence coding the psychrophilic leader peptide PsD separately 
as follows.The Fab lc gene was PCR amplified by standard methods from 
pGAPZalphaA-lc source vector, kindly provided by Prof. D. Mattanovich, University of 
Natural Resources and Applied Life Sciences, Vienna (BOKU). Lc-S-fw and Lc-BE-rv 
primers (Tab. 6) were used to insert a 5’ SalI and 3’ Bst98I-EcoRI restriction sites 
respectively. Moreover, the reverse primer was designed in order to introduce a 
Shine Dalgarno sequence (Fig. 10) into the 3’ lc gene by silent mutagenesis. The 
amplified fragment was cloned into pGEMTeasy (Promega) vector and its nucleotide 
sequence was checked by sequencing to rule out the occurrence of mutations during 
synthesis. The fragment was then digested with SalI/EcoRI and cloned into the 
corresponding sites of a previously digested pPM13psD vector thus obtaining a 
pPM13psD-lc plasmid. In parallel, Fab hc gene was PCR amplified from 
pGAPZalphaA-lc source vector, kindly provided by Prof. D. Mattanovich, University of 
Natural Resources and Applied Life Sciences, Vienna (BOKU), in order to add a 5’ 
Acc65I and 3’ XhoI/EcoRI restriction sites by using primers Hc-A-fw and Hc-XE-rv 
respectively (Tab. 6). The fragment encoding the PsD signal peptide was also PCR 
amplified from pPM13psD vector in order to insert 5’ BamHI/Bst98I and 3’ Acc65I 
restriction sites by using PsD-BB-fw and PsD-A-rv primers respectively (Tab. 6). The 
amplified hc and psD gene fragments were digested with BamHI/Acc65I and 
Acc65I/EcoRI and cloned into pUC18 plasmid (New England Biolabs) previously 
digested with BamHI/EcoRI vector and their nucleotide sequences was checked by 
sequencing.  
For Fab 3H6 operon construction (Fig. 10) the resulting gene fusion psD-hc was 
excised from pUC18psD-hc by Bst98I/XhoI double digestion. In parallel, the fusion 
gene psD-lc was excised from the previously constructed pPM13psD-lc vector by 
NdeI/Bst98I double digestion. The two obtained gene fragments: psD-lc 
(NdeI/Bst98I) and psD-hc (Bst98I/XhoI) were finally cloned into a modified pPM13 
vector (unpublished results) previously digested with NdeI/XhoI in-frame to a C-
terminal 6xHis tag coding sequence thus obtaining the pPM13-fab expression vector.  
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For pUCRP-fab expression vector construction the fab operon was excised from the 
previously constructed pPM13-fab plasmid by NdeI/EcoRI double digestion and 
cloned into the same restriction sites of pUCRP expression vector (Papa et al., 
2007). 
VHH D6.1 expression vector construction – The vhh D6.1 gene was PCR amplified 
according to standard methods  (Sambrook and Russell, 2001) from pHEN-D6.1 
source vector kindly provided by Dr. A. De Marco, IFOM-IEO campus Milan, in order 
to insert a 5’ SalI and a 3’ NotI restriction sites by using primers VH-S-fw and VH-N-rv 
respectively (Tab. 6). The amplified fragment was cloned into pGEMTeasy 
(Promega) vector and its nucleotide sequence was checked by sequencing to rule 
out the occurrence of mutations. The vhh D6.1 gene was then digested with SalI/NotI 
and cloned into the previously constructed pUCRP-scFv expression vector by 
replacing the scFvOx gene excised by a SalI/NotI double digestion. The resulting 
expression vector, pUCRP-vhh contains the vhh D6.1 gene in-frame to N-terminal 
PsD and C-terminal c-Myc and 6xHis tag coding sequences (Fig. 14)    
 
Table 6: Plasmids and oligonucleotides 
 
Plasmid Description References 
pPM13 
Vector deriving from the pUC18 plasmid, containing 
the T/R box, the psychophilic promoter 13 and the 
transcription termination signal from PhTAC125 aspC 
gene 
Duilio et al., 2004 
pPM13psD 
pPM13 containing PhDsbA signal peptide coding 
sequence 
Unpublished results 
pPM13psA 
pPM13 containing Ph - amylase  signal peptide coding 
sequence Unpublished results 
pPM13-his 
pPM13 containing C-terminal 6xHis tag coding 
sequence Unpublished results 
pPM13psD-scFv 
Expression vector for constitutive periplasmic 
production of ScFvOx-c-Myc  antibody fragment This work 
pFFamy* 
Expression vector for N-terminal amylase fusion for 
extracellular secretion  
Cusano et al., 2006 
pFFamy-scFv 
Expression vector for constitutive production and 
extracellular secretion of ScFvOx 
This work 
pUCRP 
Psychrophilic expression vector containing 
PSHAb0363 promoter region 
Papa et al., 2007 
pUCRP -gal 
Expression vector for L-malate inducible production of 
psychrophlic -galactosidase from P. haloplanktis 
TAE79 
Papa et al., 2007 
pUCRP-his 
pUCRP containing C-terminal 6xHis tag coding 
sequence 
Unpublished results 
pUCRP-scfv 
Expression vector for periplasmic L-malate inducible 
production of ScFvOx-c-Myc-6xHis  antibody fragment 
This work 
pPM13psD-lc 
Expression vector for periplasmic production of Fab 
3H6 light chain 
This work 
pUC18psD-hc 
pUC18 cloning vector containing the Fab 3H6 hc gene 
fused to psD signal peptide coding sequence 
This work 
pPM13-fab 
Expression vector for constitutive Fab 3H6  periplasmic 
production  This work 
pUCRP-fab 
Expression vector for periplasmic L-malate inducible 
production of Fab 3H6 
This work 
pUCRP-vhh 
Expression vector for periplasmic L-malate inducible 
production of VHHD6.1-c-Myc-6xHis   
This work 
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Oligonucleotides Sequence 5’ - 3’ Restriction site 
Sc-SS-fw CAGCCCCGGGTCGACATGGCCG’ SalI-SmaI 
Sc-tagE GCTTGTCGAATTCCTATGCGGCCC EcoRI 
PsD-N-fw CGGCGCATATGCTTAAAAAATTAAAACTGAG NdeI 
c-Myc-X-rv ATATCTCGAGGGCCCTTGCGGCCCCATTC XhoI 
Lc-S-fw ATAATGTCGACGAAACAACTGTGACCCAGTC SalI 
Lc-BE-rv CGAATTCTTAAGCATTAACACTCTCCTCTGTTGAAG EcoRI/Bst98I 
Hc-A-fw TAGGTACCGTCCAACTGCAGCAGTCTG Acc65I 
Hc-XE-rv AGAATTCTACTCGAGACAAGATTTGGGCTCAAC EcoRI/XhoI 
PsD-BB-fw GGAGGATCCATGCTTAAGAAATTAAAACTGAG BamHI/Bst98I 
PsD-A-fw CAGGTACCTTCAAAGTTTGCTGCCAAGTG Acc65I 
VH-S-fw ATCGTGTCGACATGGCTGAGGTGC SalI 
VH-N-rv ATATATGCGGCCGCAATGGAGACGGTG NotI 
Fab-RT-fw TTCAACAGAGGAGAGTGTTAATGC none 
qRT-PCR primers Sequence 5’ - 3’ Target sequence  
0363-fw:  TTGGCATAATGCTCAGTTTTCATT PSHAb0363 
0363-rv: ACCGTAAATAAGTGTAGCGGCAAA PSHAb0363 
GP-fw CGATGATAGCCGGGATTTTC PSHAb0479 
GP-rv CGCCCATTCCTTTTTGGATA PSHAb0479 
GalT-fw GGGTGCAGGTATTCGAAAACA PSHAa1770 
GalT-rv GTAATTGCTGCTGCGACCAA PSHAa1770 
Alg-fw GGTGAAGGGTGACGAGTCGTT PSHAa1748 
Alg-rv CGCGTTTACACGGCGAATA PSHAa1748 
TF-fw TGGCGAAGTAATGCAACGTAAT PSHAa2063 
TF-rv CTTCAAGTGCTTTTGGAGCAAA PSHAa2063 
 
Analytical procedures 
Biomass determination - For biomass determination suitable sample volumes were 
washed in demineralised water, collected and dried on pre-weighed filter discs and 
dried at 110°C until constant weight. The dry cell weight was correlated with OD at 
600nm throughout the following equation: 
Dry cell weight (g L-1) = 0,74 x OD600nm  
Cell lysis – For recombinant -galactosidase production analysis aliquots of bacterial 
pellet corresponding to 1 mL culture volume were resuspended in 1mL Lysis buffer 
(Na phosphate buffer 0,1M pH 7,8, EDTA 2 mM, DTT 1 mM, Triton X-100 1% v/v, 
lisozyme 5 mg mL-1, PMSF 1 mM) and incubated at 15°C for 30’. The suspension 
was then centrifuged at 10000rpm for 15 mins at 4°C and the supernatant used for 
activity assays. For analysis of recombinant antibody fragments production and 
purification, aliquots of bacterial pellet corresponding to 50 mL culture volume were 
resuspended in Na phosphate buffer 50 mM pH 8, NaCl 300 mM, PMSF 1 mM and 
subjected to 5 cycles of French Press (Sinstem, Limited Basic Z Model) at 1,8 kbar. 
The resulting suspension was subjected to ultracentrifugation (Beckman 50.2Ti) at 
45000rpm for 2h at 4°C and the supernatant used for further analysis.  
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Periplasmic proteins preparation- Bacterial pellets were resuspended in 1/20 of 
culture volume of borate buffer (Na2B4O7 200 mM, NaCl 130 mM, EDTA 5 mM, pH 8) 
and incubated 18h at 4°C. The suspension was centrifuged at 8000 rpm for 15min at 
4°C and the supernatant used for further analysis. 
SDS-PAGE and Western blotting analysis – Protein samples (5 g protein extracts 
and 500ng pure proteins) were analyzed by Polyacrylamide Gel Electrophoresis 
(Sodium Dodecyl Sulphate-PAGE) (10% acrylamide, w/v) according to standard 
methods (Sambrook and Russell, 2001). For Western blotting analysis, 1 g protein 
extracts were subjected to standard polyacrylamide gel electrophoresis (SDS-
PAGE), under non-reducing conditions in the case of Fab 3H6, and transferred to a 
polyvinylidene difluoride membrane (PVDF) (Immobilon PSQ, Millipore). 
Proteins immunodetection - After blocking the membrane 1h at RT in blocking (buffer 
phosphate buffer saline (PBS), 5% w/v skimmed milk, 0,05% v/v Triton X-100) 
immunodetection was performed as follows: for Fab 3H6 anti-light chain detection, 
anti-human- -light chain mAb-alkaline phosphatase conjugate (Sigma) was diluted 
1:2000 in blocking buffer and incubated 2h at RT. Blots were developed using the 
colorimetric AP-substrate kit (Biorad). For Fab 3H6 HC detection anti-His tag mAb 
(Sigma-Aldrich) was diluted 1:1000 in blocking buffer and incubated for 16h at 4°C. 
Peroxidase conjugate anti-mouse IgG (Calbiochem) was used as secondary 
antibody. Proteins were detected by chemiluminescence (Pierce).  
For ScFvOx and VHHD6.1 detection anti c-Myc mAb (Calbiochem) was diluted 
1:5000 in blocking buffer and incubated for 1h at RT. Peroxidase conjugate anti-
mouse IgG (Calbiochem) was used as secondary antibody. Proteins were detected 
by chemiluminescence (Pierce). 
For cold -amylase detection P. haloplanktis TAB23 anti- -amylase antiserum was 
diluted 1:4000 in blocking buffer and incubated 1h at RT. Peroxidase conjugate anti-
rabbit IgG (Sigma-Aldrich) was used as secondary antibody. Proteins were detected 
by chemiluminescence's (Pierce). 
ELISA quantification – For Fab 3H6 quantification a sandwich ELISA was performed 
as described in previous studies (Gach et al., 2007). Pure Fab 3H6 used as standard 
was purchased from Rockland. 
Concentrations of active ScFvOx were determined by ELISA assay as previously 
described by Lange and co-workers (Lange et al., 2005). Refolded purified ScFvOx 
IB produced in E. coli (Lange et al., 2005) was used as standard for the assay. 
Enzymatic assays - Protein concentration was determined with the Bio-Rad protein 
assay (Bradford, 1976), using bovine serum albumine as standard.  
Recombinant cold-active -galactosidase was assayed spectrophotometrically at 
25°C as previously reported (Hoyoux et al., 2001). 
Alkaline phoshatase activity assay was performed according to Jones et al., 1989. 
Enymatic kinetic were registered with a DU7500 spectrophotometer (Beckman). 
Amino acids and total ammonium quantification – Residual amino acids concentation 
during P. haloplanktis TAC125 cultivation was evaluated by AccQ·Tag TM Amino Acid 
Analysis method as described by Cohen and Michaud, 1993. AccQ·FluorTM Reagent 
Kit was purchased from Waters. Sample derivatisation has been performed 
accordind to manufacturer’s instructions. For calibration standard 50 pmol of each 
amino acid derivative (L-Leu, L-Ile, L-Val) were used separately. For calibration 
curve, different dilutions of L-Leu, L-Ile and L-Val derivative were used separately at 
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concentrations ranging from 0,0125 to 3,1250 mM. For total ammonium quantification 
a calibration curve ranging from 0,32 to 10,00 mM NH4Cl derivative was used. A 
Waters Alliance 2695 HPLC system (Waters) was utilised for the HPLC analyses. 
AccQ·Tag TM amino acid column Nova-Pak C18, 4 μm (150×3.9 mm) from Waters 
was used. The column was thermostated at 37 °C and 10 μL was the injection 
volume (concentration of amino acids 5–200 pmol). A gradient mobile phase was 
used for chromatography. The mobile phase consisted of eluent A (140 mM NaOAc, 
1,107 mg L-1 EDTA, 2,35 mL L-1 triethylamine pH 5,05 with H3PO4) and eluent B 
(60% v/v acetonitrile, HPLC grade). The best gradient separation program was the 
following: 
Time 0 min: A—100%, B—0% 
Time 0.5 min: A—98%, B—2% 
Time 15 min: A—93%, B—7% 
Time 19 min: A—90%, B—10% 
Time 29 min: A—67%, B—33% 
Time 37 min: A—0%, B—100% 
Time 38 min: A—100%, B—0% 
Time 50 min: A—100%, B—0% 
L-malate quantification – Residual L-malate concentration during P. haloplanktis 
TAC125 cultivation was analysed by HPLC (Hewlett Packard 1050) analysis using an 
ionic exchange column Aminex HPX-87H (Bio Rad). The mobile phase was 15 mM 
sulphuric acid. For the calibration curve L-malate concentrations ranging from 0,93 
up to 29,85 mM were used.  
RNA preparation and RT - Total RNA was isolated from pellets corresponding to 
500 l of P. haloplanktis TAC125 cell culture (RNasy Mini kit, Qiagen) and subjected 
to in-column DNase treatment (Rnase-Free Dnase Set, Qiagen). Quality of the RNA 
isolation was checked by gel electrophoresis followed by quantification in 
spectrophotometer according to Sambrook and Russell, 2001. Only samples showing 
a A260nm/A280nm ratio ≥ 0,8 were used for further experiments. 
Reverse transcription (RT) reactions were performed using SuperScript II RNase H- 
Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions using 
100 pmol of specific primers (Tab. 6) on approximately 5 μg of total purified RNA. In 
addition, RT negative control reactions were performed where water was added 
instead of template.  
Analysis of mRNA by RT-PCR - For the evaluation of Fab 3H6 operon mRNA stability 
PCR amplifications (Sambrook and Russell 2001) were performed using 2 μl of RT 
reaction sample as a template, Taq DNA polymerase (Promega) using Fab-RT-fw 
and Hc-XE-rv specific primers (Tab. 6) An additional PCR reaction on DNA-free total 
RNA was carried as negative control. PCR products were visualised by agarose gel 
electrophoresis on a 1% agarose gel containing 1 μg mL-1 ethidium bromide.  
Analysis of mRNA by qRT-PCR -  The qRT-PCR method was used to determine the 
relative amount of specific transcriptional products in the presence/absence of 
different compounds or physical stimuli. The qRT-PCR was performed with cDNAs 
prepared from 2 separate cultures per treatment. A total of 12 data were obtained per 
point derived from two cDNA separate preparations from each culture. Each of the 
four cDNA samples obtained was amplified in triplicate experiments.  
Real-time PCR was carried out using a StepOne™ Real Time PCR System  (Applied 
Biosystems) and the amplification of the target sequences was detected using SYBR 
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Green technology. The housekeeping gene ihfB was chosen as an internal control to 
correct for variations of mRNA amounts and cDNA synthesis efficiency. 
The primers for specific amplification were designed by Primer Express® Software 
Version 3.0 (Applied Biosystems) and are listed in Table 6. qRT-PCR amplification 
mixtures (20 μl) contained 2 μl template cDNA, 2x SYBR® Green I Master Mix (10 μl) 
(Applied Biosystems) and 300 nM forward and reverse primer. A non-template 
control reaction mixture was included for each gene. The PCR cycling programme 
was as follows: holding stage, 1 cycle of 95°C for 10 min; cycling stage, 40 cycles at 
95°C for 15 s, 60°C for 60 s; melting curve stage 1 cycle at 95°C for 15 s, 60°C for 60 
s, 95°C for 15 s with a temperature increment of +0,3°C. Specificity of the reaction 
was checked by analysis of the melting curve of the final amplified product. 
Experiments and data analysis were performed using StepOne™ Software v2.0 by 
ΔΔCt method (Applied Biosystems User Bulletin, 1997). 
ScFvOx and VHHD6.1 affinity purification 
The 6xHis tagged recombinant antibody fragments ScFvOx and VHHD6.1 were 
affinity purified on Ni2+-NTA resin in batch conditions. 200 l of HIS-Select Nickel 
Affinity Gel resin (Sigma-Aldrich), pre-equilibrated with binding buffer (Na-phosphate 
buffer 50 mM pH 8, NaCl 300 mM) were incubated with about 25 mg of crude protein 
extracts for 16h at 4°C while shaking. Five washing steps were performed with 
washing buffer (Na-phosphate 50 mM pH 8, NaCl 300 mM, imidazole 30 mM). 
Protein elution was carried with 50 l of elution buffer (Na-phosphate 50 mM pH 8, 
NaCl 300 mM, imidazole 250 mM). A second elution step was performed with 50 l of 
the same elution buffer supplemented with 500 mM imidazole. 
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Abstract
Different species of microorganisms including yeasts, filamentous fungi and bacteria have been used
in the past 25 years for the controlled production of foreign proteins of scientific, pharmacological
or industrial interest. A major obstacle for protein production processes and a limit to overall
success has been the abundance of misfolded polypeptides, which fail to reach their native
conformation. The presence of misfolded or folding-reluctant protein species causes considerable
stress in host cells. The characterization of such adverse conditions and the elicited cell responses
have permitted to better understand the physiology and molecular biology of conformational
stress. Therefore, microbial cell factories for recombinant protein production are depicted here as
a source of knowledge that has considerably helped to picture the extremely rich landscape of in
vivo protein folding, and the main cellular players of this complex process are described for the
most important cell factories used for biotechnological purposes.
Review
One of the main bottlenecks in recombinant protein pro-
duction is the inability of the foreign polypeptides to
reach their native conformation in heterologous host
cells, which usually results into their prevalence in the
insoluble cell fraction. The unusually high and non-phys-
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Microbial Cell Factories 2008, 7:11 http://www.microbialcellfactories.com/content/7/1/11iological rates of recombinant protein production and the
occurrence of significant amounts of misfolded protein
species drive the cells to a global conformational stress
condition. This situation is characterized by a series of
individual physiological responses provoked in order to
minimize any toxicity of misfolded protein species and to
restore cellular folding homeostasis. The generalized use
of microbial cell factories for biological synthesis of pro-
teins and the growing interest in the physiological aspects
of conformational stress have converted recombinant
cells into schools of protein folding, from which scientists
are learning about the cell-protein relationships during
the complex process of in vivo protein folding.
The purpose of this review is to summarize the major con-
cepts of the cell biology of protein folding. For that,
eukaryotic cells, illustrated by yeasts and filamentous
fungi are dissected regarding the mechanics and composi-
tion of their folding machinery, misfolding stress
responses and strategies to cope with conformational
stress. The complexity of the folding, trafficking and secre-
tion machineries of these cell factories is presented versus
the relatively simple folding scheme in bacterial cells such
as Escherichia coli that are also common hosts for recom-
binant protein production. Despite the existing obvious
differences, evolutionary conserved physiological traits
regarding folding stress can be identified when comparing
eukaryotic and prokaryotic hosts. Furthermore, practical
implications of all these findings to improve protein pro-
duction processes are discussed in their biotechnological
context.
Protein folding and conformational stress in 
eukaryotic cells
Yeasts and filamentous fungi are among the most fre-
quently used eukaryotic cell systems for recombinant pro-
tein production, in part due to the performance of post-
translational modifications that bacteria cannot perform,
that are, in most cases, required for proper protein activ-
ity. In eukaryotic cells, endoplasmatic reticulum (ER) res-
ident proteins are responsible for correct protein folding.
The list of such folding-assistant proteins includes cal-
nexin, chaperones of the hsp70 and hsp90 families (e.g.
BiP/Grp78, Grp94), the protein disulfide isomerases (Pdi)
which catalyze the formation of disulfide bonds and the
peptidyl-prolyl-isomerases. Some of the post-transla-
tional modifications such as N-glycosylation are initiated
in the ER lumen. Both natural and recombinant proteins
are only exported to the Golgi by vesicular transport when
their correct conformation has been assured by a glucose-
dependent surveillance mechanism of the ER. Unless
there is a differing signal, proteins intended for secretion
are directed from the Golgi to the outside of the plasma
membrane by specific transport vesicles [1,2]. A schematic
overview of the protein folding processes is presented in
Figure 1, while the responses to secretion stress are sum-
marized in Figure 2.
The protein folding process and subsequent secretion is a
rather complex process involving many interacting partic-
ipants. Due to this interdependence, genetically increas-
ing the rate of one step can lead to rate-limitation of
another one, which can then become the bottleneck of the
expression system. Moreover, in most cases the rate limit-
ing step in the eukaryotic secretion pathway has been
identified to be the exit of proteins from the ER [3].
Linked to this control point is a mechanism called ER-
associated protein degradation (ERAD), which is respon-
sible for the retention of misfolded or unmodified non-
functional proteins in the ER and their subsequent
removal. Protein degradation is executed by linking the
misfolded protein to ubiquitin after it has been re-translo-
cated into the cytosol through the same ER translocon
pore where it had been imported. The ubiquitin-marked
protein is then recognized and degraded by the 26S pro-
teasome in the cytosol (recently reviewed by [4,5].
Two quality control systems in the ER ensure that only
correctly folded, modified and assembled proteins travel
further along the secretory pathway. The UDP-glu-
cose:glycoprotein glucosyltransferase (UGT) is a central
player of glycoprotein quality control in the ER (reviewed
among others by [6]). After addition of the core glycan
(GlcNac2-Man9-Glc3) to specific asparagine residues of
the nascent polypeptide, the three terminal glucose resi-
dues have to be clipped off before the protein can exit the
ER. Non-native polypeptides are tagged for reassociation
with the ER-lectin calnexin by readdition of the terminal
glucose onto the N-glycan mediated by UGT. This enzyme
specifically recognizes and binds to molten globule-like
folding intermediates, thereby acting as sensor of the pro-
tein folding status. Re-glucosylation of erroneous glyco-
proteins prevents their release from the calnexin cycle and
subsequent secretion. Upon persistent misfolding, N-gly-
cosylated polypeptides are slowly released from calnexin
and enter a second level of retention-based ER quality
control by aggregating with the BiP chaperone complex
[7]. This correlates with the loss in the ability to emend
misfolding. The BiP complex is involved in co-transla-
tional translocation of the nascent polypeptide into the
ER lumen and preferentially binds to hydrophobic
patches. Prolonged binding to either calnexin or the BiP
complex targets the polypeptides to the ERAD, however,
the exact mechanisms remain elusive (reviewed by [6]).
The fact that accumulation of proteins in the ER is able to
influence the synthesis of foldases and chaperones such as
BiP and Pdi by transcriptional activation in the nucleus
lead to the conclusion early on that there must be an intra-
cellular signalling pathway from the ER to the nucleus,Page 2 of 18
(page number not for citation purposes)
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see [8,9]).
After having passed ER quality control successfully, pro-
teins intended for secretion have to be transported to the
Golgi network. Specialized cargo vesicles that selectively
incorporate these proteins bud from the ER and are tar-
geted to the Golgi membrane by the activity of the coat
protein complex II (COPII). In the Golgi network proteins
undergo additional post-translational modifications and
are subjected to sorting mechanisms that finally target
them to their final destination. Possible trafficking routes
include direction to the plasma membrane, to the endo-
somal compartments, to the vacuole, as well as retrograde
transport to the ER (review by [10]). Secretory proteins are
then delivered to the cell surface by specialized post-Golgi
Schematic representation of protein folding, quality control, degradation and secretion in yeast (as an example for lower eukaryotic cells)Figu e 1
Schematic representation of protein folding, quality control, degradation and secretion in yeast (as an exam-
ple for lower eukaryotic cells). Secretory proteins are transported into the ER through the Sec61 translocon complex of 
the ER membrane either co-translationally or post-translationally. In the latter case, cytosolic chaperones (Ssa1-4, Ssb, Sse1/2) 
support solubility and prevent aggregation of the polypeptide chains. After translocation to the ER, nascent polypeptides are 
bound by BiP and mediated to mature folding in an ATP-dependent cyclic process of release of and binding to BiP. The forma-
tion of correct disulfide bonds is mediated in a cycle of Pdi and Ero activity, which may lead to the formation of reactive oxygen 
species (ROS). Correctly folded protein is released to transport vesicles, while prolonged BiP binding, indicating misfolding, 
leads to retrograde translocation to the cytosol and proteasomal degradation (ERAD). Nascent glycoproteins are bound by 
calnexin and mediated to correct folding and processing of the N-glycans. Failed folding leads to binding by the BiP complex 
and targeting to ERAD, while correctly folded and processed glycoproteins are released to transport vesicles. Prolonged bind-
ing of BiP to partially misfolded proteins leads to the induction of the unfolded protein response (UPR), mediated by Ire1 (see 
also figure 2).
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Schematic representation of secretion stress responses in eukaryotesFigure 2
Schematic representation of secretion stress responses in eukaryotes Secretory proteins are translocated to the ER 
either during their translation or post-translationally. Folding of these proteins in the ER can be disturbed by environmental 
factors or it can be inhibited experimentally by agents inhibiting protein folding like dithiothreitol (DTT) and Ca-ionophores or 
agents inhibiting glycosylation like tunicamycin. It has been observed that foreign proteins often do not fold well and cause con-
formational stress. Several responses of the cell to impaired protein folding in the ER have been discovered: 1.) Unfolded pro-
tein response (UPR). Genes encoding folding helpers like the chaperone Bip and the foldase protein disulfide isomerase Pdi, 
and a large number of other genes involved in other functions of the secretory pathway are induced. The proteins Ire1 and 
Hac1 involved in this signal transduction pathway are shown in the figure. 2.) Translation attenuation. The translation initiation 
factor eIF2 alpha is phosphorylated, and subsequently translation initiation is inhibited. This reduces the influx of proteins into 
the ER. This response is only known from mammalian cells. 3.) Repression under secretion stress (RESS). The mRNA levels of 
genes encoding secreted proteins are down-regulated during ER stress. This response has been discovered in filamentous fungi, 
but there is evidence for its occurrence in plants.
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Microbial Cell Factories 2008, 7:11 http://www.microbialcellfactories.com/content/7/1/11secretory vesicles that dock to and fuse with the plasma
membrane. The process called exocytosis includes target-
ing of the secretory vesicles to the appropriate membrane
mediated by the Exocyst, a multiprotein complex, and by
interaction of the v-SNAREs (vesicle, in yeast: Snc1/2 pro-
teins) and t-SNAREs (target membrane; Sso1/2p and
Sec9p) and release of the cargo proteins outside the cell
after fusion of the secretory vesicle with the plasma mem-
brane.
Impact of the environment on folding and folding stress
During the recent years, it has become evident that a vari-
ety of metabolic and environmental stresses may have a
strong impact on recombinant protein production. Both
types of stress factors occurring during industrial produc-
tion processes in yeasts, along with potential metabolic
and cell engineering approaches to overcome production
constraints, were reviewed in Mattanovich et al. [11].
Among environmental factors that affect protein folding
and secretion, especially temperature, low pH, high osmo-
larity and oxidative stress may play an important role.
While many studies have been performed on optimizing
fermentation conditions for maximum specific productiv-
ity in yeasts, data correlating increased product yields to
improved protein folding and secretion mechanisms are
still missing. Similar reports regarding the impact of culti-
vation conditions on protein production in filamentous
fungi remain scarce and usually limited to case studies
[12-14]. Wang et al. [15] reviewed the impacts of bioproc-
ess strategies on recombinant protein production in fila-
mentous fungi, and concluded that the major effect of the
environmental changes correlates to varying morphologi-
cal forms, which exhibit different secretory capacities.
Temperature
Temperature has a profound impact on cell metabolism
and abundance/regulation of folding-related genes/pro-
teins (hsp70 family, ER-membrane proteins, etc.). Lower-
ing the cultivation temperature from 30 to 20–25°C has
been reported to increase product titers in yeasts in several
cases [16-19]. While it may be speculated that a lower
growth temperature is leading to lower specific growth
rates, thus enabling folding of the recombinant proteins
at a lower rate, it was shown recently in chemostat cultures
that actually gene regulatory events take place. In contin-
uous cultures of Pichia pastoris expressing a human anti-
body Fab fragment specific productivity of the
heterologous protein was significantly increased during
the chemostat process at lower temperature (1.4-fold on
average). Several genes related to protein targeting to the
ER and folding (SSA4, SEC53, KAR2, ERO1) and core
metabolism genes were found among the genes down-reg-
ulated at 20°C, as were the product genes [20]. Transcrip-
tion of genes involved in the regulation of vesicular
transport, exocytosis, ER-associated protein degradation
as well as markers for response to oxidative and hyperos-
motic stress was enhanced in comparison to 25°C steady
state. The reduction in transcriptional activity of the core
metabolism is a likely explanation for the reduced mRNA
levels of the product genes (LC and HC), which were
under control of the glycolytic GAP (glyceraldehyde 3-
phosphate dehydrogenase) promoter. The authors
hypothesized that at lower temperature a reduced amount
of folding stress is imposed on the cells, consequently
leading to a higher rate of correctly folded product.
Although lower temperature has been shown to improve
protein secretion rates, this still depends on the nature of
the heterologous protein. Production of a hyperther-
mophilic enzyme was improved by cultivation at higher
temperature (40°C) in Saccharomyces cerevisiae, thereby
reducing ER folding stress [21].
Additionally to regulatory events, many positive effects of
temperature shifts on protein production might be linked
to cell wall composition (porosity) and cell cycle. Indeed,
increased levels of chitin and cell wall linking beta-glu-
cans have been determined in yeast cells grown at 37°C
compared to 22°C in batch cultures [22].
Generally, it turns out that cultivation at an optimized
temperature is one of the crucial parameters for improved
specific productivity, as it is likely to direct carbon fluxes
towards heterologous protein production, and maintains
the cells in the more secretion competent phases of the
cell cycle.
Oxygenation
Redox processes play a major role in heterologous protein
production, both related to the oxidation of the product
to form disulfide bonds, and to oxidative stress of the host
cell during cultivation. Cultivation of methylotrophic
yeasts like P. pastoris on methanol leads to significant oxi-
dative stress, which may be relieved by the addition of
antioxidants like ascorbic acid [23]. Similarly, the expres-
sion of antioxidant enzymes like superoxide dismutase
was reported to relieve oxidative stress [24].
Apart from environmental stressors, oxidative stress can
be imposed on the host cells by intrinsic factors such as
leakage in the respiratory pathway, beta-oxidation of lip-
ids, or accumulation of misfolded protein in the ER. There
is strong evidence that oxidative stress is connected to
growth temperature. While in most cases lower growth
temperature results in lower oxidative stress, Gasser et al.
[20] showed that the genes coding for the key regulatory
enzymes of both the cell redox homeostasis (thioredoxin
reductase TRR1, thioredoxin peroxidase TSA1, glutath-
ione oxidoreductase GLR1) and osmoregulation
(mitogen-activated protein (MAP) kinase HOG1) werePage 5 of 18
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rates occur. Generally, the secretory pathway compart-
ments maintain a higher oxidized status compared to the
cytosol in order to enable disulfide-bond formation.
Finally the electrons generated during the oxidative fold-
ing cycles are transferred to molecular oxygen and may
lead to the formation of reactive oxygen species [25].
Interestingly, it was shown recently that very low oxygen
supply enhances the secretion rate of heterologous pro-
teins in P. pastoris significantly, which led to the develop-
ment of a hypoxic fed batch strategy with over 2-fold
increased productivity [26].
Osmolarity
So far no clear connection between medium osmolarity
and protein folding has been established. Previous data
indicate that the response is extremely transient [27]; and
even less is known of the effect of osmolarity on heterolo-
gous protein production. Mager and Siderius [28]
describe temporary cell growth arrest (either at G1 or G2/
M) upon hyperosmotic stress conditions accompanied by
the induction of the high osmolarity glycerol (HOG)
kinase pathway in S. cerevisiae. Intracellular glycerol levels
are increased in order to adjust osmo-balance through the
modification of cell wall integrity. Unlike in animal cells
where an osmotic shock leads to increased exocytosis
[29], and hyperosmotic GS-NS0 mammalian cells that
exhibit an increased specific production rate (albeit
decreased growth rate) as compared with iso-osmotic cul-
tures [30], osmo-regulated secretion behaviour in fungi
remains unproven. In methanol grown P. pastoris cells,
salt stress prior to induction was shown to have a positive
effect on single chain antibody scFv titers [19], while Lin
et al. [18] reported a negative effect of salt supplementa-
tion on the secretion of an Fc fusion protein.
pH
Osmolarity and pH seem to trigger highly interrelated
responses. From an industrial point of view the main
desired effect of low pH is to reduce the activity of host
proteases which can lead to severe protein degradation
(reviewed among others by [31]), but no uniform picture
has been assigned to the correlation of pH and protease
activity in the culture broth. Both in yeasts and filamen-
tous fungi changing the pH of the culture medium can sig-
nificantly improve protein yields, however, this effect is
most probably not directly associated with improved pro-
tein folding mechanisms. On the other hand, lower extra-
cellular pH requires higher energy to maintain
intracellular pH values constant/physiological, thereby
delaying cell growth and enforcing the cell wall barrier
[22,32,33]. Subsequently this more rigid cell wall may
diminish secretion efficiency of the pH stressed cells. Lin
at al. [18] tested different pH values (ranging from 3.0 to
7.2) during fed batch production of a Fc fusion protein in
P. pastoris and reported detection of the heterologous pro-
tein only at the highest pH of 7.2, however, the authors
conclude that the pH optimum is strongly protein and
strain dependent.
Folding stress and heterologous protein production
The ER-resident chaperone BiP (binding protein, in yeast
encoded by KAR2) belongs to Hsp70 family of heat shock
proteins and it is present in the lumen of the endoplas-
matic reticulum of all eukaryotes. The yeast homologue is
sometimes referred to as Grp78. Binding to BiP prevents
the nascent part of secretory or transmembrane proteins
from misfolding, until synthesis of the protein is finished.
It has been suggested that BiP is not only involved in the
translocation of the nascent polypeptides across the ER
membrane into the ER lumen, but that it is a key element
of an ER-resident quality control mechanism that prevents
unfolded proteins from leaving the ER [34]. Other func-
tions associated to BiP are the solubilisation of folding
precursors, stabilization of unassembled protein subunits
and redirecting misfolded polypeptide chains to the
cytosol for ubiquitin-labeling and subsequent degrada-
tion by the proteasome (ERAD, ER-associated protein deg-
radation, [35]). Besides a basal constitutive expression
level, BiP transcription is induced by the presence of
mutant and misfolded proteins in the ER lumen and by
stress effects that result in the accumulation of unfolded
proteins [36], presumably including the high level expres-
sion of heterologous proteins. A saturation of the secre-
tory pathway seems possible, as extractable levels of free
folding assistants BiP and Pdi1 decrease when heterolo-
gous proteins are overexpressed in S. cerevisiae [37]. Kauff-
man et al. [38] observed an induction of BiP during the
expression of a scFv fragment in this yeast species, and
Hohenblum et al. [39] have reported increased levels of
BiP upon expression of recombinant human trypsinogen
in P. pastoris. Likewise, biPA and pdiA transcript levels
were increased due to heterologous protein overexpres-
sion, as well as upon high level secretion of homologous
enzymes in filamentous fungi [40-42].
ER-associated protein degradation is a complex process in
which misfolded proteins in the ER are redirected to the
translocon for retranslocation to the cytosol, where they
are subjected to proteasomal degradation. Additionally,
excess subunits of multimeric proteins that are unable to
assemble are degraded through the ERAD mechanism.
According to Plemper et al. [43], the malfolded proteins
are retro-translocated through the Sec61-complex translo-
con pore, through which they had entered the lumen of
the ER before, accompanied by ubiquitination at the
cytosolic side of the ER membrane. The labeling of sub-
strates destined for degradation by the cytosolic 26S pro-
teasome requires an Ub (ubiquitin) activating enzyme, anPage 6 of 18
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tin itself. In P. pastoris three essential components of the
ERAD pathway have been shown to be up-regulated upon
production of an antibody Fab fragment in correlation to
higher protein secretion rates: HRD1, coding for an Ub
protein ligase, that is able to recruit Ub conjugating
enzymes (such as the gene product of UBC1) next to the
Sec61 translocon pore complex [20].
Prolonged ER retention of misfolded proteins entails
repetitive rounds of oxidative protein folding attempts by
foldases such as Pdi and consequently results in the gen-
eration of reactive oxygen species (ROS). Alleviation of
the ER stress is accomplished by the upregulation of the
UPR and subsequent induction of the ERAD, however,
prolonged UPR induction can also contribute to the stress
situation by the accumulation of ROS. In this context,
both oxidative stress and ERAD occur in addition to UPR
induction when hydrophobic cutinase accumulates in the
ER of S. cerevisiae [44], while hirudin production in P. pas-
toris lead to increased levels of ROS [23]. Recently it has
been shown that overstraining or failure of the ERAD
components leads to persistent ER stress conditions and
subsequent cell death in both yeasts and higher eukaryotic
cells [45,46].
The unfolded protein response pathway is activated by a
unique mechanism not known in any other signal trans-
duction pathway (for a recent review see [47]). The sensor
protein Ire1p [48] resides in the ER membrane and pos-
sesses both kinase and endonuclease activities. When
unfolded proteins accumulate in the ER, Ire1p undergoes
autophosphorylation and oligomerisation, and catalyses
the cleavage of the mRNA encoding the UPR transcription
factor, called Hac1/hacA in yeasts and filamentous fungi
[49,50] or Xbp1 in mammalian cells [51]. In this way
Ire1p initiates an unconventional intron splicing event
that has been shown in S. cerevisiae to be completed by
tRNA ligase [52]. Splicing of yeast HAC1 mRNA removes
a translation block mediated by the intron [53] and ena-
bles formation of the activator protein. For mammalian
Xbp1 it has been shown that the unspliced mRNA pro-
duces an unstable protein that represses the UPR target
genes, whereas the spliced mRNA is translated to a potent,
stable activator protein [51]. In the filamentous fungi Tri-
choderma reesei, Aspergillus nidulans [50] and Aspergillus
niger [54], the hac1/hacA mRNA is truncated at the 5'
flanking region during UPR induction, in addition to the
unconventional intron splicing. This truncation removes
upstream open reading frames from the mRNAs, most
probably increasing translation initiation at the start
codon of the HAC1/HACA open reading frame. Kincaid
and Cooper [46] identified a novel function of Ire1p in
the degradation of mRNAs encoding selected secretory
proteins thus avoiding potential overload of the ER and
the translocon complex a priori.
ER-associated stress responses such as UPR and ERAD
were reported to be induced upon overexpression of sev-
eral heterologous proteins, e.g., human tissue plasmino-
gen activator (t-PA) in T. reesei [55] and A. niger [56], and
bovine chymosin in A. nidulans [57]. Similarily, overex-
pression of Fab fragments [20] and Rhizopus oryzae lipase
[58] revealed UPR induction in P. pastoris.
In another layer of ER stress regulation, mammalian cells
can attenuate translation initiation during unfolded pro-
tein accumulation into the ER, in order to reduce the
influx of proteins to the ER. This regulation pathway is ini-
tiated by the ER membrane kinase PERK that has some
similarity with Ire1 [59]. PERK phosphorylates the trans-
lation initiation factor eIF2alpha, resulting in drastic
reduction in translation. This mechanism is not known in
yeasts or filamentous fungi, and PERK orthologues can
not be found in the genomes of the lower eukaryotes.
Interestingly, the filamentous fungi T. reesei [60] and A.
niger [61] have an alternative mechanism for controlling
the protein influx to the ER. In conditions of ER stress the
mRNAs encoding secreted proteins are rapidly down-reg-
ulated. This mechanism called RESS (repression under
secretion stress) was shown to be dependent on the pro-
moters of the genes encoding secreted proteins, and thus
it probably functions at the level of transcription [60]. It
has been observed that in Arabidopsis thaliana a large
number of genes encoding secreted proteins are down-
regulated when cells are exposed to ER stress [62], imply-
ing the possibility that RESS might also exist in plants.
Overcoming folding stress for improved protein production
Although promising expectations emerged that increased
BiP levels would result in increased folding capacity in the
ER, and thus improved secretion rates, the findings were
rather inconsistent and unpredictable. Some studies
emphasize that overproduction of BiP stimulates protein
secretion in S. cerevisiae (5-fold increase in secretion of
human erythropoietin [63], 26-fold increase in bovine
prochymosin [64], 2.5-fold increase in the titer of anti-
thrombotic hirudin due to 2.5 times higher biomass
yields [65]). While the secretion level of plant thaumatin
in Aspergillus awamori was increased up to 2.5-fold com-
pared to a wild type strain due to bipA overexpression
[66], the secretory behaviour of the same protein was not
affected by overexpression of KAR2 in S. cerevisiae [64].
According to Wittrup and coworkers, a reduction of BiP
levels leads to decreased secretion of foreign proteins,
however, no effect was observed upon a 5-fold overexpres-
sion of BiP on secretion levels of three different recom-
binant proteins in S. cerevisiae [67], and neither for
cutinase in A. awamori [68]. Other reports even suggest aPage 7 of 18
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els of A. niger glucose oxidase (GOX) decreased 10-fold
upon BiP overexpression in Hansenula polymorpha [69]. As
prolonged binding to BiP seems to direct proteins rather
to degradation than to the secretory pathway, it becomes
more obvious why the overexpression of this chaperone
alone does not result in higher levels of secreted foreign
proteins, but can negatively influence expression levels, as
reported by Kauffman et al. [38] and van der Heide et al.
[69]. Interestingly, Pyrococcus furiosus beta-glucosidase
secretion in S. cerevisiae is diminished with increased BiP
levels, but benefited from higher protein disulfide isomer-
ase (Pdi) levels, although the protein did not contain any
disulfide bonds [70], pointing at the chaperone activity of
Pdi, as discussed below.
Conesa et al. [71] examined the impact of overexpression
of two ER quality control factors, BiP and calnexin, on the
secretion of glycosylated Phanerochaete chrysosporium man-
ganese peroxidase (MnP) in A. niger, as the expression lev-
els of these genes were induced upon recombinant
protein production. While BiP overproduction dimin-
ished manganese peroxidase secretion levels severely,
overexpression of calnexin resulted in a four- to fivefold
increase in the extracellular MnP levels. Higher levels of
calnexin also showed beneficial effects in mammalian
and baculo virus expression systems [72,73]. Recently, the
co-overexpression of calnexin was shown to stimulate the
secretion of three glycoproteins and one unglycosylated
product (HSA) in H. polymorpha (2–3 fold on average;
[74]). On the other hand, secretion of human serum albu-
min (HSA) remained unaffected by raising calnexin levels
in Schizosaccharomyces pombe [75], while in S. cerevisiae
deletion of the calnexin gene CNE1 was reported to
enhance secretion of both antitrypsin [76] and unstable
lysozymes [77,78].
Protein disulfide isomerase (Pdi) is a multifunctional pro-
tein resident in the ER lumen that is responsible for the
correct formation of disulfide bonds during oxidative
folding and the isomerisation of uncorrectly folded
disulfides. Apart from this foldase activity, Pdi also acts as
a chaperone. An additional PDI gene copy in S. cerevisiae
successfully improved secretion of human growth factor
by 10-fold, of S. pombe acid phosphatase by 4-fold [63]
and of human lysozyme by around 30–60% [79]. Human
lysozyme as well as HSA production could also be
enhanced by the same strategy in Kluyveromyces lactis (1.8
fold and 15 fold, respectively; [80,81]). Both S. cerevisiae
PDI1 and the P. pastoris own homolog were proven to be
functional in P. pastoris by facilitating secretion of the
human parathyroid hormone (hPTH, [82]), human anti
HIV1 2F5 Fab [83], and Necator americanus secretory pro-
tein Na-ASP1 [84], the latter reporting a correlation
between the secretory enhancement and the PDI copy
number. Generally, no clear picture emerged from the co-
overexpression of the two folding helpers, BiP and Pdi.
Whereas synergistic action of BiP and Pdi was suggested
regarding the improvement of the secretion of various sin-
gle chain fragments (scFv) in S. cerevisiae [85], a 2-fold
increase in secretion of the A33scFv in P. pastoris was only
achieved by additional copies of KAR2, but not PDI, and
not by the combination of both [86], in analogy to the
antagonistic effect observed in CHO cells [87]. Coexpres-
sion of KAR2, PDI1 or SSO2 exhibited no effect on secre-
tion of gamma-Interferon (IFNgamma) in H. polymorpha
[88]. Moreover, coexpression of cypB, which encodes a fol-
dase of the ER secretory pathway [89], did no increase pro-
duction of tissue plasminogen activator (t-PA) in A. niger,
although t-PA production elicited an UPR response
detectable through elevated transcript levels of bip, pdi and
cypB [90]. Thus, it seems that the effect of coexpression of
chaperone and foldase genes strongly depends on the
properties of the target protein and, moreover, it seems
that fine-tuned overexpression of these genes are required
to generate a functional secretory network to improve for-
eign protein overproduction. For example, in A. niger,
overexpression of bip to a certain threshold was beneficial
for plant sweet protein thaumatin production, but above
this threshold level thaumatin production decreased [66].
Similarly, defined levels of Pdi were required for optimum
thaumatin secretion in A. niger [91].
The flavoenzyme Ero1 is required for oxidation of protein
dithiols in the ER. It is oxidized by molecular oxygen and
acts as a specific oxidant of protein disulfide isomerase
(Pdi). Disulfides generated de novo within Ero1 are trans-
ferred to Pdi and then to substrate proteins by dithiol-
disulfide exchange reactions [92]. Duplication of either
KlPDI1 or KlERO1 genes led to a similar increase in HSA
yield in K. lactis, while duplication of both genes acceler-
ated the secretion of HSA and improved cell growth rate
and yield. Increasing the dosage of KlERO1 did not affect
the production of human interleukin 1beta, a protein that
has no disulfide bridges [93].
Finally, another approach to stimulate the secretory path-
way concertedly is to overexpress the unfolded protein
response (UPR) activating transcription factor Hac1. Tran-
scriptional analyses in S. cerevisiae revealed that up to 330
genes are regulated by Hac1, most of them belonging to
the functional groups of secretion or the biogenesis of
secretory organelles (e.g. ER-resident chaperones, fol-
dases, components of the translocon). Interestingly, genes
encoding proteins involved in protein degradation, vesic-
ular trafficking, lipid biogenesis and vacuolar sorting are
also induced by Hac1 [94]. In this context, Higashio and
Kohno [95] describe the stimulation of ER-to-Golgi trans-
port through the UPR by inducing COPII vesicle forma-
tion. The homologs of S. cerevisiae HAC1 in T. reeseiPage 8 of 18
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and the effects of UPR induction by constitutive overex-
pression of these genes have been evaluated. The heterol-
ogous overexpression of T. reesei hac1 in S. cerevisiae
yielded a 2.4-fold improvement in Bacillus α-amylase
secretion, and a slight increase in the yeast endogenous
invertase as well as in total protein secretion. S. cerevisiae
HAC1 overexpression was shown to enhance secretion of
the endogenous invertase (2-fold), and recombinant α-
amylase (70% increase), but did not effect secretion of T.
reesei EGI, a protein supposed to accumulate in the ER.
Disruption of HAC1 in S. cerevisiae led to a reduced secre-
tion of the two recombinant proteins (α-amylase -75%,
EGI -50%), but not of the endogenous invertase [96].
Similar results could also be seen in A. awamori, where
overproduction of A. awamori hacA ameliorated secretion
of Trametes versicolor laccase and bovine preprochymosin
7-fold and 2.8 fold, respectively [97], and in P. pastoris,
where heterologous expression of S. cerevisiae HAC1
increased the secretion rate of a Fab antibody fragment
[83].
Novel strategies: genome wide-screening
All these approaches are limited to the existing knowledge
base. Novel processes might be identified and targeted to
improve secretion (including non-UPR regulated genes)
through different approaches. In this regard, high
throughput flow cytometry and cell sorting are valuable
tools to isolate overproducing clones [98]. One approach
is to screen overexpression libraries for improved secre-
tion of heterologous protein, which is anchored to the cell
surface via agglutinin (Aga2p) and detected by immun-
ofluorescent staining. Shusta et al. [99] showed that the
levels of surface-displayed single chain T-cell receptors
correlated strongly with the soluble expression of the
respective proteins. A 3-fold higher secreting clone could
be isolated out of a library potentially as large as 108 in a
couple of weeks [100]. Screening of a yeast cDNA library
in S. cerevisiae surface display strains identified cell wall
proteins, translational components and the folding assist-
ant Ero1 as beneficial for the secretion of various antibody
fragments [101]. However, one potential drawback of this
high throughput method is that the display efficiency of
the protein of interest can be dominated by its fusion part-
ner Aga2p, as BiP and PDI overexpression had no effect on
surface display levels of the scFvs although they increased
soluble expression levels [85].
Furthermore, genome-wide analytical tools like DNA
microarrays are regarded as data mining source for physi-
ological effects, stress regulation and host engineering.
Sauer et al. [102] have analysed the differential transcrip-
tome of a P. pastoris strain overexpressing human
trypsinogen versus a non-expressing strain. 13 out of the
524 significantly regulated genes were selected, and their
S. cerevisiae homologs were overexpressed in a P. pastoris
strain producing a human antibody Fab fragment [103].
Five previously characterized secretion helpers (PDI1,
ERO1, SSO2, KAR2/BiP and HAC1), as well as 6 novel,
hitherto unidentified, factors, more precisely Bfr2 and
Bmh2 involved in protein transport, the chaperones Ssa4
and Sse1, the vacuolar ATPase subunit Cup5 and Kin2, a
protein kinase connected to exocytosis, proved their ben-
efits for practical application in lab scale production proc-
esses by increasing both specific production rates as well
as volumetric productivity of an antibody fragment up to
2.5-fold in fed batch fermentations of P. pastoris [103].
Protein folding and conformational stress in 
prokaryotic cells
Since early recombinant DNA times, bacteria (especially
E. coli) have been the most widely used microorganisms
for recombinant protein production due to genetic sim-
plicity, fast growth rate, high cell density production and
availability of a spectrum of genetic systems, among oth-
ers. For production processes being efficient, foreign genes
are expressed from plasmids and under the control of
inducible promoters, what results into non physiological
and unusually high transcription rates. Strong production
of recombinant proteins can lead to a stressful situation
for the host cell, with the extent of the bacterial stress
response being determined by the specific properties of
the recombinant protein, and by the rates of transcription
and translation [104]. This fact has a clear and profoundly
negative impact on productivity and probably protein
quality. In addition, recombinant proteins fail, very often,
to reach their native conformation when produced in bac-
teria [105]. This is caused by a coincidence of diverse
events impairing protein folding including bottlenecks in
transcription and translation, undertitration of chaper-
ones and proteases, improper codon usage and inability
of disulfide-bond formation [106,107]. Misfolded pro-
tein species usually deposit as amorphous masses of insol-
uble material called inclusion bodies [108], recorded as
by-products of bacterial protein production processes.
Inclusion bodies are mainly formed by the deposition of
unfolded or partially misfolded protein species that inter-
act through hydrophobic patches unusually exposed to
the solvent and with high amino acid sequence homology
[109,110]. The specificity in protein aggregation makes
inclusion bodies highly pure in composition and there-
fore enriched in the recombinant protein itself. However,
also truncated versions of the recombinant product, other
plasmid-encoded proteins, but also defined host cell pro-
teins can get entrapped within bacterial inclusion bodies
[111-116]. Moreover, the presence of folding assistant
proteins in inclusion bodies [117-119] confirm that spe-
cific interactions lead to entrappment of cellular proteins
in these aggregates. The high purity of inclusion bodies
makes them a convenient source of easily extractable pro-Page 9 of 18
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dures, a fact that has been largely exploited for
biotechnology purposes [120]. The potential routes of a
newly synthesized protein in the bacterial cytosol are
illustrated in Figure 3.
Although inclusion bodies are mainly found in the cyto-
plasm, they occur also in the bacterial periplasm if pro-
teins have been engineered to present a leader peptide for
secretion [121]. In fact, a control quality system mostly
separated from that acting in the cytoplasm assist folding
of secreted proteins in the periplasmic space of gram neg-
ative bacteria. This is regulated through the combined
activity of two partially overlapping systems, regulated by
the alternate σ factor σE and by the Cpx envelope stress sig-
nalling system, that intricately combine the activity of
chaperones and proteases [122,123]. However, the simul-
taneous activation of stress signals in both bacterial com-
partments upon the production of misfolding prone
proteins strongly suggest a close physiological and genetic
connection between cytoplasmic and extracytoplasmic
systems [124]. The quality control and conformational
stress in the periplasmic space has been extensively
revised elsewhere [121,125].
Different to the unfolded protein response (UPR)
described in eukaryotic cells, the physiological reaction to
conformational stress in the bacterial cytoplasm has not
Schematic representation of protein folding and aggregation in recombinant E. coliFigure 3
Schematic representation of protein folding and aggregation in recombinant E. coli. After de novo synthesis, a 
fraction of recombinant proteins (especially heterologous proteins with conformationally complex disulfide bridges) do not 
reach their native conformation and aggregate as insoluble deposits named inclusion bodies. Protein aggregates already exist in 
the soluble cell fraction, and can involve native or quasi-native protein species. The main cytoplasmic chaperones involved in 
the protein folding process (red arrows) include the trigger factor, DnaK, DnaJ, GrpE, GroEL and GroES. Both soluble aggre-
gates and individual protein species can enter the virtual insoluble cell fraction (indicated by a dashed line) and deposit as inclu-
sion bodies, in a fully reversible process (green arrows). Protein release from inclusion bodies is mainly controlled by DnaK, 
ClpB and IbpA,B. Proteases (lon, ClpP and others) attack both soluble and insoluble species with folding defects. In particular, 
proteases degrade inclusion body proteins in situ, or through a more complex process intimately related to the protein release 
process, and therefore, strongly dependent on DnaK.
De novo 
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Folding intermediates Native or quasi-native species
Misfolded species
Polypeptides
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Degradation
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of recombinant E. coli has resulted in a catalogue of genes
up-regulated during protein production [126,127].
Among them several heat shock genes have been identi-
fied (including those encoding the proteases Lon, ClpP,
HslV and HslU, and the chaperones IbpA, IbpB, DnaK,
DnaJ, ClpB, HtpG, MopA and MopB among others) but
also other ones not directly involved in protein quality
(such as YagU, YojH, YbeD and others) and whose precise
role remains to be identified. This fact indicates that the
conformational stress imposed by protein production is
more complex and physiologically distinguishable from
that caused by thermal denaturation, namely the heat
shock response [128,129], and includes several overlap-
ping stress responses [104] Well characterized stress
events have been observed during recombinant protein
production such as SOS DNA repair [130] and stringent
responses [131], although it is still be solved whether such
reactions are directly associated to the prevalence of
unfolded or misfolded protein species and the eventual
connection with the σ32-regulated heat shock response.
The expression of some of these stress genes is being used
as a convenient marker of conformational stress in recom-
binant cells [132].
The bacterial conformational stress itself has been poorly
characterized from its physiological side. Instead, many
efforts have been addressed to a rather practical issue such
as minimizing aggregation, what in turn has resulted in a
better comprehension of in vivo protein folding proc-
esses. Since solubility has been considered for a long time
being synonymous with protein quality, increasing the
relative yield of soluble protein has been targeted by phys-
icochemical approaches. From already classical studies, it
is well known that high temperatures impair protein fold-
ing and favour aggregation of the recombinant proteins as
inclusion bodies [133,134]. Therefore, reducing the
growth temperature has been a general strategy used to
minimize inclusion body formation [135-137] that, like
other strategies, has rendered moderately positive, but
unpredictable and product-dependent results [107].
Fusion of folding-reluctant species to highly soluble
homologous or thermostable proteins has in some cases,
resulted in moderate enhancement of the passenger pro-
tein solubility [106,138,139].
Chaperones and protein degradation
Folding failures of recombinant proteins produced in E.
coli is generally attributed to a limitation in the cell con-
centration of folding assistant elements, which cannot
process the newly synthesized aggregation prone polypep-
tides. This assumption is physiologically supported by the
overexpression of chaperone genes, in particular of chap-
erone genes from the heat-shock protein family, in
response to recombinant protein overproduction
[126,127,133]. Thus, coproduction of the main heat
shock chaperones (specially GroEL and DnaK) together
with the target protein has been largely explored as a way
to minimize aggregation and to enhance the solubility of
the recombinant protein product (reviewed in [140-
143]). In many cases, solubility has been significantly
enhanced by coexpression of individual chaperone genes,
while in others an even negative effect on product stability
and host viability has been observed. Selection of the suit-
able chaperone(s) is still a trial-and-error process. How-
ever, more recent results indicate that complete
chaperones gene sets rather than individual chaperone
genes with synergistic and/or cooperative activities (such
as DnaK-DnaJ-GrpE and GroEL-GroES sets) will lead to a
more predictable improvement of target protein solubil-
ity. [144-147].
Interestingly, when producing enzymes or fluorescent
proteins in DnaK- cells, the biological activities and there-
fore the conformational quality of aggregated polypep-
tides is much more close to that of soluble versions,
compared to wild type cells [148-150]. Furthermore, the
overexpression of the dnaK gene along with a model GFP
recombinant protein dramatically reduces the specific flu-
orescence of a GFP fusion in both soluble and insoluble
versions [151]. This indicates that DnaK directly or indi-
rectly impairs the folding state of the aggregated proteins.
In this regard, the production of GFP variants in absence
of DnaK results in highly fluorescent inclusion bodies
[152]. In these cells, both the protein yield and quality
were dramatically enhanced although the solubility is
lower than in the wild type, as expected. This occurs by the
inhibition of GFP proteolysis mediated by the proteases
Lon and ClpP, which participate in the in vivo disintegra-
tion of inclusion bodies in absence of protein synthesis
[153,154]. Probably, such proteases act coordinately in a
disaggregation complex [155-157] in which DnaK, ClpB
and IbpAB remove aggregated polypeptides for proteo-
lytic digestion. Therefore, although solubility can be
indeed enhanced by high levels of DnaK, GroEL and other
chaperones it occurs at expenses of quality and yield,
probably by generally stimulating proteolysis [116]. In
fact, solubility and conformational quality are not only
non coincident parameters [158] but highly divergent
protein features [152].
Disulfide-bond formation in recombinant E. coli
Usually, the cytoplasmic space of E. coli is a reducing envi-
ronment. Therefore, disulfide-bonds within proteins are
not formed, a fact that represents an additional obstacle
for proper folding of many recombinant proteins. There
are two approaches to produce disulfide-bonded proteins
in E. coli expression, namely in vitro refolding of inclusion
body proteins under appropriate redox conditions [120]
or manipulating in vivo conditions by either convertingPage 11 of 18
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the protein into the periplasmic space or even further into
the culture medium (less reducing environments). Cor-
rect disulfide bond formation in the periplasm of E. coli is
a catalyzed process, where the oxidation of cysteine pairs
occurs through the transfer of disulfides from the highly
oxidizing DsbA/DsbB proteins to the proof-reading pro-
teins DsbC/DsbD which are able to rearrange non-native
disulfides to their native configuration [159]. In particu-
lar, overexpression of DsbC has been shown to increase
the yield of correctly disulfide-bonded proteins in the
periplasm of E. coli [160-162]. The co-expression of
eukaryotic protein disulfide isomerases in E. coli can also
favour the formation of disulfide bonds in the periplas-
mic space [163,164].
Disulfide bond formation in the cytoplasm of E. coli can
occur when the genes encoding thioredoxin reductase
(trxB) and glutathione oxido-reductase (gor) are inacti-
vated [165,166]. A double-mutant strain containing
appropriate mutations, known as Origami, has been used,
for example, to generate active variants of tissue-type plas-
minogen activator [165] and functional antibody frag-
ments in the E. coli cytoplasm [167,168]. In some cases,
recovery of functional cytoplasmic disulfide-bonded pro-
teins can be further enhanced by coexpressing signal
sequence deficient periplasmic chaperones and/or
disulfide-bond isomerases such as DsbC
[165,167,169,170]. Unfortunately, trxB gor mutants
exhibit impaired growth characteristics [112,165], but, at
least for antibody fragments it has been shown that
expression yields of correctly disulfide-bonded proteins in
the cytoplasm can be similar to those obtained by secre-
tion into the periplasmic space [171].
Protein folding and secretion in non-conventional 
bacterial expression systems
Although E. coli is still the most commonly used prokary-
otic organism for heterologous protein production, other
bacterial hosts are becoming more and more attractive.
Gram-positive Bacilli strains are also frequently employed
at industrial level. In contrast to E. coli, their outer enve-
lope has no lipopolysaccharides, also called "endotoxins"
since they exert a pyrogenic activity in humans or other
mammals. Therefore, many pharmaceutically relevant
products have been obtained in several strains [172]. In
addition, the Bacilli strains are attractive hosts because
they have a naturally high secretion capacity, as they
export proteins directly into the extracellular medium.
Amongst Bacilli species, the protein secretion pathway in
B. subtilis have been deeply investigated at molecular level
and a comprehensive literature survey is reported in
[173]. Several bottlenecks in the expression and secretion
of heterologous proteins have been highlighted [174].
The secretory pathway of proteins can be divided into
three functional stages: the early stage, involving the syn-
thesis of secretory pre-proteins, their interaction with
chaperones and binding to the secretory translocase com-
plex; the second stage, consisting in translocation across
the cytoplasmic membrane; and the last stage, including
removal of the N-terminal signal peptide, protein refold-
ing and passage through the cell wall. A pivotal role in the
whole secretion process is played by molecular chaper-
ones [175]. B. subtilis has two types of molecular chaper-
ones, intracellular and extra-cytoplasmic molecular
chaperones. GroES, GroEL, DnaK, DnaJ and GrpE are
intracellular molecular chaperones. Besides being
involved in and largely responsible for protein folding
and minimizing aggregation, these chaperones maintain
pre-proteins (the products to be secreted) in transloca-
tion-competent conformations [176]. PrsA is the only
known extracytoplasmic folding factor in B. subtilis. PrsA
is a lipoprotein that consists of a 33 kDa lysine-rich pro-
tein part and the N-terminal cysteine with a thiol-linked
diacylglycerol anchoring the protein to the outer leaflet of
the cytoplasmic membrane [177]. Subsequent folding of
a secreted mature protein into a stable and active confor-
mation usually requires PrsA protein. In prsA mutants, the
secretion and stability of some model proteins is
decreased, if not abolished, while overproduction of PrsA
enhances the secretion of exoproteins engineered to be
expressed at a high level [178].
There is, however, a physiologic limit to the overloading
of B. subtilis secretory pathway. The massive production of
homologous and heterologous exoproteins has been
reported to induce a phenomenon called "protein secre-
tion stress response" [179]. The CssRS two-component
regulatory system is able to detect the presence of partially
folded or unfolded exo-protein intermediates and acti-
vates the transcription of several genes, among which a
key role is played by htrAB. These genes encode two mem-
brane localised serine proteases involved in the proteoly-
sis of aberrant products [180].
Several gene expression systems using non-conventional
prokaryotic organisms as host cells have been developed
over the last decades. Each bacterial host was generally
implemented to overcome defined problems/bottlenecks
observed during the recombinant production of specific
protein classes in conventional systems, such as E. coli and
B. subtilis. The use of such non-conventional systems is
still very limited and largely suffers from the lack of
molecular details concerning host physiology and any
other phenomenon related to massive recombinant pro-
tein production. Notwithstanding, some of them may rep-
resent useful model systems to further investigate on the
optimization of recombinant protein folding and quality.Page 12 of 18
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mentation of an Antarctic Gram negative bacterium as
production host. Pseudoalteromonas haloplanktis TAC125
was isolated from a sea water sample collected in the
vicinity of the Dumont d'Urville Antarctic station, in Terre
Adélie. It is characterised by fast growth rates, combined
with the ability to reach very high cell densities even in
uncontrolled laboratory growth conditions and to be eas-
ily transformed by intergeneric conjugation [181]. There
features made P. haloplanktis TAC125 an attracting host for
the development of an efficient gene-expression system
for the recombinant protein production at low tempera-
tures of thermal-labile and aggregation-prone proteins
[182]. Furthermore, it was the first Antarctic Gram-nega-
tive bacterium which genome was fully determined and
carefully annotated [183].
Since high temperatures have a general negative impact
on protein folding due to the strong temperature depend-
ence of hydrophobic interactions that mainly drive the
aggregation reaction [184], and favour conformational
stress, the production of recombinant proteins at low tem-
peratures represents an exciting model to study the
dynamics of protein folding and misfolding and to
improve the quality of the products. The growth of E. coli
below 37°C has been often explored to minimize aggre-
gation but without consistent, protein-irrespective results.
Also, the use of suboptimal growth temperatures might
negatively affect the biology of the host cell and the per-
formance of the process in undesirable and non predicta-
ble ways. Recombinant protein production in
psychrophilic bacteria, i.e. at temperature as low as 4°C,
may minimize undesired hydrophobic interactions dur-
ing protein folding, desirably resulting in enhancing the
yield of soluble and correctly folded products while oper-
ating close to the optimal growth range. Furthermore,
with respect to mesophilic cells growing at suboptimal
temperatures, psychrophiles contain a full set of folding
factors already adapted to assist optimally, when required,
protein folding at freezing temperatures.
The efficiency of the cold-adapted expression system was
tested by producing several aggregation-prone products in
P. haloplanktis TAC125, such as a yeast α-glucosidase
[182], the mature human nerve growth factor [182], and
a cold adapted lipase [185]. All the recombinant products
resulted to be fully soluble and biologically competent.
Concluding remarks
In vivo protein folding is a very complex issue that
involves many cellular proteins and physiological
responses. During recombinant protein production, con-
formational stress conditions elicited by the synthesis of
aggregation prone polypeptides profoundly alter the
physiology of the host cell, triggering mechanisms
addressed to manage potentially toxic misfolding protein
species and to recover the cell folding homeostasis. The
use of different microorganims as factories for recom-
binant protein production, including yeast, filamentous
fungi and bacteria has resulted in dramatic gains of infor-
mation about the biology of such stress responses, and
has provided valuable information to better understand
the mechanics of in vivo protein folding and aggregation.
However, so far it has not been possible to create the "per-
fect folding environment". Especially with respect to
industrial protein production processes, the direct impact
of altered process conditions on recombinant protein
folding remains unclear. Ongoing research in the authors'
labs is targeted to elucidate the physiological responses of
different eukaryotic and prokaryotic microbial hosts on a
genome wide level in order to interrelate environmental
stresses to protein folding/aggregation mechanisms and
eliminate bottlenecks.
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Abstract: Micro-organisms that thrive at low temperatures produce cold-adapted enzymes which generally display high catalytic effi-
ciency making these biocatalysts particularly interesting either for investigating stability/flexibility relationships, or for their quite wide 
applications.  
Psychrophilic lipases and esterases have attracted attention because of their increasing use in the organic synthesis of chiral intermediates 
due to their low optimum temperature and high activity in cold conditions, which are favourable properties for the production of rela-
tively frail compounds. In addition, these enzymes have an advantage under low water conditions due to their inherent greater flexibility, 
wherein the activity of mesophilic and thermophilic enzymes is severely impaired by an excess of rigidity.  
In this review we present an up to date overview on some psychrophilic esterases and lipases from microbial sources. The different ex-
perimental strategies available for the search of psychrophilic biocatalysts and their application to discover novel cold-adapted lipolytic 
enzymes will be outlined. Some structural features that justify the unusually high enzymatic activity at low temperature will be discussed, 
in view of the recent achievements concerning the use of cold-adapted lipases and esterases in the synthesis of fine chemicals. 
Keywords: Psychrophilic micro-organisms, cold-active enzymes, ?/? hydrolase fold, ester synthesis. 
INTRODUCTION 
Life at low temperatures is abundant, diverse and widespread, 
with organisms from all three domains of life being represented. 
These cold-adapted, or psychrophilic, micro-organisms have been 
found to not only endure, but to flourish under the harsh conditions 
of permanently low-temperatures. In fact, for some, this environ-
ment is not only optimal, but mandatory for sustained cell prolifera-
tion, with moderate to high temperatures (e.g., >12°C) being delete-
rious [1]. Clearly, adaptations at level of structural and physiologi-
cal organisation have occurred, which allow these psychrophilic 
micro-organisms to overcome key obstacles inherent to life at low 
temperatures [2].  
An up-to-date survey of the adaptive features characteristic to 
psychrophilic organisms can be found in a recent book [3]. It is out 
of doubt that one of the strongest effect of low temperatures on 
biological systems is the slowdown of reaction rates, a simple ob-
servation that can result as the sum of several phenomena, such as 
an alterations in the strength of enzyme-substrate interactions, an 
increased viscosity of the solvent and an altered solubility of pro-
teins, salts and gases and ultimately leading to protein cold-
denaturation [4-5]. 
As a result of these diverse adverse effects, most biological re-
actions display an approximately 16- to 80-fold drop in activity on 
reducing the temperature from 37°C to 0°C. In contrast, psychro-
philic micro-organisms have been found to maintain relatively high 
metabolic fluxes at low temperatures, indicating that adaptation of 
the enzymatic repertoire has taken place to allow for appropriate 
reaction rates.  
Focusing only on microbial enzymes isolated from organisms 
inhabiting permanently cold environments, about 200 biocatalysts 
have been characterized so far (February 2009) [3]. The majority of 
them acquired specific structural features correlating with enzyme 
cold adaptation, but it is now widely accepted that no structural  
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feature is present in all cold-adapted enzymes, and no structural 
features always correlate with cold adaptation [6]. It is frequently 
observed that proteins from psychrophiles are thermo labile and 
more flexible than their counterparts from thermophiles. Many 
cold-adapted proteins have regions of local flexibility, particularly 
around the active site. The high local flexibility is translated into a 
reduction in ?H# (change in activation enthalpy between the ES 
ground state and the corresponding activated complex), high kcat, 
and, in the majority of cases, high Km. Therefore, the often associ-
ated high activity and low stability of cold-adapted enzymes under-
lie a general principle of activity-stability trade-off [6].  
The two above mentioned properties of cold adapted biocata-
lysts make these enzymes of great interest in many industrial appli-
cations, where a high catalytic efficiency in low temperatures proc-
esses is required and the easy inactivation of the added catalysts by 
moderate heating is an added value [7]. 
Esterases and lipases are the most applied biocatalysts in indus-
trial applications. The reasons of this success are numerous and 
related to the wide diversity in the substrates recognised, combined 
to the exquisite chemoselectivity, regioselectivity and stereoselec-
tivity frequently displayed by this class of enzymes. Furthermore, 
they are readily available in large quantities because many of them 
can be produced in high yields from microbial organisms and the 
crystal structures of many lipolytic enzymes have been solved, 
making possible the design of rational engineering strategies. Fi-
nally, they do not usually require cofactors nor do they catalyse side 
reactions.  
Despite the lack of significant sequence similarity between li-
pases and esterases of different families, they do share a common 
three-dimensional fold, known as the ?/? hydrolase fold. This fold 
is also found in proteins of other functional families, including Ser 
proteases, haloperoxidases, haloalkane-dehalogenases and chlorine-
esterase, which highlights the value of the fold as a template for 
various enzymes.  
It was discovered that lipases and esterases carry out their func-
tion as carboxyl ester hydrolases by virtue of a catalytic triad, 
which is a mirror image of that found in serine proteases such as 
chymotrypsin. The triad is composed of a serine, a carboxylic acid 
residue (Asp or Glu) and a histidine, in this order in the sequence, 
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and the mechanism of action proceeds through four consecutive 
steps. Fig. (1) summarizes this process as described for the Candida 
antarctica lipase B [8]. When substrates are hydrolysed, the car-
boxyl carbon of the leaving fatty acid is hydrogen-bound to the 
serine. The histidine (stabilized by the acidic residue) can donate a 
hydrogen to the leaving alcohol, after which a water molecule is 
added to the carbonyl group and the serine regains its hydroxyl 
group. As in the case of proteases there is an anion intermediate, 
stabilized in a so-called oxyanion hole by two or three hydrogen 
bonds [9].  
Due to these structural/functional similarities, it is still difficult 
to predict a priori if a lipolytic enzyme is an esterase or a lipase. 
Although the presence of a so called “lid” in lipases has been some-
times claimed to discriminate between the two types of enzymes, 
the number of true lipases not displaying this structural feature is 
growing. Therefore, the most reliable tool to classify the lipolytic 
enzymes is the most classical one: testing the substrate specificity. 
Water-insoluble long-chain acylglycerols (?C10) are very good 
substrates for lipases only, while esters with short-chain fatty acids 
(?C10), at least partially soluble in water, are hydrolysed by es-
terases.  
Is there a need for cold-adapted esterases and lipases? The in-
terest on cold-adapted lipolytic enzymes is related to several as-
pects: they are interesting objects of study to highlight their physio-
logical and/or structural adaptive mechanisms; many industrial and 
commercial applications would benefit from the use of psychro-
philic enzymes; lipases are potentially useful in the production of 
secondary chemical compounds, of "domestic" compounds such as 
soap, and in the degradation of organic matter, i.e. "bioremedia-
tion". For instance, the most commercially important field of appli-
cation for hydrolytic lipases is their addition to detergents, which 
are used mainly in household and industrial laundry and in house-
hold dishwashers. Godfrey and West (1996) reported that about 
1000 tons of lipases are sold every year in the area of detergents. 
The use of cold-active lipase in the formulation of detergents is of 
great advantage in cold washing that mean to reduce the energy 
consumption and wear and tear of textile fibres [10].  
In the next sections, we summarized recent results on some 
psychrophilic esterases and lipases from microbial sources. The 
different experimental strategies available for the search of psy-
chrophilic biocatalysts and their application to discover novel cold-
adapted lipolytic enzymes have been summarised. A brief discus-
sion on several structural features that justify the unusually high 
enzymatic activity at low temperature of these enzymes have been 
reported, in view of the recent achievements concerning the use of 
cold-adapted lipases and esterases in the synthesis of fine chemi-
cals. 
1. STRATEGIES FOR THE SEARCH OF NOVEL COLD-
ADAPTED LIPOLYTIC ENZYMES 
The isolation of novel enzymes with specific properties is the 
result of several experimental strategies that could be distinguished 
in: classical, genomic and metagenomic approach. In the following 
paragraphs each strategy will be outlined together with some se-
lected examples of cold-active lipolytic enzymes isolation. It is 
worth mentioning that the three approaches differ significantly in 
the expected size of the enzymatic repertoire potentially accessible 
to the screening procedures. In fact classical and genomic ap-
proaches require the microbial source isolation and its cultivation in 
laboratory conditions. This prerequisite makes it impossible to ana-
lyse the content of all the uncultivable microbes, a large fraction 
that can reach up to 99.8% of the micro-organisms present in some 
environments. To overcome this overwhelming limit, the metage-
nomic approach has been developed. This strategy allows the study 
of collective genomes of all micro-organisms thriving in a given 
habitat without the need of their culturing. 
1.1. The Classical Approach 
Classical approach consists in the isolation of the enzymatic ac-
tivity of interest from a given bacterial strain by screening it with 
classical molecular techniques. As previously mentioned, cold-
adapted microbial strains can be isolated from a wide array of cold 
environments either natural (i.e. polar and alpine ecosystems) or 
artificial (refrigerators or cold-rooms, for instance). These environ-
ments may be also characterized by other dominant parameters, 
such as unusually high values of pH or salinity, and these properties 
may be used as pre-selection criterion when a lypolitic enzyme with 
peculiar properties is searched. A rapid and cheap method to dis-
criminate which strains possess lipolytic activity is used as first step 
in the screening programme. A convenient assay is the cultivation 
of the strains on agar plates containing 1% tributyrin. The strain 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Proposed CAL B reaction mechanism. In step 1 of the reaction, an ester substrate enters the active site and is subjected to nucleophilic attack by 
Ser177, activated by proton abstraction by the His346/Asp280 pair. The resulting tetrahedral intermediate is stabilised by interactions with the backbone nitro-
gen of Gly, and the protonated side chain of Asp. In step 2, His346 releases its proton to the alcohol product as the tetrahedral intermediate collapses. The 
alcohol leaves the site, and a water molecule enters (step 3). After being activated by the His/Asp pair, the water molecule attacks the acyl enzyme to generate 
a second tetrahedral intermediate, which then collapses to release the carboxylate product (step 4). Taken from [8]. 
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showing the highest lipolytic activity is then picked out and a suit-
able library of its genomic DNA is constructed. The chromosomal 
DNA is extracted and enzymatically digested in order to obtain 
fragments with sizes between 1 to 5 kb. The purified gene frag-
ments are then ligated with commercial cloning vectors and the 
library is constructed by transforming the recombinant plasmids 
into competent Escherichia coli cells. A second screening step on 
agar plates is required for the identification of the library clones 
containing lipase encoding genes. Clones showing lipase activity by 
forming a clear halo on the agar plates containing tributyrin and 
supplemented with the appropriate antibiotic are finally selected. 
The new identified cold-active lipase is then over-expressed in the 
recombinant host and purified for further characterization.  
At the moment, several microbial sources of cold-active lipases 
are available. As shown in Table 1, the most of cold-active li-
pases/esterases producing micro-organisms are cold-adapted bacte-
ria, mostly isolated from Antarctic and polar regions. Other power-
ful sources of cold-active lipolytic enzymes are bacterial genera 
isolated from deep-sea water and sediments or refrigerated milk and 
food samples. The investigations on cold-active lipases are also 
extended to mycotic sources (Table 1). Even though only a few 
lipolytic fungi were reported to produce cold-active lipases, an 
extensive research has been carried out on the cold-active lipase B 
of Candida antarctica (CAL-B), which is widely used in industrial 
applications.  
Over the last few years many examples of cold-active bacterial 
lipolytic enzymes isolated by classical approach were reported. The 
first example of isolation of cold-active lipolytic enzymes from a 
psychrophilic bacterium was from the Antarctic strain Psychrobac-
ter sp. TAA144 (previously called Moraxella TAA144) [11]. Re-
cently, the isolation of a cold-active lipase from the Antarctic deep-
sea psychrotrophic bacterium Psychrobacter sp. 7195 and its char-
acterization has been described [12]. By screening a genomic DNA 
library, an open reading frame of 954 bp coding for a lipase gene, 
lipA1, was identified, cloned, and expressed in Escherichia coli 
BL21 (DE3) cells. The purified recombinant LipA1 enzyme 
showed highest activity at pH 9.0 and low stability at temperatures 
higher than 30°C, indicating that it is a typical cold-adapted alka-
line lipase. 
Another recent paper reports the isolation of cold-active LipP 
from Moritella sp.2-5-10-1 by classical approach [13]. The recom-
binant LipP enzyme, expressed in E. coli BL21 (DE3), showed a 
relatively low activity maybe due to incorrect protein folding and 
its tendency to aggregate into inclusion bodies. It is interesting to 
note that several papers reports the limits highlighted by E. coli to 
correctly produce and process recombinant lipases and esterases 
[14]. One of the main limitations experienced while producing pro-
teins in conventional bacterial mesophilic systems is the need to 
operate at their optimal growth temperature (usually 37ºC) for the 
production process. Since temperature has a general negative im-
pact on protein folding, the production of recombinant proteins at 
low temperatures represents an exciting model to improve the qual-
ity of the products. Recombinant protein production in psychro-
philic bacteria, i.e. at temperature as low as 4°C, may minimize 
undesired hydrophobic interactions during protein folding, possibly 
enhancing the yield of soluble and correctly folded products. There-
fore, overexpression of cold-active lipase could be achieved in non 
conventional hosts naturally adapted to the growth at very low tem-
peratures [15]. 
1.2. The Genomic Approach 
The isolation of novel enzymes can also be achieved by com-
bining in silico genome analysis with in vivo functional characteri-
zation. Genomic approach requires the knowledge of the whole 
genome sequence of the microbial source. Nowadays, several ge-
nomes of psychrophilic micro-organisms are available and their 
number in steadily increasing (Table 2). By using bioinformatic 
tools is possible to identify genes potentially encoding lipolytic 
enzymes and to predict their properties or some new features by 
comparing in a multiple alignment protein coding regions highly 
conserved at the nucleotide level. After the in silico selection, the 
genes of interest are PCR amplified from the microbial source and 
then over-expressed in an appropriate recombinant host for further 
recombinant protein purification and characterization.  
To illustrate this strategy, the Gram-negative Antarctic bacte-
rium Pseudoalteromonas haloplanktis TAC125 (P. haloplanktis 
TAC125), reports two examples of cold-active lipolytic enzyme 
characterization. The genome of the Antarctic organism contains 
several genes annotated as putative esterase/lipase encoding se-
quences. Recently, a gene coding for a putative esterase activity 
corresponding to the CDS PSHAa1385 has been functionally char-
acterized [16]. The 843 bp gene was cloned, recombinantly ex-
pressed in E. coli and the encoded product was identified as a cyto-
plasmic, dimeric feruloyl esterase. Another P. haloplanktis 
TAC125 gene, PSHAa0051, selected on the bases of the peculiar 
features of the encoded product, which was annotated as “putative 
secreted esterase”, was also recombinantly expressed in the same 
cold adapted bacterium [15]. The recombinant protein, named Lip1, 
found associated to the bacterial outer membrane although contain-
ing none of the already described anchoring domains, was purified 
and functionally characterized [17]. 
Table 1. Micro-Organism Producing Cold-Active Lipases 
Bacteria Source References 
Moraxella sp. strain TA144 Antarctic habitat [11] 
Psychrobacter immobilis strain B10 Antarctic habitat [74] 
Pseudomonas sp. strain B11-1 Alaskan soil [75] 
Pseudomonas fluorescens Refrigerated human placental extracts [76] 
Pseudomonas sp. strain KB700A Subterranean environment [77] 
Psychrobacter sp. Ant 300 Antarctic habitat [78] 
Photobacterium lipolyticum M37 Marine habitat [79] 
Psychrobacter sp. 7195 Antarctic habitat [12] 
Moritella sp. 2-5-10-1 Antarctic habitat [13] 
Fungi   
Candida antarctica Antarctic habitat [80] 
Candida antarctica Antarctic habitat [81] 
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1.3. The Metagenomic Approach 
The major limitation of the two described methodologies, clas-
sical gene cloning and genomic approach, is the need to cultivate 
the lipase-producing micro-organisms in laboratory conditions. In 
spite of the great variety of potential sources of novel enzymes, it is 
estimated that more than 99% of the prokaryotic organisms are so 
far uncultivable [18] and therefore not accessible for biotechnology 
and basic research. However, valuable resources from uncultivable 
microbial communities can be exploited by using metagenomic 
approach. This approach is based on the culture-independent re-
trieval of genomic DNA from microbial communities living in par-
ticular environments [19]. Metagenomic libraries construction in-
volves the same methods as the cloning of genomic DNA of indi-
vidual micro-organisms; that is, DNA fragmentation by restriction-
enzyme digestion or mechanical shearing, insertion of DNA frag-
ments into an appropriate vector system, and transformation of the 
recombinant vectors into a suitable host. Once established, metage-
nomic libraries can be accessed and tested by multiple screening 
methodologies to discover novel biocatalysts. The principal testing 
criteria include the functional screening [20-22], the identification 
of interesting genes based on sequence homology through PCR or 
random sequencing [19] and the large-scale shotgun sequencing 
[23, 24], the hybridization [25] or the detection of substrate induced 
gene expression [26]. 
Several cold-active lipases have been identified by the metage-
nomic approach during the last years. 
A novel low temperature active lipase was isolated from a me-
tagenomic library of Baltic Sea sediment bacteria [27]. A fosmid 
library with inserts of 24-39 kb was generated and screened for 
clones producing lipolytic activity. A 978 bp open reading frame 
was selected encoding a putative lipase/esterase, called h1Lip1. 
Further characterization of the recombinant enzyme confirmed that 
it was a lipase. 
The same strategy was adopted to search another cold-active li-
pase from the sea sediment samples at Edison Seamount, South 
West Pacific [28]. The sequence analysis of the selected fosmid 
clone revealed the presence of an open reading frame (EML1) 
showing similarities to lipases. EML1 enzyme was then recombi-
nantly produced in E. coli BL21, and purified for biochemical char-
acterization. Based on the data of optimum conditions for the re-
combinant enzyme activity and the calculated activation energy, it 
was suggested that EML1 is cold-active, consistent with the origin 
of the sample.  
The reported examples show that metagenomic approach, using 
extreme environment samples, can provide an opportunity to isolate 
enzymes perfectly adapted to extreme working conditions which 
display unique primary sequence. On the other hand, the method 
suffers the general limitations of the heterologous gene-expression 
screening in E. coli which have been discussed in full details else-
where [29]. 
2. STRUCTURAL/FUNCTIONAL RELATIONSHIP IN 
COLD-ADAPTED LIPOLYTIC ENZYMES 
2.1. General Structural Features of Lipases and Esterases 
The superfamily of carboxyl ester hydrolases (which comprises 
also lipases and esterases) includes ubiquitous enzymes of great 
physiological function with a wide range of substrate specificities; 
they are member of the ?/? hydrolase family. 
Since its original discovery [30] the ?/? hydrolase fold has 
grown into a large superfamily of proteins that appear to be related 
by divergent evolution. The fold has proved remarkably adaptable, 
allowing it to carry out a truly impressive range of functions. The 
members vary in subunit size and oligomeric structure so that it is 
difficult to give a concise definition of the fold – they are predomi-
nantly simple hydrolytic enzymes with a conserved ?/? structural 
core. Enzymatic catalysis utilises a 'catalytic triad' of residues that 
is usually comprised of a serine (nucleophile), a histidine and an 
aspartic acid that occur after the same secondary structure elements 
in the ?/? structure – as shown in Fig. (2). The term catalytic triad 
was first applied to the active site residues of a number of families 
of proteolytic enzymes. These families include the well-known 
eukaryotic serine proteases, cysteine proteases, and subtilisin-like 
enzymes. The catalytic triad is a particularly useful arrangement of 
amino acids and has probably arisen several times during the course 
of evolution – the overall structures of the serine proteases and the 
?/? hydrolase fold enzymes are quite different and their triads are 
clearly related by convergent evolution.  
What are the features of a typical ?/? hydrolase fold protein? 
This question has been raised and addressed on several occasions 
[31], and it will be only briefly dealt with here. The basic canonical 
fold was originally defined as having eight strands, the second 
strand being antiparallel to the others. The strand order is 12435678 
with helices that connect all. The strands have a super-helical twist 
such that the first and last strands are orthogonal to each other. The 
most conserved feature of the fold and its key signature is the so-
called 'nucleophilic elbow' – a ? turn with the nucleophile at its 
apex. The sharpness of this turn requires that it posses a pair of non-
Ramachandran backbone dihedral angles and small side chains, 
often glycine, on the residues at positions two before and two after 
the nucleophile (Nu-2, Nu+2). The residue at Nu+3 also needs to be 
small to avoid a steric clash with strand 4.  This conservation of 
amino acids is frequently used to identify the nucleophile. The ge-
ometry of the nucleophilic elbow allows it to make a close approach 
to the substrate and also allows it to form part of the “oxy-anion 
binding hole” that stabilizes the negatively charged transition state 
formed during hydrolysis.  This oxy-anion hole is usually formed 
by two backbone nitrogen atoms; the first always from the residue 
immediately following the nucleophile, the second usually between 
strand 3 and helix A. In most cases the oxy-anion hole is evident in 
the resting state of the enzyme, but in some cases substrate binding 
is required for activation [32]. The Asp/Glu and His residues of the 
Table 2. Sequenced Genomes of Cold-Adapted Bacteria 
Species/strain Source References 
Colwellia psychrerythraea 34H Artic marine sediment [82]  
Desulfotalea psychrophila LSv54 Marine sediment, Svarlbard [83] 
Methanococcoides burtonii DSM6242 Ace lake Vestfold Hills Eastern Antarctica [84] 
Pseudoaltermonas haloplanktis TAC125 Antarctic sea-water [85] 
Psychromonas ingrahamii 37 Under-ice sea-water, Alaska [86] 
Photobacterium profundum SS9 Amphipod, Sulu Trench [87] 
Psychrobacter arcticus 273-4 Tundra permafrost, Siberia [88] 
Psychrobacter cryohaloentis K5 Cryopeg, Siberia [88] 
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catalytic triad are usually located in a loop containing two reverse 
turns at the end of strands 7 and 8 respectively. Although the cata-
lytic machinery of ?/? hydrolase enzymes is very similar, the way 
by which they bind substrates varies from protein to protein.  In 
most cases, substrate binding occurs in a “cap” domain that sits 
over the catalytic triad.  The cap domains are built from one or 
more peptides that emanate from the C-terminal ends of strands 4, 
6, 7 or 8.  The differing sizes of the cap domains give rise to subunit 
molecular weights that vary considerably. 
Although most of the ?/? hydrolase fold enzymes can be easily 
classified as such, there are other members that have some, but not 
all of the fold characteristics. Perhaps the most profound difference 
in the family members is in their function. Most of the proteins are 
simple esterases, lipases or peptidases. The mechanisms of these 
proteins have been studied and in many cases appears to be very 
similar to that of the serine proteases. 
Lipases and esterases are collectively known as lipolytic en-
zymes, which hydrolyze hydrophobic long- and short-chain car-
boxylic acid esters. Due to their respective solubility, esterase activ-
ity occurs in aqueous solution, while lipolytic reactions occur at the 
lipid–water interface, implying that the kinetics cannot be described 
by Michaelis–Menten equations, as these are valid only if the cata-
lytic reaction takes place in one homogenous phase [33]. Lipolytic 
substrates usually form equilibrium between monomer, micellar 
and emulsified states, resulting in the need for a suitable model 
system to study lipase kinetics. The best-known phenomenon 
emerging from early kinetic studies of lipolytic reactions became 
known as ‘interfacial activation’, describing the fact that the activ-
ity of lipases is enhanced towards insoluble substrates that form an 
emulsion [9]. 
Lipases, in contrast to esterases, were therefore defined as car-
boxylesterases acting on emulsified substrates. The determination 
of their 3D structures seemed to provide an elegant explanation for 
interfacial activation: the active site of lipases was found to be cov-
ered by a surface loop, which was called the lid (or flap). Upon 
binding to the interface, this lid moves away, turning the ‘closed’ 
form of the enzyme into an ‘open’ form, with the active site now 
accessible to the solvent; at the same time, a large hydrophobic 
surface is exposed, which is thought to facilitate binding of the 
lipase to the interface. More recently, it turned out that the presence 
of a lid-like structure is not necessarily correlated with interfacial 
activation: lipases from Pseudomonas aeruginosa [34], P. glumae 
[35], and Candida antarctica CalA and CalB [36], and LipA lipase 
from Serratia marcescens [37], do not show interfacial activation 
but nevertheless have an amphiphilic lid covering their active sites. 
This observation led the conclusion that the presence of a lid do-
main and interfacial activation are unsuitable criteria to classify an 
enzyme as a lipase. Therefore, the current definition is rather sim-
ple: a lipase is a carboxylesterase that catalyses the hydrolysis of 
long-chain acylglycerols [33]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2A,B): (A) Schematic representation of ?/? idrolase canonical fold. * represent the catalytic residues. (B) The 3D overall fold of Archeoglobus fulgidus 
carboxylesterase: ?-strands and helices belonging to the canonical ?/? hydrolase fold are shown. The residues of the catalytic triad are shown in ball-and-stick 
representation: Ser160, His285 and Asp255. Taken from [89]. 
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2.2. Lipolytic Enzymes Adaptation to Cold Conditions 
Psychrophilic enzymes are of great interest in the scientific 
community, and are currently under study to characterize their 
physical and chemical properties in an attempt to understand the 
molecular basis of cold adaptation. Low temperatures have a nega-
tive effect on enzyme kinetics: any drop off in temperature results 
in an exponential decrease in reaction rate. For example, lowering 
the temperature by 10 C° causes a two-fold to four-fold decrease in 
enzyme activity [10, 38]. Therefore, enzymes from psychrophiles 
show high catalytic efficiency in the 0–20 °C temperature range, 
temperatures at which counterparts from mesophilic or thermophilic 
organisms do not allow adequate metabolic rates to support life or 
cellular growth. Such high activity balances the cold-induced inhi-
bition of reaction rates. However, the structure of cold-adapted 
enzymes is also heat-labile. Indeed, low stability at moderate tem-
peratures (usually >40 °C) is the other peculiar characteristic of 
psychrophilic enzymes [39-40]. This trend was revealed by calo-
rimetric analysis of residual enzyme activities after incubation at 
increasing temperatures (it should be pointed out, however, that the 
loss of activity at moderate temperatures might not be always di-
rectly related to the loss of enzyme structure). It is generally be-
lieved that cold adaptation results from a combination of lack of 
selective pressure for thermostability and strong selection for high 
activity at low temperatures [41]. Psychrophilic enzymes are often 
characterized by high flexibility, which allows better interaction 
with substrates, and by lower activation energy requirements in 
comparison with their mesophilic and thermophilic counterparts. 
Hence, the presence of high flexibility could explain both thermo-
lability and high catalytic efficiency at low temperatures [42]. The 
higher structural flexibility of psychrophilic enzymes, as compared 
to their mesophilic and thermophilic counterparts, could be the 
result of a combination of several features: weakening of in-
tramolecular bonds (fewer hydrogen bonds and salt bridges as com-
pared to mesophilic and thermophilic homologs have been shown); 
a decrease in compactness of the hydrophobic core; an increase in 
the number of hydrophobic side chains that are exposed to the sol-
vent; longer and more hydrophilic loops; a reduced number of 
proline and arginine residues; and a higher number of glycine resi-
dues [43]. However, each protein family adopts its own strategy to 
increase its overall or local structural flexibility by using one or a 
combination of these structural modifications. 
Earlier studies on the structural adaptation of extremophilic en-
zymes [44-47], were based on comparative analysis, also using 
homology modeling in cases where no experimental three-
dimensional structures were available. These approaches could give 
valuable information on rules to be followed by protein engineers to 
produce modified enzymes with suitable features for biotechnologi-
cal applications [48].  
A clear example of this study was the model construction of the 
PhTAC125 Lip1, using the crystal structure of the Geobacillus 
stearothermophilus carboxylesterase Est30 as template [17]. The 
most evident difference consisted in the presence of a large extra-
loop (32 amino acids long), placed between a ?-helix (?E) and the 
following ?-sheet (?8) with respect to the Geost Est30 structure. As 
far the size of the active site pocket is concerned, PhTAC125 Lip1 
displayed a wider groove with respect to the Geost Est30 one and 
the PhTAC125 Lip1 surface resulted to be more hydrophobic than 
that of Geost Est30. The above tendency to be more hydrophobic 
than the thermophilic counterpart is also observed in PhTAC125 
Lip1 active site pocket. Geost Est30 active site groove was charac-
terised by the presence of a positively charged surface, which has 
no counterparts in the model of the psychrophilic enzyme.  
Furthermore, because of their high catalytic efficiency at low 
temperatures, psychrophilic enzymes are investigated for their high 
potential economic benefit: in particular, they could be utilized in 
novel industrial processes requiring less energy. 
3. USE OF THE COLD-ADAPTED ESTERASES AND LI-
PASES IN FINE CHEMICAL SYNTHESIS: ESTER SYN-
THESIS 
Novel catalytic synthetic methods in organic chemistry that 
have to satisfy increasingly stringent environmental constraints are 
in great demand by chemical industry. Moreover novel catalytic 
procedures are essential to produce new classes of organic com-
pounds that are becoming targets of biomedical research Enzyme-
catalysed chemical transformations are now widely recognized as a 
good alternative to traditional organic synthesis, and as convenient 
solutions to same intractable synthetic problems. In organic synthe-
sis these biocatalysts can be used as the sole catalyst in reaction, in 
combination with other enzymes or with non biological reagents. In 
addition many enzymes can accept unnatural substrates and can be 
engineered to modify their stability substrate specificity and spe-
cific activity. 
Lipase, due to their high catalytic efficiency, selectivity, and the 
“far than harsh” conditions in which they operate, are used to pro-
duce some of industrially important chemicals, traditionally manu-
factured from fats and oils by chemical processes, with greater ra-
pidity and better specificity under mild conditions [49]. The in-
creasing interest in bacterial lipases is based on their potential to 
catalyze the hydrolysis of fats (their natural function), trans-
esterification, alcoholysis and esterification among other reactions. 
Indeed lipases, which cleave ester bonds of triacylglycerols with the 
subsequent release of free fatty acids, diacylglycerols, monoacyl-
glycerols and glycerol, are also able to catalyze the reverse reac-
tions (esterification, inter-esterification and trans-esterification) 
provided that the aqueous medium is replaced by an organic or a 
biphasic aqueous/organic medium. Indeed, various esters and lac-
tones are among the substances synthesized using bacterial lipases 
[14], moreover the high selectivity of these enzymes is a key fea-
ture of these biocatalysts which are used in the resolution of race-
mic mixtures for preparation of optically pure compounds.  
From the biotechnological standpoint there are numerous ad-
vantages of conducting enzymatic conversions in organic solvents 
as opposed to water: (i) high solubility of most organic compounds 
in nonaqueous media; (ii) ability to carry out new reactions impos-
sible in water because of kinetic or thermodynamic restrictions; (iii) 
relative ease of product recovery from organic solvents as com-
pared to water; and (iv) the insolubility of enzymes in organic me-
dia, which permits their easy recovery and reuse and thus eliminat-
ing the need for immobilization. It was demonstrated that some 
lipases act as a catalyst in the 99.98% organic medium; in addition, 
upon dehydration the enzymes acquire some remarkable new prop-
erties, e.g. they become more thermostable and more selective to 
trans-esterification and able to catalyze several processes including 
esterification, aminolysis, acyl exchange, thiotrans-esterification, 
and oximolysis; some of these reactions proceed to a substantial 
extent only in nonaqueous solvents [50]. 
Esterification is generally a water limited reaction because the 
equilibria catalyzed by hydrolytic enzymes is in favour of hydroly-
sis [51]. Water plays multiple roles on lipase-catalyzed esterifica-
tions performed in nonconventional media. It is widely known that 
water is necessary for the catalytic function of enzymes because it 
participates, directly or indirectly, in all non-covalent interactions 
that maintain the conformation of the catalytic site of enzymes. On 
the other hand, in esterification/hydrolysis reactions it is known that 
the water content affects the equilibrium conversion of the reactions 
as well as the distribution of products in the media [52]. Particularly 
for esterification, as the water content increases, lower equilibrium 
conversions are achieved. So, there is therefore a conflicting situa-
tion because under very low hydration conditions, enzyme effi-
ciency is generally poor and hence reaction kinetics is too slow. 
Although the role of water in promoting enzyme action is not fully 
established, it is thought that when the associated water falls below 
a certain level, the enzymes become more rigid and then perhaps 
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less efficient [53]. Psychrophilic enzymes might therefore have a 
potential advantage for applications under low water conditions as a 
result of their inherent greater flexibility, which will be particularly 
useful in conditions wherein the activity of mesophilic and thermo-
philic enzymes is severely impaired by an excess of rigidity. This 
will allow the use of lower water content with the consequence of 
increasing yield [54]. 
Several ester synthesis reaction using cold-active lipases have 
been reported [14]. In particular, the lipase from Candida antarc-
tica fraction B (CAL-B) [36] is a robust lipase in organic synthesis, 
showing high catalytic efficiency in several ester synthesis reac-
tions [14]. 
3.1. Synthesis of Short-Chain Flavour Esters 
Short-chain esters are compounds with wide applications 
mainly in food and cosmetic industries due to their characteristic 
fragrance and flavour. Moreover, some of these esters are also be-
ing used in the pharmaceutical industry. Most of the commercial 
esters can be directly obtained by extraction from plant materials, 
but the high cost and low quantities of product achieved make this 
technique inadequate for industrial applications. Then, the industrial 
production of this kind of compounds has been traditionally carried 
out by chemical synthesis. In the last decade, biotechnology has 
been considered for the production of esters used in food industry, 
since the obtained flavour can be labelled as ‘natural’ [55]. Thus, 
the enzymatic synthesis using lipases seems to be a competitive 
alternative to traditional chemical synthesis. 
CAL-B was employed as a biocatalyst for esterification reac-
tions leading to the synthesis of short-chain flavour esters in an 
organic solvent [56]. Lairos and co-workers demonstrated that 
Candida antarctica lipase CAL-B showed substrate specificity in 
the synthesis of esters in hexane involving reactions of short-chain 
acids having linear (acetic and butyric acids) and branched chain 
(isovaleric acid) structures, an unsaturated (tiglic acid) fatty acid, 
and phenylacetic acid with n-butanol and geraniol. Moreover they 
observed the alcohol specificity of the enzyme for esterification of 
acetic and butyric acids with four alcohols, such as n-butanol, 
isopentanol, 2-phenylethanol, and geraniol.  
3.2. Regioselective and Enatioselective Ester Synthesis 
Chiral compounds constitute a significant part of the fine 
chemical market, and biocatalysis has proven to be a valuable tool 
in the production of enantiomerically pure compounds. Therefore 
one of the main application of lipase lies clearly in the exploitation 
of the outstanding properties of biocatalysts with respect to che-
moselectivity, regioselectivity and, particularly, stereoselectivity for 
the production of enantiomerically pure compounds. 
C. antarctica lipase B is an excellent biocatalyst which provides 
some specific examples of stereoselective biotransformations. In a 
recent paper [57], the use of C. antarctica lipase B in the synthesis 
of monoester of pyridoxine (vitamin B6) was investigated. Pyridox-
ine (PN) is one of the three members of the vitamin B6 group, and 
it is the most important form of commercial vitamin B6, because its 
ester derivatives have broad applications in food industry, cosmet-
ics and medical supplies [58]. Regioselective esterification of pyri-
doxine is a difficult task since the pyridine-ring possesses three 
hydroxyl groups (including one primary -OH and two secondary –
OH) of similar reactivity; as a result, it is very difficult to discrimi-
nate among these three groups from a chemical point of view. Fur-
thermore, the chemical methods leading to such regioselective ana-
logues involve multi-step protection and deprotection procedures 
owing to its multiple hydroxyl groups. So the lipase enzymatic 
reactions were used to provide a helpful option to achieve regioi-
somer of pyridoxine ester. C. antarctica lipase B catalyzed esterifi-
cation of pyridoxine [57] provides not only an effective selection of 
one out of the three hydroxyl groups thus leading to synthesis of 
regioselective monoester.  
Ong and co-workers [59] proposed an alternative enzymatic 
route in the preparation of enantiopure (S)-ketoprofen using CAL-B 
biocatalyst making use of its remarkable properties e. g. regio, ste-
reo, and substrate specificity. Ketoprofen, a non-steroidal anti-
inflammatory drug (NSAID), is still marketed and administered as 
racemic mixture of “R” and “S” enantiomers, which are equivalent 
on an unit weight basis. However, (S)-ketoprofen and (R)-
ketoprofen display significantly different pharmacological activities 
and benefits [60]. The paper investigates [59] the performance of 
free Candida antarctica lipase B (CALB) in a mixed solvent sys-
tem for enantioselective esterification of (R)-ketoprofen, leaving the 
target product (S)-ketoprofen in unreacted form (Fig. 3). The effects 
of enzyme loading, substrate concentration, alcohol to acid molar 
ratio, type of solvents and reaction temperature were studied and, in 
the optimum reaction conditions, a conversion of (R)-ketoprofen of 
81% was obtained. 
3.4. Polyester Synthesis 
Usually, condensation poly-esterifications are performed by es-
ter-interchange reactions or by direct esterification of hydroxyacids 
or diacid/diol combinations [61], using chemical catalysts. These 
reactions need harsh conditions (e.g., temperatures > 200°C) and 
metal catalysts are potentially problematic for certain product end 
uses. Indeed, these reaction conditions can limit product molecular 
weight and prevent the possibility of using building blocks that are 
not stable at such temperature-catalyst conditions. 
The use of enzymes for polymer synthesis allows carrying out 
these reactions in the absence of heavy metals, at lower tempera-
tures, and with increased selectivity. Biocompatibility, biodegrad-
ability, and environmental acceptability of biotechnologically pro-
duced polyesters are desired properties in agricultural and medical 
applications [62]. The discovery that lipases can also catalyze ester 
syntheses and trans-esterification reactions in organic solvent sys-
tems paved the way of enzyme catalyzed synthesis of biodegradable 
polyesters [63-65]. Indeed, lipases as catalysts can boast about (i) a 
promising substrate-conversion efficiencies for non-natural sub-
strates, (ii) high enantio- and regioselectivity, (iii) catalyst recy-
clability.  
Previous studies on lipase-catalyzed poly-esterifications have 
focused on reactions between diols and activated diacids. For ex-
ample, Russell and co-workers [66] showed that by using CALB, 
the solventless co-polymerization of divinyl adipate and 1,4-
butanediol gave the corresponding polyester with an average mo-
lecular weight (Mw) of about 23200. However, activation of diacids 
is expensive and limits the potential technological impact of these 
methods. Important progress has been made in lipase-catalyzed co-
polymerizations of acid and alcohol monomers using nonactivated 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3): Application of Candida Antarctica lipase B in the enantioselective 
esterification of (R,S)-ketoprofen. Taken from [59]. 
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free acids [67-68]. The polymerization of aliphatic diols with 
isopthalic acid was described [69] using CALB as the catalyst. 
Uyama et al. [70] reported that Candida antarctica lipase catalyzed 
condensation reactions between sebacic acid and 1,5-pentanediol in 
bulk to give aliphatic polyesters with Mn of 14 000. Binns et al [67] 
investigated reactions of adipic acid and 1,4-butanediol using 
CALB. The reactions were performed under solvent-free conditions 
and the product obtained was a polyesters with Mw of about 2200. 
Mahapatro and co-workers reported the catalysis of condensation 
polymerizations between adipic acid and 1,8-octanediol by CALB 
[71]. Furthermore they extended the study to different substrates: 
the diols studied include 1,4-butanediol, 1,6-hexanediol, and 1,8-
octanediol (HO-(CH2)nOH, where n ) 4, 6, and 8, respectively), the 
diacids studied include succinic, glutaric, adipic, and sebacic acids 
demonstrating that reactions with longer chain length diacids (seba-
cic and adipic acid) and diols (1,8-octane and 1,6-hexane diol) pro-
vided higher reactivity than systems with shorter chain-length 
diacids (succinic and glutaric) and 1,4-butanediol [72]. 
CALB was applied also for bulk poly-esterifications of linear 
aliphatic hydroxyacids like 6-hydroxyhexanoic acid, 10-
hydroxydecanoic acid, 12-hydroxydodecanoic acid, and l6-
hydroxyhexadecanoic acid [73]. The above references strongly 
established the possibility of performing polymerization reactions 
between diacids and diols in the presence and absence of solvents. 
CONCLUSIONS AND PERSPECTIVES 
In this review we reported an overview on cold adapted es-
terases and lipases from microbial sources, describing some struc-
tural features that justify the unusually high enzymatic activity at 
low temperature of these enzymes. Moreover our attention was 
focused on the different strategies available to discover novel cold-
adapted lipolytic enzymes and on the recent use of cold-adapted 
lipases and esterases in the synthesis of fine chemicals.  
Cold active lipases have proven to be promising enzymes to re-
place the conventional processes of the biotechnological industries. 
Moreover, these enzymes represent an extremely versatile group of 
enzymes that are capable of performing a variety of reactions 
thereby presenting a fascinating field for future research. However, 
several studies are necessary to overcome several bottlenecks con-
cerning the high enzyme cost, its low activity and/or stability in 
some conditions and the low biodiversity of cold-adapted microbes 
explored so far. The development of novel recombinant DNA tech-
nologies such as, site-directed mutagenesis and metagenomics have 
a positive effect on the expression and production of greater 
amounts of recombinant proteins, which means more competitive 
prices, by introducing new or improved catalytic activities of these 
proteins at low temperature. Therefore, several efforts have to be 
made in order to attain economical overproduction of cold active 
lipase and to obtain modified lipase more stable and active.  
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Abstract  
Background 
Protein over-production in Escherichia coli often results in formation of inclusion bodies (IBs). 
Some recent reports have shown that the aggregation into IBs does not necessarily mean 
that the target protein is inactivated and that IBs contain a high proportion of correctly folded 
protein. This proportion is variable depending on the protein itself, the genetic background of 
the producing cells and the expression temperature. In this paper we have evaluated the 
influence of the production process design on an inclusion bodies protein quality. 
Results 
The present paper describes the recombinant production in Escherichia coli of the 
flavohemoglobin from the Antarctic bacterium Pseudoalteromonas haloplanktis  TAC125. 
Flavohemoglobins are multidomain proteins requiring FAD and heme cofactors. The 
production was carried out in several different experimental setups differing in bioreactor 
geometry, oxygen supply and the presence of a nitrosating compound. Inall production 
processes, the recombinant protein accumulates in IBs, from which it was solubilized in non-
denaturing conditions. Comparing structural properties of the solubilized flavohemoglobins, 
i.e. deriving from thedifferent process designs, our data demonstrated that the protein 
preparations differ significantly in the presence of cofactors (heme and FAD) and as far as 
their secondary and tertiary structure content is concerned. 
Conclusions 
Data reported in this paper demonstrate that other production process parameters, besides 
growth temperature, can influence the structure of a recombinant product even if it 
accumulates in IBs. To the best of our knowledge, this is the first reported example in which 
the structural properties of a protein solubilized from inclusion bodies have been correlated to 
the production process design. 
 
Background  
Protein over-production in Escherichia coli (E. coli) often results in formation of inclusion 
bodies (IBs). Aggregation most probably occurs as a consequence of interactions among the 
newly-formed folding intermediates which expose hydrophobic residues at their surface [1]. 
For a long time it was believed that IBs were compact, insoluble aggregates of misfolded 
proteins [2], remaining in the cell as biologically inactive deposits.  
However, some recent reports have shown that the aggregation into IBs does not necessarily 
mean that the target protein is inactivated [3, 4]. Structural data collected from many model 
proteins revealed the presence of significant proportions of native-like secondary structure in 
IBs proteins [5, 6]. Consequently, it is not surprising that the analysis of the biological 
properties of IBs formed by enzymes demonstrated in some cases the occurrence of 
enzymatic activity inside the IBs [3, 7]. These evidences introduced the concept that IBs are 
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composed, at least partially, by functional polypeptides, whose deposition is necessarily 
driven by discrete aggregation determinants, that act irrespective of the global folding state of 
the protein [8]. It has been observed that IBs containing a high proportion of correctly folded 
protein can be easily solubilized under non-denaturing conditions [9] by using mild 
detergents or polar solvents, widely preserving the target protein folding. 
The prevalence and extent of native structure and biological activity of IB proteins is variable 
depending on the protein itself, the genetic background of the producing cells and the 
expression temperature [6, 10]. 
Flavohemoglobins (flavoHbs) have been identified in a number of bacteria and yeasts [11]. 
These proteins are characterized by a modular structure, where a N-terminal hemoglobin 
domain, displaying a classical three-over-three -helical sandwich motif around a single 
heme b [12], is linked to a C-terminal FAD-containing reductase domain which resembles 
ferredoxin reductase [13]. The flavoHbs C-terminal domain binds NAD(P)H and transfers 
electrons to the heme in the globin domain via FAD [14, 15].  
It is generally believed that flavohemoglobins provide protection against NO and related 
reactive nitrogen species although the exact mechanisms of action is still under debate [16, 
17, 18, 19, 20].  
A flavoHb encoding gene (PSHAa2880) was identified by in silico genome analysis of the 
Antarctic Gram-negative marine eubacterium Pseudoalteromonas haloplanktis TAC125 (P. 
haloplanktis TAC125) [22]. In the present paper, the recombinant production of the 
psychrophilic flavoHb (hereinafter called PhflavoHb) in E. coli cells was carried out in several 
different experimental setups in order to identify the best production condition . Indeed, 
previously reported results, on E. coli flavoHb, demonstrated that the heterologous over-
production of flavoHb may lead to host cell damage [29] due to the action of  flavoHb. as a 
potent generator of products of oxygen radical partial reduction (i.e., superoxide and 
peroxide) [27, 28]. Due to the expected toxicity of the recombinant product, flavoHb 
recombinant productions were carried out exploring several expression systems and/or 
microbial cell factories, with different results [29]. Amongst many other examples reported in 
literature, recombinant production of E. coli flavoHb in E. coli was obtained in absence of 
oxygen and in presence of nitrosating compound, an experimental setup in which the hmp 
gene expression is physiologic and the flavoHb activity is required [30]. Starting from the 
above information, in the present work, the recombinant production of the flavoHb from the 
Antarctic Gram-negative bacterium P. haloplanktis TAC125 [22] was performed in E. coli 
cells condition differing in presence of nitrosating compound and in O2 viability. 
All production processes resulted in the accumulation of the recombinant protein in IBs, from 
which it was solubilized in non-denaturing conditions. Comparing structural properties of the 
solubilized PhflavoHbs, i.e. deriving from the different production processes, our data 
demonstrated that the protein preparations differ significantly in the presence of cofactors 
(heme and FAD) and in their secondary and tertiary structure, demonstrating the impact of 
the specific production process design on the quality of inclusion bodies protein. 
 
Results  
Recombinant production of P. haloplanktis TAC125 flavohemoglobin in E. coli cells 
resulted in full deposition of the protein in the inclusion bodies. 
The PSHAa2880 gene was PCR amplified to suitably introduce NdeI and SalI restriction 
sites, and cloned into pET22b vector corresponding sites, thus generating the recombinant 
pET22b-2880 plasmid.  
E. coli BL21(DE3) cells were transformed with the recombinant vector and, keeping in mind 
that proteins coming from psychrophilic micro-organisms are often characterized by a 
moderate to extreme thermal-lability [23], the production of the PhflavoHb was carried out at 
20°C. However, two different production process setups were explored. First, E. coli 
BL21(DE3)(pET22b-2880) recombinant cells were grown in a 7.5 L automatic fermenter, in 
which the recombinant mesophilic cells were grown aerobically at 20°C till the culture density 
reached the value of 0.6 OD at 600 nm. Induction was then performed by IPTG, in the 
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following conditions: i) addition of heme and FAD precursors (i.e. D-aminolevulinic acid, 
FeCl3, and riboflavin); ii) addition of the nitrosating compound sodium nitroprusside (SNP), 
and iii) in microaerophilic conditions (dissolved oxygen tension always below 5% of 
saturation). Microareophilic conditions were achieved by stopping air supply during the next 
16-18 hr of fermentation. The second experimental condition consisted in growing 
recombinant cells in shake flask at 20°C until the culture absorbance at 600 nm reached 0.6 
OD, when the protein production was induced in the same conditions as in automatic 
fermenter but without SNP and in aerobic conditions. 
Then, cells coming from the above production processes were analyzed looking for 
production and soluble/insoluble distribution of the recombinant protein by cell fractionation 
followed by SDS-PAGE analysis. Both production processes resulted in the total deposition 
of recombinant flavohemoglobin as cytosolic inclusion bodies (IBs), that were called flask-
flavoHb IBs and ferm-flavoHb IBs if derived from cells grown in shake flasks or in fermenter, 
respectively.  
Recombinant P. haloplanktis TAC125 flavohemoglobin is solubilized from inclusion 
bodies by non-denaturing solutions.  
Treatment of P. haloplanktis TAC125 flavo-Hb IBs with different non-denaturing solvents 
such as low concentration of mild detergents or polar solvents was applied to the recovery of 
the recombinant protein in solution. Identical aliquots of flask-flavoHb IBs and ferm-flavoHb 
IBs were incubated overnight at 4°C with different non-denaturing solutions (i.e. buffered 
solutions containing 0.2% N-lauroyl sarcosine, or 5% DMSO, or 5% n-propanol, or 0.5% 
Triton X-100, or 1% Na-deoxycholate). Solubilized proteins were then separated from the 
insoluble matter by a centrifugation step and subjected to SDS-PAGE analysis. As shown in 
figure 1, both ferm-flavoHb IBs (panel A) and flask-flavoHb IBs (panel B) are partially 
solubilized in all tested conditions, although the solubilization yields (defined as the 
percentage of solubilized proteins relative to the total amount contained into the IBs sample) 
result to be quite different (Table 1).Percentage of solubilization of IBs in different solvents  
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Figure 1  - Solubilization of flavoHb inclusion bodies produced in automatic fermenter (panel A) 
and shake flask (panel B) 
Same amounts of IBs were re-suspended in 40 mM Tris/HCl, pH 8.0 buffer containing different non denaturing 
agents. Same volumes of solubilized proteins were analysed by SDS-PAGE. Black star indicates that the loaded 
sample corresponds to one tenth of the other samples. 
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 % solubilized protein 
Solubilization solvent ferm-flavoHb 
 
flask-flavoHb 
 5 % di n- propanol in 40 mM Tris/HCl, pH 8.0 6 ± 0.7 5 ± 0.1 
00.5 % Triton X-100 in 40 mM Tris/HCl, pH 8.0 8 ± 0.6 10 ± 0.9 
0.5 % DMSO in 40 mM Tris/HCl, pH 8.0 9 ± 0.9 5 ± 0.4 
0.1 % Na-deoxycholate in  40 mM Tris/HCl, pH 8.0 22 ± 1.5 12 ± 0.3 
0.2 % N-lauroyl sarcosine in  40 mM Tris/HCl, pH 8.0 95 ±1.0 57±0.8 
Table 1 Percentage of solubilization of IBs in different solvents  
 
was calculated using as 100% the protein concentration obtained dissolving IBs in urea 8 M 
and comparing this value with the protein concentration of samples obtained by treatment 
with different solvents. Evaluation of protein concentration was obtained by measuring the 
absorbance at 280 nm (Abs280). Indeed, best recovery in solution was obtained in N-lauroyl 
sarcosine either for ferm-flavoHb IBs or flask-flavoHb IBs (Table 1), but the corresponding 
solubilization yields exceed 95% in case of ferm-flavoHb IBs, while only about fifty percent of 
total proteins contained into IBs from flask culture went in solution. It is worth mentioning that 
in figure 1 the loaded amount of N-lauroyl sarcosine solubilized samples correspond to one 
tenth of the other samples. 
The two solubilized IBs preparations also differ in their respective protein composition. As 
shown in figure 1, flask-flavoHb IBs seems to contain several proteins other than flavoHb 
(panel B), while IBs produced in fermenter contains almost only the psychrophilic 
recombinant protein (panel A). 
Structural comparison of recombinant P. haloplanktis TAC125 ferm- and flask-flavoHb. 
Flavohemoglobins extracted from either flask-flavoHb IBs (flask-flavoHb) or ferm-flavoHb IBs 
(ferm-flavoHb) were subjected to further analyses to investigate the presence of the two 
protein cofactors, i.e. heme and FAD.  
Absorption spectra of heme-containing proteins are characterized by the presence of Soret 
signal, a peak centered at about 413 nm. 
Therefore, UV/VIS absorption spectra of 
each solubilized flavoHb were recorded, 
and their respective spectra regions 
between 380 and 450 nm are shown in 
figure 2. Only the ferm-flavoHb spectrum 
is characterized by the presence of a 
typical Soret signal, centered at about 413 
nm (Figure 2). Then, the presence of the 
FAD cofactor in flask-flavoHb and ferm-
flavoHb proteins was investigated by 
fluorescence measurements. In detail, 
emission spectra between 500 nm and 
600 nm, exciting at 450 nm, were 
recorded and are shown in figure 3. An 
emission signal at 520 nm, which is 
indicative of the presence of the FAD 
cofactor, was only detected in the ferm-
flavoHb fluorescence spectrum (Figure 3). 
To explore the secondary structure of 
flask-flavoHb and ferm-flavoHb proteins,  
flask-flavoHb 
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Figure 2  - Absorption spectra of ferm-flavoHb 
and flask-flavoHb 
Absorption spectra of cold-adapted flavohemoglobin 
extracted from IBs produced in fermenter (ferm-flavoHb) 
and in flask (flask-flavoHb). The spectra were recorded in 
0.2% N-lauroyl sarcosine, 40 mM Tris/HCl pH 8.0, and the 
proteins concentration was 2 µM.  
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Figure 3  - Fluorescence spectra of ferm-flavoHb and flask-flavoHb 
Fluorescence spectra of cold-adapted flavohemoglobin extracted from IBs produced in fermenter (ferm-flavoHb) 
and in flask (flask-flavoHb). The spectra were obtained exciting at 450 nm and recording emission between 500 
nm and 600 nm. The proteins were in 0.2% N- lauroyl sarcosine, 40 mM Tris/HCl pH 8.0, and their concentration 
was 2 µg/µl 
circular dichroism measurements were performed. As shown in figure 4, both proteins 
display secondary structure, although not identical since the two recorded CD spectra are 
clearly not superimposable. The collected CD data were used to calculate the percentage of 
-helix, -sheets and random coil for each protein (by using the software K2d, accessible 
through the site www.embl-heidelberg.de/~andrade/k2d [24, 25]). As shown in table 2, the 
two proteins differ significantly in their secondary structure content, and the ferm-flavoHb 
protein is predicted to have a higher content of either -sheets or -helix. 
 
 
 
 
 
 
 
 
 
 
 
Table 2  - Percentage of calculated secondary structures of ferm- flavoHb and flask-flavoHb  
Percentage of secondary structures was calculated from CD data spectra by K2d software (Merelo, Andrade). 
K2d offer an algorithm for the estimation of the percentages of protein secondary structure from UV circular 
dichroism spectra using a Kohonen neural network  
 
The structural comparison between flask-flavoHb and ferm-flavoHb proteins was then 
extended to the study of fluorescence emission spectra of tryptophan residues (3 Trp 
residues are present in the PhflavoHb sequence). Emission spectra in the range between 
310 nm and 500 nm, exciting at 295 nm, were recorded and are presented in figure 5. Both 
proteins display an emission spectrum λmax close to 338 nm, indicating that Trp residues are 
not solvent exposed. Both protein preparations were fully denatured by addition of 
guanidinium chloride (at a final concentration of 6 M) and the exposure of the tryptophan 
residues to a more polar environment was mirrored by the shift of the emission maximum to 
366 nm (data not shown). Spectra presented in figure 5 differ in the intensity of λmax signal, 
where flask-flavoHb protein has a fluorescence emission at 338 nm about three times higher 
than that of ferm-flavoHb. To investigate if the FAD cofactor, which is present only in ferm-
flavoHb protein, is responsible for the observed quenching of the signal at 338 nm, 
 
 
Estimation of protein secondary 
structure from CD spectra by K2d 
 ferm-flavoHb flask-flavoHb 
-helix 46 % 39 % 
-sheets 23 % 17 % 
random coil 31 % 44 % 
Wavelength (nm) 
flask-flavoHb 
ferm-flavoHb  
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tryptophan fluorescence spectra of flask-flavoHb were recorded in the presence of two molar 
ratio of exogenous FAD. As shown in figure 6, the intensity of λmax signal is not quenched by 
the addition FAD molecule, neither in the presence of the higher 1:1 FAD:protein molar ratio.  
Figure 5  - Tryptophan fluorescence spectra of ferm-flavoHb and flask-flavoHb  
Fluorescence spectra of ferm flavoHb (A) and flask-flavoHb (B) obtained recording an emission spectra between 
200 nm and 500 nm exciting at 295 nm. Fluorescence spectra were recorded in 0. % N lauroyl sarcosine, 40 mM 
Tris/HCl pH 8.0, protein concentration was 2 µg/µl. 
 
Analysis of different parameters influence on inclusion bodies protein  
In order to understand what parameter is relevant in flavohemoglobin production, i. e. if the 
observed differences between flask-flavoHb ferm-flavoHb depend on the SNP presence or 
on oxygen availability, three different production process setups were explored. The 
production of the PhflavoHb was carried out at 20°C in 7.5 L automatic fermenter, in 
microaerophilic conditions without SNP, in aerobic condition with and without SNP (in 
previously described induction conditions). Then, cells coming from the above production 
processes were analyzed and flavohemoglobin resulted to accumulate in inclusion bodies in 
all tested condition. P. haloplanktis TAC125 flavo-Hb  IBs extracted from the different 
production processes were solubilized in presence of 0.2% N-lauroyl sarcosine (Figure 7). As 
shown in Figure 7, the solubilized IBs produced in fermenter contains almost only the 
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Figure 4  - CD analysis of ferm-flavoHb and flask-flavoHb 
CD analysis of ferm-flavoHb (A) and flask-flavoHb (B). The CD spectra were recorded in phosphate buffer 40 
mM pH 8.0 at 25°C, the proteins concentration was 100 ng/µl. In case of ferm-flavoHb secondary structure 
prediction, the program has given a maximum error of 0.080.  The maximum error obtained for flask-flavoHb 
secondary structure prediction is 0.085. This means that the sum of the errors in the prediction of the alpha, 
beta and random percentage values divided by three is expected to be less then 0.085. In both cases the error 
values are below the threshold maximal error 0.227. Maximal errors above this value indicate that the result 
given by the network prediction is not reliable.  
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psychrophilic recombinant protein 
indicating that the different protein 
composition of .solubilized IBs of flavoHb 
and fermHb (Figure 1) was due to the 
(fermentation device) system used to 
grow the cells, i.e flask or bioreactor. The 
analyses aimed to investigate the 
presence of the heme and FAD (data not 
shown) demonstrated that proteins 
obtained in microaerophilic conditions 
without SNP and in aerobic condition with 
and without SNP lack of both cofactors. 
 
Discussion  
Several recent reports have shown that 
IBs could contain proteins that posses a 
native-like secondary structure and an 
enzymatic activity [3, 5, 6, 7]. Moreover, it 
has been reported that IBs containing a 
high proportion of correctly folded protein 
can be easily solubilized under non-
denaturing conditions [9] 
In this paper we report a case in which 
using different process design we obtained always recombinant proteins in IBs easily 
solubilized under non-denaturing conditions t, although their common attitude to be 
solubilzed recombinant proteins derived from the different production prosses differ in 
presence of cofactors and in their secondary and tertiary structure. In detail, we produced a 
flavohemoglobins from the Antarctic Gram-negative bacterium P. haloplanktis TAC125 [22] in 
E.coli cells in fermenter in the presence of a nitrosating compound and in microaerobiosis. In 
parallel, PhflavoHb 
was produced in E. 
coli recombinant cells 
in standard conditions, 
i.e. grown in shake 
flasks by an aerobic 
production scheme 
and in absence of 
SNP. Both processes, 
carried out at 20°C, 
resulted in the 
accumulation of the 
recombinant protein in 
cytoplasmic inclusion 
bodies. The treatment 
of ferm-flavoHb IBs 
and flask-flavoHb IBs 
with a N-lauroyl 
sarcosine solution 
highlighted unexpected differences in i) the solubilization yield, and ii) the composition of the 
solubilized matter. This evidence prompted us to carry out a structural comparison of the two 
recombinant PhflavoHbs, in order to assess if the production setup could influence the main 
structural features of IBs proteins. Data reported in the present paper demonstrate that the 
two proteins differ significantly, mainly in the presence of FAD and heme cofactors. Indeed, 
when subjected to suitable spectroscopic analyses, proofs of the presence of heme  and 
FAD were collected only in the case of ferm-flavoHb. Furthermore, CD spectra demonstrate 
FAD: flask-flavoHb (1:10) 
FAD: flask-flavoHb  (1:1) 
 
Wavelength (nm) 
Figure 6  - Tryptophan fluorescence spectra of 
flask-flavoHb in presence of FAD  
Tryptophan fluorescence spectra of flask-flavoHb  in 
presence of FAD cofactor. FAD was added to flask-flavoHb 
protein at molar ratio of 1:10 and 1:1. Fluorescence 
spectra were recorded in 0.2% N-lauroyl sarcosine, 40 mM 
Tris/HCl pH 8.0, proteins concentration was 2 µg/µl.  
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     47.0 kDa 
     
     36.0 kDa 
 
     26.0 kDa  
 
     20.0 kDa    
Ph-flavoHb 
(44 kDa) 
Figure 7 - FlavoHb inclusion bodies produced in automatic fermenter 
in different conditions 
SDS-PAGE of flavoHb IBs extracted from culture obtained in microaerophilic 
conditions without SNP (1), in aerobic condition with (2)and without SNP(3). IBs 
were-suspended in 0.2% N-lauroyl sarcosine 40 mM Tris/HCl, pH 8.0. 
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that both proteins possess a secondary structure, but the ferm-flavoHb content of alpha-helix 
and beta-sheets is higher than that observed in the protein produced in flask. 
Taking advantage from the presence of three tryptophan residues along the PhflavoHb 
protein sequence, fluorescence emission spectra of tryptophan residues were recorded. Both 
spectra are characterized by a λmax emission signal around 338 nm, a result indicative that 
the Trp residues are not exposed to the solvent. Indeed, in these experimental conditions, 
unfolded proteins usually present a shift of λmax towards 350 nm. As expected, when the 
proteins were chemically denatured by guanidinium chloride a shift of the λmax emission 
signal was observed (new maximum at 366 nm, data not shown). These data are highly 
suggestive that both proteins display a 3D structure, although likely not identical. In fact, 
fluorescence intensity at λmax of flask-flavoHb is about three times higher than that of protein 
produced in fermenter. This different spectroscopic behavior is not justified by the likely 
quenching effect of FAD cofactor associated only to the ferm-flavoHb. Therefore, the 
observed difference in intensity of λmax signal could be due to some amino acids residues 
close to tryptophan residues that work as fluorescence quencher in ferm-flavoHb. These 
results are suggestive of a different chemical surrounding around the tryptophan residues in 
flask-flavoHb and ferm-flavoHb proteins, indicating that the two proteins differ in 3D structure 
too. 
Moreover reported results demonstrated that observed differences between flask-flavoHb 
ferm-flavoHb depend on a synergic effect of SNP presence and microaerophilic 
conditionsindee only in this condition we obtained a flavoHb endowed with FAD and heme 
cofactors 
Lacking a structural/functional characterization of native PhflavoHb, a final assessment on 
the quality of the recombinant proteins produced in this work cannot be formulated. However, 
the presence of FAD and heme cofactors, together with the collected indirect evidences of a 
different secondary and, eventually, tertiary structures, looks very promising of a better 
quality of flavoHb obtained in the presence of a nitrosating compound and in 
microaerobiosis. .  
 
Conclusions  
The present paper describes the recombinant production of a flavohemoglobin, a 
multidomain protein requiring FAD and heme cofactors for its activity. Two significantly 
different production process designs were exploredboth resulting in the full product 
accumulation in IBs. Data reported here demonstrate that other process parameters, besides 
growth temperature, influence the quality of a recombinant product even if it accumulates in 
IBs. To the best of our knowledge, this is the first reported example in which the quality of 
protein solubilized from inclusion bodies has been correlated to the production process 
design.  
 
Methods 
Bacterial strains, plasmid and culture condition 
The E. coli BL21(DE3) (Novagen) strain was routinely used for cloning and expressing recombinant 
gene. Cells were grown in Luria-Bertani (LB) medium at 20°C. When required, Ampicillin (Sigma) was 
added at 100 μg/ml. Plasmid pET-22b (Novagen) was utilized for cloning and expression. Restriction 
and modifying enzymes were obtained from Promega. The oligonucleotides were custom synthesized 
from PRIMM. 
Cloning of the PSHAa2880gene 
The primer pairs for the PSHAa2880 gene (Oligo 2880 fw 5’ 
TTCATATGTTATCTGATAAAACTATTGAAA 3’, Oligo 2880 rv 5’ 
AAGTCGACTTATAGATCTTGATGCGG 3’) were designed on the basis of the P. haloplanktis 
TAC125-genome sequence [31]. Sequences corresponding to the NdeI site and a SalI site were 
introduced in the forward and reverse primers, respectively. The amplifications were performed in a 
mixture containing 80 ng of P. haloplanktis TAC125-genomic DNA as template, 50 pmol of each 
oligonucleotide primer, 1.8 mM MgCl2, 50 mM KCl, 20 mM Tris-HCl pH 8.3, 0.1% gelatine, 200 μM 
dNTP in a final volume of 50 μl. The mixtures were incubated at 95°C for 10 min, then 1.25 units of 
Taq DNA polymerase were added. Twenty cycles of amplification (consisting of 1 min at 95°C, 1.5 min 
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at 60°C and 1 min plus 5sec/cycle at 72°C) were carried out and followed by a cycle in which the 
extension reaction at 72°C was prolonged for 15 min in order to complete DNA synthesis. The 
amplified fragment was cloned and its nucleotide sequence checked to rule out the occurrence of any 
mutation during synthesis. The NdeI-SalI-digested fragment of the PSHAa2880 gene was then 
subcloned into the corresponding sites of the expression vector pET-22b, obtaining the plasmid 
pET22b-2880. The recombinant vector was used to transform E. coli BL21(DE3) cells, that were used 
for the following production processes. All DNA manipulation were performed as  previously described 
[32] 
Shake Flask Culture 
For the over-expression of cold-adapted flavoHb in flask, a single colony of recombinant E. coli 
BL21(DE3) (pET22b-2880) was inoculated in LB medium supplemented with 4 g/L glucose and 
ampicillin (100 μg/ml) and allowed to grow at 20°C, in the rotary shaker, until absorbance at 600 nm 
reached ~0.6 OD. The culture was then induced with 1 mM isopropyl-β-D-thiogalactopyranoside and 
further incubated for another 16-18 h at 20°C in the presence of 50 M of D-aminolevulinic acid,  
FeCl3, 100  riboflavin. After production, the cell culture was aliquoted, centrifuged, and the 
supernatant was discarded. The bacterial pellet was stored for further analysis. 
Laboratory Fermentation  
A proper preinoculum of overnight grown recombinant E. coli BL21(DE3) (pET22b-2880) was diluted 
in 4.5 L of LB medium supplemented with 4 g/L glucose and ampicillin (100 μg/ml) in a 7.5-L Techfors 
S (Infors, HT Switzerland) automatic fermenter. Cells were grown aerobically at 20°C till the culture 
density reached the value of 0.6 OD at 600 nm. Induction was then performed by 1 mM IPTG, in the 
presence of 50 M mM D-aminolevulinic acid,  FeCl3, 100  riboflavin and 0.4 mM sodium 
nitroprusside (SNP). Then, air supply was stopped during the next 16-18 hr of fermentation keeping a 
microaerophilic conditions (dissolved oxygen tension always below 5% of saturation).  
In case of production of the PhflavoHb in aerobic condition with and without SNP the preinoculum of 
overnight grown recombinant E. coli BL21(DE3) (pET22b-2880) was diluted in 2.5 L of medium and 
dissolved oxygen tension was maintained always above 30% of saturation. 
After production, the cell culture was collected, centrifuged, and the supernatant was discarded. The 
bacterial pellet was stored for further analysis. 
Protein inclusion bodies extraction  
Biomass was harvested at the end of the production process by centrifugation, and the wet bacterial 
pellet was resuspended in 10 mM Tris/HCl, pH 8.0. Samples were kept on ice and disrupted by 
sonication using an Branson sonicator (Model B-15), using a program consisting of 20 cycles (30’’ on, 
60’’ off, intensity 4.5). After disruption of the cells, samples were centrifuged at 5000 rpm for 30 min at 
a constant temperature of 4°C. The supernatant was discarded, and the inclusion bodies fraction was 
washed twice with chilled water, divided in several aliquots and incubated overnight for the 
solubilization at 4°C in 40 mM Tris/HCl, pH 8.0 buffer containing alternatively: 
• 5% di n-propanol; 
• 0.5% Triton X-100  
• 5% DMSO 
• 1% Na-deoxycholate.; 
• 0.2% N-lauroyl sarcosine 
As negative control the insoluble matter was treated with water. After the incubation, the suspensions 
were centrifuged at 4400xg for 15 minutes at 4°C. The supernatants were analyzed by SDS-PAGE.  
Protein concentration measurements 
The Bradford method [33] was applied to determine protein concentration. In case of protein 
solubilized from IBs with different solvents a qualitative measure of protein content was determined by 
measuring the amount of light absorbed at 280 nm (Abs280).  
Spectroscopic Measurements 
UV–Vis absorption spectra were recorded in UNIKON 930spectrophotometer. Fluorescence 
measurements were carried out in a PERKIN ELMER LS 50B fluorospectrometer . Circular dichroism 
(CD) spectra were obtained in a Jasco spectropolarimeter (model J-715) equipped with a 
thermostatically controlled cell holder.  
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Abstract 
The 2-on-2, previously named truncated haemoglobins, are monomeric low molecular weight oxygen-
binding proteins that share the overall topology with vertebrate haemoglobins. Although several 
studies on 2-on-2 haemoglobins have been reported, their physiological and biochemical functions are 
not yet well defined, and various roles other than binding oxygen have been suggested. Three genes 
encoding 2-on-2 haemoglobins have been identified in Pseudoalteromonas haloplanktis TAC125 
(PhTAC125), a psychrophilic Antarctic marine bacterium, raising the question whether their function 
is related to its ability to cope with the high oxygen concentration in cold sea water. To investigate the 
function played by one of the three trHbs, PhHbO, a PhTAC125 genomic mutant strain was 
constructed, in which the PSHAa0030 gene was knocked out. The mutant strain was grown under 
controlled conditions and several aspects of bacterium physiology were compared with those of wild-
type cells when dissolved oxygen tension and growth temperature were changed. In details, we 
compared their respective growth behaviour, the transcription of same genes (the three 2-on-2 
haemoglobins genes and of a gene encoding a flavohaemoglobin) and sensitivity to H2O2 and 
nitosating agents. Data presented in this paper point towards the involvement of PhHbO in oxidative-
and nitrosative-stress resistance, a key aspect of the molecular adaptation of Ph TAC125 to the 
Antarctic marine environment. 
 
Key words: Pseudoalteromonas haloplanktis TAC125; cold-adapted bacterium; 2-on-2 haemoglobin; 
oxydative and nitrosative stress; peroxidase  
 
Introduction  
Life at low temperature imposes a wide array of challenges to marine bacteria. One of them is related 
to the increase of gas solubility in cold water. Indeed, at low temperatures the enhanced oxygen 
solubility significantly increases the production rate of toxic reactive O2 species (ROS). From the 
genome analysis of Colwellia psychroerythraea [19] and Desulfotalea psychrophila [29], a common 
strategy to face this environmental challenge can be envisaged, consisting in developing enhanced 
antioxidant capacity owing to multiple genes that encode catalases and superoxide dismutases. By 
contrast, in silico analysis of the Pseudoalteromonas haloplanktis TAC125 (PhTAC125) genome 
suggests that this Antarctic marine bacterium may cope with increased oxygen solubility by 
multiplying O2-scavenging enzymes (such as dioxygenases) and deleting entire metabolic pathways 
which generate ROS as side products. The remarkable deletion of the ubiquitous molybdopterin-
dependent metabolisms in the PhTAC125 genome [18] can be regarded in this perspective. 
Furthermore, the micro-organism is remarkably resistant to H2O2 [18], and this ability was correlated 
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in silico to the presence of several enzymes involved in scavenging chemical groups affected by ROS 
(such as peroxiredoxins and peroxidases), and to the presence of one catalase-encoding gene (katB) 
and a possible paralog (PSHAa1737) [18]. 
In this context, our interest was focused on oxygen-binding proteins involved in oxygen scavenging 
and/or transport, eventually contributing to PhTAC125 adaptation to high oxygen concentration in 
cold sea water. 
Bacteria may produce three types of haemoglobins (Hbs), namely 2-on-2 or truncated Hbs (trHbs), 
monomeric Hbs and flavohaemoglobins (flavoHbs). 2-on-2 haemoglobins are monomeric low-
molecular weight oxygen-binding haemoproteins and their fold is based on a “2 on 2” α-helical 
sandwich [35]. Three main trHb groups have been identified based on sequence clustering, i.e. group I 
(also named HbN), group II (also named HbO) and group III (also named HbP) [33, 34, 35]. All these 
trHbs are able to bind diatomic ligands such as O2, CO, and NO, with different affinities [20]  The 
high oxygen affinity displayed by most trHbs makes their role as O2 transporters very unlikely [21, 35] 
Several other functions have been proposed, e.g. trHbs have been suggested to be involved in the 
response to oxidative and nitrosative stresses [5, 7] or to function as oxygen sensors [35]. 
The PhTAC125 genome contains three genes encoding trHbs and one that codes for a flavoHb [9]. 
The presence of several 2-on-2 haemoglobins encoding genes raises the question whether their 
function can be related to Ph TAC125 ability to cope with the high oxygen concentration of cold sea 
water. This hypothesis and the availability of several genetic tools [25] suitably developed for 
PhTAC125 prompted us to use this organism to investigate the functional role of 2-on-2 Hbs in 
Antarctic cell physiology. Indeed some microorganisms with interesting truncated globins (i.e. 
Mycobacterium tuberculosis, Nostoc commune, Chlamydomonas eugamentos and Paramecium 
caudatum) are not readily amenable to genetic manipulation; as a consequence, the experimental 
demonstrations of proposed physiological hypothesis are limited [28]. We have recently reported the 
recombinant production and purification of PhHbO [9], one of the three PhTAC125 trHbs. To 
investigate its physiological role, a genomic mutant strain was constructed, in which the PhHbO 
encoding gene (PSHAa0030) was inactivated by insertional mutagenesis. The mutant strain was 
grown under controlled conditions and its growth behaviour was compared with that of wild-type 
cells, when dissolved oxygen tension (DOT) and growth temperature changed. This approach allowed 
proposing a likely role of PhHbO in the adaptation of PhTAC125 to the Antarctic marine 
environment. 
 
Material and Methods 
Bacterial strains and growth conditions. PhTAC125 [18] was isolated from Antarctic sea water. 
Escherichia coli DH5α [11] was used as host for gene cloning and was routinely grown in Luria-
Bertani broth [30] at 37°C with the appropriate antibiotic selection.  
PhTAC125 was grown in minimal medium [23] supplemented with 0.5% yeast extract and 0.2% 
galactose. 100 µg/ml ampicillin, 50 µg/ml chloramphenicol were added to liquid cultures when 
transformed. Antarctic bacterium was made recombinant by intergeneric conjugation as previously 
reported [25]. Batch cultivations were performed in a computer-controlled bioreactor (Sixfors 
Systhem, Infors) equipped with control units (pH, DOT, temperature, rpm) at 4°C and 15°C. pH was 
maintained at 7.0±0.05 by the addition of 1% H2SO4 or 5% NH4OH. Under extreme aerobiosis 
condition, DOT was maintained always above 80% by modifying stirring speed and aeration rate. In 
microaerobiosis (DOT always below 5% saturation) air supply was stopped after inoculum. For each 
strain, the growth kinetics were followed in triplicate in at least two independent experiments.  
Construction of plasmids. Standard methods were employed for DNA manipulation and isolation, 
amplification by PCR, and DNA sequencing [2, 30]. Restriction enzymes, T4 DNA ligase, alkaline 
phosphatase, T4 polynucleotide kinase Klenow fragment, Taq DNA polymerase were supplied from 
Boehringer-Roche, Amersham-Pharmacia Biotech, Promega, and New England Biolabs. DNA 
fragment purification was carried out with the QUIAEX II kit from Qiagen GmbH. The amplified 
fragments were cloned and checked by nucleotide sequencing to rule out the occurrence of mutations 
during synthesis.  
Vector pVS0030 and PhTAC125-30 mutant construction. The reaction of PCR [30] was employed 
to amplify a DNA fragment of PSHAa0030 gene. PhTAC125 genomic DNA was used as PCR 
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template and two primers were designed to amplify a 241bp-long region of the PHSAa0030 gene and 
to introduce two SphI sites (Oligo S0030fw 5’-TTGCATGCATACTAGGTGGAGAAGC-3’ and 
Oligo S0030rv 5’-AAGCATGCGCGCAAGTCTTGATC-3’). The amplified DNA fragment was 
digested by SphI, and inserted into the pVS plasmid [24] corresponding site. The pVS0030 vector was 
mobilized by intergeneric conjugation into PhTAC125 cells and insertion mutants were screened on 
plates at 4°C containing carbenicillin (30µg/ml) as selection agent. 
Construction of vector pUC0030. pUC0030 was constructed starting from pUCC vector, a plasmid 
deriving from the pUCLOriT/R plasmid [32], containing the T/R box, the transcription termination 
signal from the PhTAC125 aspC gene and the chloramphenicol-resistance gene. The nucleotide region 
including the PSHAa0030 gene and its upstream region was amplified to introduce HindIII and 
BamHI restriction sites using oligo 0030 fw (5’-TTAAGCTTTAGCTCCCTTACCGCC-3’) and oligo 
0030 rv (5’-AAGGATCCGTGCCAGCTTTAAGGC-3’). The PCR product was subjected to double 
HindIII and BamHI digestion, purified, and inserted into pUCC vector corresponding sites. 
RNA preparation and RT-PCR. Total RNA was isolated (RNeasy Mini kit, Qiagen) from 500 µl 
aliquots of PhTAC125-30 mutant and PhTAC125 wildtype cell cultures withdrawn at different growth 
times at 4°C, 15°C, microaerobiosis and extreme aerobiosis, and subjected to in-column DNase 
treatment (Rnase-Free Dnase Set, Qiagen). Reverse-transcription (RT) reactions using SuperScript II 
RNase H- Reverse Transcriptase (Invitrogen) were performed using 100 pmol of specific primers. In 
detail, reverse transcriptase analyses were performed on approximately 5 µg of purified RNA using 
PHSAa0030 specific primers 0030Sfw (5’-TTGCATGCATACTAGGTGGAGAAGC-3’) and 
0030Xrv (5’-AAGCATGCGCGCAAGTCTTGATC-3’), PhTAC125 PHSAa0458 specific primers 
0458Erv (5’-CTTTGCTCGAGCATAGCATTAATTAG-3’) and 0458Sfw (5’-
AATGGGCATGCCGGCATAGAAAAAC-3’), PSHAa2880 specific primers 2880Srv (5’-
GAGTATTTTCGCAAGCATGCAAATAC-3’) and 2880Efw (5’-
ATTTTGCTCGAGCACTACCCAATTG-3’), PSHAa2217 specific primers 2217Srv (5’-
GCTTTTTGCATGCATAATAGCCAAGC-3’) and 2217Efw (5’-
TACCCAGCTCGAGGATGCATTTTATG-3’). PCR amplifications were performed using 2 µl of RT 
reaction sample as a template, Taq DNA polymerase (Promega) and specific target primer pairs. An 
additional PCR reaction on DNA-free total RNA was performed as negative control. 
Disk diffusion assays. The sensitivity of the PhTAC125-0030 mutant and PhTAC125 wild-type cells 
to 100 mM GSNO, 100 mM SNP, 256 mM H2O2, and 100 mM spermidine NONOate was assayed at 
15°C in a plate diffusion assay [3].  
Peroxidase assay. E. coli BL21(DE3) containing the plasmid pET-HbO was grown in LB medium 
supplemented with kanamycin (50 µg/ml) and PhHbO production and purification was carried out as 
previously described [9]. 
The peroxidase activity of the purified protein was assaed by UV–VIS spectrophotometry (UNIKON 
930) using ABTS (2,2‘-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) and H2O2 as substrates. The 
concentration of PhHbO in the reaction was estimated by the method of Bradford. Formation of the 
ABTS cation radical was followed at 415 nm, using ε 415 nm = 36 mM–1 cm–1. The pH values were 
5.0, 7.0, and 8.0. using 100 mM citrate–phosphate (pH 3.0–7.0) and 100 mM Tris–HCl (pH 8.0–10.0). 
Assays were performed at 25 °C, 15°C and 4°C in a 1-cm cell in the presence of 20 mM ABTS and 5 
mM H2O2. The specific activity was measured as the mean value of triplicate samples. 
 
Results 
Construction of the PhTAC125-30 mutant by insertional mutagenesis and growth of mutant 
cells under controlled conditions. 
To assess the function of PhHbO, a PhTAC125 mutant strain (hereafter called PhTAC125-30 mutant) 
was constructed, in which the PSHAa0030 gene was knocked-out. A PCR-amplified PSHAa0030 gene 
fragment was cloned into the pVS suicide vector optimized for PhTAC125 insertional mutagenesis 
[24]. The resulting vector, pVS0030, was mobilized in PhTAC125 cells and insertion mutants were 
screened on plates containing carbenicillin as selection agent. Occurrence of the genome insertion was 
demonstrated by PCR analysis (data not shown) carried out on genomic DNA from a selected clone.  
The growth profiles of the PhTAC125-30 mutant and wild-type cells were recorded at 4°C and 15°C, 
and under two oxygenation conditions, i.e. in microaerobiosis where DOT was constantly kept below 
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5% saturation (DOT< 5%), and in “extreme” aerobiosis, where DOT was kept above 80% saturation 
(DOT> 80%).  
As shown in Fig. 1 and Table 1, regardless of temperature, growth of the PhTAC125-30 mutant in 
extreme aerobiosis is lower than that of wild-type cells, both in terms of biomass production and 
specific growth rate. 
 
 
Table 1. Main growth parameters of PhTAC125 wild-type and mutant cells calculated from the growth kinetics displayed in 
Fig.1 Each growth kinetic was carried out in triplicate and at least in two independent experiments 
. 
These results indicate that the presence of PhHbO protein in wild-type cells is a clear advantage when 
cells are grown at high concentration of oxygen. In microaerobiosis, both strains were slowed down in 
their replication kinetics. At the lower temperature (4°C), wild-type cells resulted better suited to the 
challenging conditions, reaching higher biomass production with respect to the mutant cells. In 
contrast, when grown at 15°C, PhTAC125-30 mutant cells grow better, reaching higher biomass yield 
(Fig. 1, Table 1). To investigate on this contradictory behaviour, a transcriptional analysis of the three 
trHbs and flavoHb encoding genes was performed. 
 
Transcriptional analysis of genes encoding 2-on-2 Hbs and flavoHb in PhTAC125-30 mutant 
and wild-type cells. 
Samples were withdrawn at different times during growth of PhTAC125-30 mutant and wild type cells 
at 4°C and 15°C, in microaerobiosis and extreme aerobiosis. Total RNA was extracted and subjected 
to RT-PCR analysis. Besides the determining of PSHAa0030 gene expression profile, transcription 
analysis of the PSHAa0458 and PSHAa2217 genes encoding the other 2-on-2 Hbs present in 
PhTAC125 genome, and of the flavoHb encoding gene PSHAa2880 was performed (Table 2). As 
expected, the PSHAa0030 gene was not transcribed in the mutant strain confirming its knock-out. In 
PhTAC125 wild-type cells, the PHSAa0030 gene was always expressed. PSHAa0458 and 
PSHAa2217 encoding the other 2-on-2 Hbs were expressed in both strains under all condition, 
whereas transcription of the flavoHb-encoding gene was detected only in mutant cells grown at 4°C in 
microaerobiosis, starting from the late exponential phase (i.e. 65h of incubation, data not shown).  
 
 
Table 2. Transcriptional analysis of genes encoding 2-on-2 Hbs and flavoHb in PhTAC125-30 mutant and wild-type cells. +, 
a specific product was obtained by RT-PCR experiment; -, no specific product was obtained +a, a specific RT-PCR product 
was obtained only in the samples withdrawn after 65 hrs of growth. Each experiment was carried out in triplicate 
 
 
 
 
 Extreme aerobiosis Microaerobiosis 
4°C 15°C 4°C 15°C 
Wild type Mutant Wild type Mutant Wild type Mutant Wild type Mutant 
µmax 0.11±0.01 0.07±0.01 0.37±0.02 0.29±0.01 - - - - 
OD600 max 4.3±0.3 3.5±0.2 7.2±0.3 5.4±0.3 1.25±0.01 1.01±0.01 0.38±0.03 0.6±0.03 
 
Extreme aerobiosis Microaerobiosis 
4°C 15°C 4°C 15°C 
Wild type Mutant Wild type Mutant Wild type Mutant Wild type Mutant 
PSHAa0030 + - + - + - + - 
PSHAa0458 + + + + + + + + 
PSHAa2217 + + + + + + + + 
PSHAa2880 - - - - - +a - - 
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Fig. 1. Growth kinetics of PhTAC125 wild type (■) and PhTAC125-30 mutant (○) at two temperatures and two oxygenation 
conditions, extreme aerobiosis (DOT>80%) and microaerobiosis (DOT<5%). Standard errors were calculated on kinetics 
carried out in triplicate and in at least two independent experiments 
 
Resistance to hydrogen peroxide and protection from sperimidine NONOate. 
To further explore the phenotypes conferred by the globin-gene mutation, Ph TAC125-30 mutant and 
wild type cells were exposed to a number of stressing reagents and their sensitivity was measured by 
disk-diffusion assay. The reagents were: H2O2 (265 mM), spermidine NONOate (100 mM), GSNO 
(100 mM) and SNP (100 mM). 
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Upon of treatment with GSNO or SNP, no significant differences in radial cell growth (P>0.05) were 
recorded (data not shown). In contrast (Table 3), the mutant strain appears sensitive to H2O2 and 
spermidine NONOate, displaying a significantly greater zone of killing when compared to wild-type 
growth (Fig. 2); in both cases this difference was significant (P<0.02). 
 
H2O2
PhT
AC1
25(pU
CC)
PhT
AC1
25-3
0(pU
CC)
PhT
AC1
25-3
0(pU
CC-
0030
)
Spermidine 
NONOate
 
 
Fig. 2. Disk diffusion assay in the presence of H2O2 (265 mM) and spermidine NONOate (100 mM). PhTAC125-
30(pUC0030): PhTAC125-30 mutant cells transformed with pUC0030: PhTAC125-30(pUCC), PhTAC125-30 mutant cells 
transformed with pUCC vector; PhTAC125 wild type cells transformed with pUCC vector 
 
To rule out the possibility that the observed sensitivity of the PhTAC125-30 mutant is due to a polar 
effect on the expression of PSHAa0030 neighbouring genes, the complementing plasmid, pUC0030, 
was constructed to restore the PhHbO function in Ph TAC125-30 mutant cells. This plasmid contains 
the PSHAa0030 gene and its upstream region (237 bp long), in which the presence of a putative 
promoter sequence was predicted by SoftBerry BPROM - Prediction of bacterial promoters software 
(http://softberry.com/berry). As shown in Table 3 and Fig. 2, the complemented strain PhTAC125-
30(pUC0030) was much less sensitive to H2O2 and spermidine NONOate, since it displayed a zone of 
killing comparable with that of the wild type. These results demonstrate restoring of wild-type 
phenotype in the complemented cells.  
 
 
Table 3. Sensitivity of PhTAC125 wild type and PhTAC125-30 mutant cells to H2O2 and spermidine NONOate. Values are 
expressed as mean diameter of the zone of killing ± SEM obtained from five independent experiments. The t-test, assuming 
equal variance (two tail), was used to analyse the significance of data and for all data resulted to be P<0.02. 
 
 Diameter of disk inhibition zone (cm) 
 
PhTAC125-
30(pUCC) 
PhTAC125-
30(pUC0030) 
PhTAC125(pUCC) 
Stress inducer    
H2O2 (265 mM) 0.82±0.13 0.31±0.08 0.26±0.05 
Spermidine NONOato  
(100 mM) 
0.84±0.15 0.59±0.16 0.56±0.11 
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Peroxidase activity of PhHbO. 
The peroxidase activity of PhHbO was assessed in the purified protein PhHbO and as shown in table 4 
the protein clearly displayed peroxidase activity at all assayed temperatures with an optimum at 4°c 
and pH 7 (Table 4). Regardless the assay pH, PhHbO peroxidase activity is reduced at higher 
temperature. 
 
 
 
 
 
Table 4. Peroxidase activity of purified PhHbO. Peroxidase activity values were reported as specific activities (IU/mg of 
purified protein). The specific activity was determined in each case as the mean value of triplicate samples. 
 
Discussion  
Amongst psychrophilic bacteria whose genome has been sequenced so far, Ph TAC125 is the only one 
having three distinct genes encoding 2-on-2 Hbs. The unusually high number of trHbs is highly 
suggestive that these proteins are bound to important physiological roles, which may be related to the 
extreme features of the Antarctic enviroment.  
The physiological role fulfilled by one of them, PhHbO, was investigated by a multidisciplinary 
approach, taking advantage of the availability of genetic tools suitably evolved for this Antarctic 
bacterium [25] combined with the possibility to study the purified protein [9].  
PhTAC125 is able to thrive in pelagic form, where cells experience high concentration of oxygen and 
other gases which characterizes cold waters. However, cells tend to concentrate at the air-water 
interface, forming a dense biofilm effective in scavenging organic particles that concentrate in the 
wave foam [18]. Due to the high cell density in the biofilm and the intense metabolic activity 
occurring within the latter, it is likely that oxygen concentration in the biofilm approaches the values 
of microaerobiosis experiments.  
The observed capability of PhTAC125 to reach very high growth yields, when provided with 
sufficient amounts of nutrients and aeration, indicates that respiration must be particularly efficient in 
this bacterium [18]. The bacterium is also able to grow in anaerobiosis, although with lower yields 
[18]. Therefore, it was expected to observe lower duplication speed and poor bacterial growth when 
PhTAC125 was cultivated in microaerobiosis, especially at the higher temperature (15°C), due to the 
lower oxygen solubility with respect to that at 4°C. Surprisingly, the growth profiles of the 
PhTAC125-30 mutant and the wild type cells showed a contradictory trend. At 4°C, the wild type 
reached higher cell density whereas at 15°C the mutant cells showed higher growth yield. To find out 
the reasons of this contradictory behaviour, a transcriptional analysis of the three trHbs and flavoHb 
encoding genes was carried out. 
The transcription of the flavoHb encoding gene (PSHAa2880) was observed only in PhTAC125-30 
mutant when grown at 4°C in microaerobiosis. Since the transcription of flavoHb encoding genes is 
usually directly or indirectly induced by NO [12, 17, 31], the observed flavoHb-gene expression is 
suggestive of the occurrence of an NO-induced stress possibly related to the PhHbO absence. As for 
the NO origin, non-enzymatic production should be excluded because it is reported to occur only in a 
nitrite-containing medium at acidic pH [7], whereas in our experimental setups the medium pH was 
always kept around the value of 7.0 (±0.05). Under anaerobic conditions, in E. coli and other bacteria, 
NO is endogenously produced by nitrite reductase [4, 14]. PhTAC125 genome contains a gene 
encoding a nitrite reductase (PSHAa1477), and therefore endogenous production of NO is likely to 
occur in microaerobiosis. As for NO accumulation, it can be spontaneously oxidized if enough amount 
of oxygen is present in solution. In microaerobiosis, oxygen availability is further reduced when the 
biomass is increased, i.e. in the late exponential phase, and NO accumulation may become a real threat 
for cell viability. Induction of flavoHb gene may be viewed as a suitable strategy aimed at 
counteracting the NO-induced stress made worse by enhanced NO solubility at low temperature and in 
the absence of PhHbO.  
 pH 5.0 pH 7.0 pH 8.0 
4°C 3,0±0,9 11,3±0,9 8,6±0,5 
15°C 2,0±0,2 9,8±0,6 9,8±0,5 
25°C 2,1±0,2 5,9±0,2 2,6±0,1 
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PhHbO plays a role in the cellular protection against NO-induced stress, as shown by the higher 
sensitivity of the PhTAC125-30 mutant then the wild type when exposed to an NO releaser, such as 
spermidine NONOate.  
The other nitrosating agents tested in the disk diffusion assay (SNP and GSNO) do not affect mutant 
cell viability. Looking at their respective mechanism of action, SNP is able to release NO only after 
nitrosation, while GSNO can act as a transnitrosating agent. In contrast, spermidine NONOate directly 
release NO with a specified half-life and is often used to study the effect of NO per se [28]. The 
observed sensitivity of Ph TAC125-30 mutant cells only to sperimidine NONOate indicates that the 
PhHbO action is related to the presence of NO per se.  
The data do not allow to define the mechanism of action, i.e. whether the protein alleviates the NO-
induced stress by simply trapping NO or whether it is able to perform enzymatic NO scavenging. In 
this respect, a recent paper on Mycobacterium tuberculosis HbN highlighted the importance of the 
Pre-A region in its O2-dependent NO dioxygenase activity [16]. PhHbO is characterised by the 
presence of an extra N-terminal sequence (20 residues long) as compared with other HbO’s. Although 
its sequence does not display any homology to M. tuberculosis HbN Pre-A motif, it would be 
interesting to correlate the presence of this N-terminal sequence with the PhHbO ability to relieve 
spermidine NONOate-induced toxicity in Ph TAC125-30 mutant cells. Further work is required to 
clarify this aspect. 
In extreme aerobiosis, the mutant growth profile is worse than that of the wild type, suggesting 
requirement of PhHbO during all growth phases. This observation indicates that PhHbO may be 
involved in protection against the stress likely induced by high oxygen concentration, and therefore its 
function is always necessary during growth. This hypothesis is supported by the disk diffusion assays, 
which correlates the sensitivity to H2O2 of PhTAC125-30 mutant to its specific genome mutation, 
since the complemented strain (PhTAC125-30(pUC0030)) displays a H2O2 sensitivity similar to that 
exhibited by the wild type. The above results suggest that PhHbO may be endowed of peroxidase 
activity. In vitro assays on purified PhHbO demonstrated that the protein has a peroxidase activity that 
is higher at under likely physiological condition i.e. the lower tested temperature (4°C). Peroxidase 
activity has been previously reported for some tetrameric Hbs, such as human and bovine Hb [10], 
monomeric Hbs [15], and trHbs [1, 21]. According to replacement studies on M. tuberculosis HbO, the 
ability of 2-on-2 Hbs to act as peroxidases was related to electron-rich, potentially oxidizable, Tyr 
(B10), Trp (G8) and Tyr (CD1) [21] in the vicinity of the haem. These residues take a 3D 
conformation, which allows electron transfer from an exogenous molecule to H2O2. The alignment of 
the PhHbO sequence with that of two other HbO’s known to display peroxidase activity, i.e. M. 
tuberculosis, MtHbO, and M. leprae, MlHbO [1, 21], highlights the presence of these three residues 
TyrCD1, TyrB10 and TrpG8 involved in the peroxidase activity (Fig. 3A). Preliminary results of 
molecular modelling and molecular dynamic simulation on PhHbO (Estrin. and Boechi, unpublished 
results) suggest that the spatial organization is compatible with their involvement in the observed 
PhHbO peroxidase activity (Fig. 3B). The results herewith reported are in agreement with previous 
data [1, 6, 21], which suggest that the active site of group II trHbs is probably not designed to perform 
gaseous ligand exchange, but rather to carry out a redox process involving oxygen or perhaps H2O2. 
The results illustrated in this paper provide the first insight into the function played by PhHbO in 
PhTAC125. The involvement of PhHbO in the cellular response to NO-induced stress was 
demonstrated, although further biochemical and physiological studies are needed to clarify the 
underlying molecular mechanism, especially in relation to the presence of a canonical flavoHb in the 
psychrophilic cells. The observation that PhHbO displays a strong peroxidase activity suggest its role 
in conferring remarkable resistance to H2O2 to Ph TAC125, widening our understanding of the 
possible strategies adopted by psychrophilic marine bacteria to cope with the challenges imposed by 
their environment.  
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Fig. 3. Structural determinants of PhHbO peroxidase activity. Panel A, amino acid sequence alignments of Mycobacterium 
tuberculosis HbO (Mt-HbO), Mycobacterium leprae HbO (Ml-HbO), and PhHbO. Conserved residues in position B10, CD1, 
and G8 are reported in bold. Panel B, spatial organization of PhHbO protein residues B10, CD1, and G8 in the surrounding 
of heme cofactor (light grey) as derived from molecular modelling and molecular dynamic simulation (courtesy of Boechi L 
and Estrin D.) 
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